[[0.266253,{"lines":{"0":[["                                                                                                                                                      ",{}]],"1":[["                                                                                                                                                      ",{}]],"2":[["                                                                                                                                                      ",{}]],"3":[["                                                                                                                                                      ",{}]],"4":[["                                                                                                                                                      ",{}]],"5":[["                                                                                                                                                      ",{}]],"6":[["                                                                                                                                                      ",{}]],"7":[["                                                                                                                                                      ",{}]],"8":[["                                                                                                                                                      ",{}]],"9":[["                                                                                                                                                      ",{}]],"10":[["                                                                                                                                                      ",{}]],"11":[["                                                                                                                                                      ",{}]],"12":[["                                                                                                                                                      ",{}]],"13":[["                                                                                                                                                      ",{}]],"14":[["                                                                                                                                                      ",{}]],"15":[["                                                                                                                                                      ",{}]],"16":[["                                                                                                                                                      ",{}]],"17":[["                                                                                                                                                      ",{}]],"18":[["                                                                                                                                                      ",{}]],"19":[["                                                                                                                                                      ",{}]],"20":[["                                                                                                                                                      ",{}]],"21":[["                                                                                                                                                      ",{}]],"22":[["                                                                                                                                                      ",{}]],"23":[["                                                                                                                                                      ",{}]],"24":[["                                                                                                                                                      ",{}]],"25":[["                                                                                                                                                      ",{}]],"26":[["                                                                                                                                                      ",{}]],"27":[["                                                                                                                                                      ",{}]],"28":[["                                                                                                                                                      ",{}]],"29":[["                                                                                                                                                      ",{}]],"30":[["                                                                                                                                                      ",{}]],"31":[["                                                                                                                                                      ",{}]],"32":[["                                                                                                                                                      ",{}]],"33":[["                                                                                                                                                      ",{}]],"34":[["                                                                                                                                                      ",{}]],"35":[["                                                                                                                                                      ",{}]],"36":[["                                                                                                                                                      ",{}]],"37":[["                                                                                                                                                      ",{}]],"38":[["                                                                                                                                                      ",{}]],"39":[["                                                                                                                                                      ",{}]],"40":[["                                                                                                                                                      ",{}]],"41":[["                                                                                                                                                      ",{}]],"42":[["                                                                                                                                                      ",{}]],"43":[["                                                                                                                                                      ",{}]],"44":[["                                                                                                                                                      ",{}]],"45":[["                                                                                                                                                      ",{}]],"46":[["                                                                                                                                                      ",{}]],"47":[["                                                                                                                                                      ",{}]],"48":[["                                                                                                                                                      ",{}]],"49":[["                                                                                                                                                      ",{}]]},"cursor":{"x":0,"y":0,"visible":true}}],[0.035126,{"lines":{"0":[["vstuart:$                                                                                                                                             ",{}]]},"cursor":{"x":10}}],[1.923862,{"lines":{"0":[["vstuart:$ .                                                                                                                                           ",{}]]},"cursor":{"x":11}}],[0.207944,{"lines":{"0":[["vstuart:$ ./                                                                                                                                          ",{}]]},"cursor":{"x":12}}],[1.193261,{"lines":{"0":[["vstuart:$ ./X                                                                                                                                         ",{}]]},"cursor":{"x":13}}],[0.304003,{"lines":{"0":[["vstuart:$ ./XS                                                                                                                                        ",{}]]},"cursor":{"x":14}}],[0.40501,{"lines":{"0":[["vstuart:$ ./XSLT_script                                                                                                                               ",{}]]},"cursor":{"x":23}}],[1.491826,{"lines":{"0":[["vstuart:$ ./XSLT_script.                                                                                                                              ",{}]]},"cursor":{"x":24}}],[0.184148,{"lines":{"0":[["vstuart:$ ./XSLT_script.sh                                                                                                                            ",{}]]},"cursor":{"x":27}}],[0.477965,{"cursor":{"x":0,"y":1}}],[0.029142,{"lines":{"0":[["                                                                                                                                                      ",{}]]},"cursor":{"y":0}}],[0.028063,{"lines":{"2":[["Press <Enter> key to continue ...",{"fg":1}],["                                                                                                                     ",{}]]},"cursor":{"x":33,"y":2}}],[1.766596,{"lines":{"4":[["date",{"fg":0}],["                                                                                                                                                  ",{}]]},"cursor":{"x":0,"y":5}}],[0.001384,{"lines":{"5":[["Wed Mar  4 14:27:35 PST 2015",{"fg":0}],["                                                                                                                          ",{}]],"7":[["pwd",{"fg":0}],["                                                                                                                                                   ",{}]],"8":[["/home/vstuart/RecordTerm_test",{"fg":0}],["                                                                                                                         ",{}]],"10":[["Press <Enter> key to continue ...",{"fg":1}],["                                                                                                                     ",{}]]},"cursor":{"x":33,"y":10}}],[1.718604,{"lines":{"12":[["----------------------------------------",{"fg":0}],["                                                                                                              ",{}]],"14":[["PMC-OA datasets downloaded previously:",{"fg":1}],["                                                                                                                ",{}]],"16":[["--------------------                                                                                                                                  ",{}]],"17":[["PMC Set 2 (AML):",{"fg":6}],["                                                                                                                                      ",{}]],"18":[["--------------------                                                                                                                                  ",{}]],"20":[["\"acute myeloid leukemia\"[title] OR \"acute myeloid leukemia\"[abstract]) \\                                                                              ",{}]],"21":[[" AND open access[FILTER] AND Myeloid Leukemia, Acute[MESH]                                                                                            ",{}]],"23":[["[ 395 hits, Feb 06, 2015 ]                                                                                                                            ",{}]],"25":[["--------------------                                                                                                                                  ",{}]],"26":[["PMC Set 3 (cancer):",{"fg":6}],["                                                                                                                                   ",{}]],"27":[["--------------------                                                                                                                                  ",{}]],"29":[["cancer AND 2015/02/14:2100[dp]                                                                                                                        ",{}]],"31":[["[ 392 hits, Feb 24, 2015 ]                                                                                                                            ",{}]]},"cursor":{"x":0,"y":33}}],[0.001436,{"lines":{"33":[["Press <Enter> key to continue ...",{"fg":1}],["                                                                                                                     ",{}]]},"cursor":{"x":33}}],[3.878599,{"cursor":{"x":0,"y":34}}],[0.001231,{"lines":{"35":[["----------------------------------------",{"fg":0}],["                                                                                                              ",{}]],"36":[["HERE IS MY ",{"fg":0}],["patterns",{"fg":1}],[" FILE:                                                                                                                             ",{}]],"37":[["----------------------------------------                                                                                                              ",{}]],"39":[["cat patterns-1.6 | more                                                                                                                               ",{}]],"41":[["Press <Enter> key to continue ...",{"fg":1}],["                                                                                                                     ",{}]]},"cursor":{"x":33,"y":41}}],[2.390771,{"cursor":{"x":0,"y":42}}],[0.00236,{"cursor":{"y":43}}],[0.022631,{"lines":{"0":[["#=============================================================================",{"fg":0}],["                                                                        ",{}]],"1":[["#   KEYWORDS / PHRASES:",{"fg":0}],["                                                                                                                               ",{}]],"2":[["#=============================================================================",{"fg":0}],["                                                                        ",{}]],"3":[["\\banemic.\\b",{"fg":0}],["                                                                                                                                           ",{}]],"4":[["\\banaemic.\\b",{"fg":0}],["                                                                                                                                          ",{}]],"5":[["\\banemia.\\b",{"fg":0}],["                                                                                                                                           ",{}]],"6":[["\\banaemia.\\b",{"fg":0}],["                                                                                                                                          ",{}]],"7":[["hematopoie                                                                                                                                            ",{"fg":0}]],"8":[["haematopoie                                                                                                                                           ",{"fg":0}]],"9":[["\\bleukemia.\\b                                                                                                                                         ",{"fg":0}]],"10":[["\\bleukaemia.\\b                                                                                                                                        ",{"fg":0}]],"11":[["APL differentiation                                                                                                                                   ",{"fg":0}]],"12":[["Auer rods                                                                                                                                             ",{"fg":0}]],"13":[["british columbia                                                                                                                                      ",{"fg":0}]],"14":[["hematopoietic                                                                                                                                         ",{"fg":0}]],"15":[["haematopoietic                                                                                                                                        ",{"fg":0}]],"16":[["leukocytosis                                                                                                                                          ",{"fg":0}]],"17":[["leukopenia                                                                                                                                            ",{"fg":0}]],"18":[["lymphoblastic lymphoma                                                                                                                                ",{"fg":0}]],"19":[["megakaryoblastic AML                                                                                                                                  ",{"fg":0}]],"20":[["myelodysplas                                                                                                                                          ",{"fg":0}]],"21":[["myeloid sarcoma                                                                                                                                       ",{"fg":0}]],"22":[["myeloprolif                                                                                                                                           ",{"fg":0}]],"23":[["National Comprehensive Cancer Network                                                                                                                 ",{"fg":0}]],"24":[["\\bNCCN\\b                                                                                                                                              ",{"fg":0}]],"25":[["#=============================================================================                                                                        ",{"fg":0}]],"26":[["#   GENES:                                                                                                                                            ",{"fg":0}]],"27":[["#=============================================================================                                                                        ",{"fg":0}]],"28":[["\\bAML\\b                                                                                                                                               ",{"fg":0}]],"29":[["\\bAML1\\b                                                                                                                                              ",{"fg":0}]],"30":[["\\bAML2\\b                                                                                                                                              ",{"fg":0}]],"31":[["\\bAML 1\\b                                                                                                                                             ",{"fg":0}]],"32":[["\\bAML 2\\b                                                                                                                                             ",{"fg":0}]],"33":[["\\bASXL1\\b                                                                                                                                             ",{"fg":0}]],"34":[["\\bBAALC\\b                                                                                                                                             ",{"fg":0}]],"35":[["\\bBCL2L11\\b                                                                                                                                           ",{"fg":0}]],"36":[["\\bBCOR\\b                                                                                                                                              ",{"fg":0}]],"37":[["\\bBCORL1\\b                                                                                                                                            ",{"fg":0}]],"38":[["\\bCALR\\b                                                                                                                                              ",{"fg":0}]],"39":[["\\bCBFA2\\b                                                                                                                                             ",{"fg":0}]],"40":[["\\bCBL\\b                                                                                                                                               ",{"fg":0}]],"41":[["\\bCEBPA\\b                                                                                                                                             ",{"fg":0}]],"42":[["\\bc-KIT\\b                                                                                                                                             ",{"fg":0}]],"43":[["\\bc–KIT\\b                                                                                                                                             ",{"fg":0}]],"44":[["\\bc—KIT\\b                                                                                                                                             ",{"fg":0}]],"45":[["\\bc‒KIT\\b                                                                                                                                             ",{"fg":0}]],"46":[["\\bCSF3R\\b                                                                                                                                             ",{"fg":0}]],"47":[["\\bDNMT3A\\b                                                                                                                                            ",{"fg":0}]],"48":[["\\bERG\\b                                                                                                                                               ",{"fg":0}]],"49":[["--More--",{"fg":0,"inverse":true}],["                                                                                                                                              ",{"fg":0}]]},"cursor":{"x":8,"y":49}}],[5.231304,{"lines":{"0":[["\\bETV6\\b                                                                                                                                              ",{"fg":0}]],"1":[["\\bEZH2\\b                                                                                                                                              ",{"fg":0}]],"2":[["\\bFLT3\\b                                                                                                                                              ",{"fg":0}]],"3":[["\\bGATA2\\b                                                                                                                                             ",{"fg":0}]],"4":[["IDH[12]                                                                                                                                               ",{"fg":0}]],"5":[["\\bJAK2\\b                                                                                                                                              ",{"fg":0}]],"6":[["\\bKDM6A\\b                                                                                                                                             ",{"fg":0}]],"7":[["\\bKMT2A\\b                                                                                                                                             ",{"fg":0}]],"8":[["\\bKRAS\\b                                                                                                                                              ",{"fg":0}]],"9":[["\\bMLL\\b                                                                                                                                               ",{"fg":0}]],"10":[["\\bMLL1\\b                                                                                                                                              ",{"fg":0}]],"11":[["\\bMPL\\b                                                                                                                                               ",{"fg":0}]],"12":[["\\bNPM1\\b                                                                                                                                              ",{"fg":0}]],"13":[["\\bNRAS\\b                                                                                                                                              ",{"fg":0}]],"14":[["\\bnucleophosmin\\b                                                                                                                                     ",{"fg":0}]],"15":[["\\bPHF6\\b                                                                                                                                              ",{"fg":0}]],"16":[["\\bPRPF40B\\b                                                                                                                                           ",{"fg":0}]],"17":[["\\bPTEN\\b                                                                                                                                              ",{"fg":0}]],"18":[["\\bPTPN11\\b                                                                                                                                            ",{"fg":0}]],"19":[["\\bRAD21\\b                                                                                                                                             ",{"fg":0}]],"20":[["\\bRARA\\b                                                                                                                                              ",{"fg":0}]],"21":[["\\bRARα\\b                                                                                                                                              ",{"fg":0}]],"22":[["\\bRAR α\\b                                                                                                                                             ",{"fg":0}]],"23":[["\\bRUNX1                                                                                                                                               ",{"fg":0}]],"24":[["\\bRUNX3\\b                                                                                                                                             ",{"fg":0}]],"25":[["\\bSETBP1\\b                                                                                                                                            ",{"fg":0}]],"26":[["\\bSETD2\\b                                                                                                                                             ",{"fg":0}]],"27":[["\\bSF1\\b                                                                                                                                               ",{"fg":0}]],"28":[["\\bSF3A1\\b                                                                                                                                             ",{"fg":0}]],"29":[["\\bSF3B1\\b                                                                                                                                             ",{"fg":0}]],"30":[["\\bSF3B3\\b                                                                                                                                             ",{"fg":0}]],"31":[["\\bSMC1A\\b                                                                                                                                             ",{"fg":0}]],"32":[["\\bSMC3\\b                                                                                                                                              ",{"fg":0}]],"33":[["\\bSOCS3\\b                                                                                                                                             ",{"fg":0}]],"34":[["\\bSRSF2\\b                                                                                                                                             ",{"fg":0}]],"35":[["\\bSTAG2\\b                                                                                                                                             ",{"fg":0}]],"36":[["\\bTET2\\b                                                                                                                                              ",{"fg":0}]],"37":[["\\bTGM6\\b                                                                                                                                              ",{"fg":0}]],"38":[["\\bTP53\\b                                                                                                                                              ",{"fg":0}]],"39":[["\\bU2AF1\\b                                                                                                                                             ",{"fg":0}]],"40":[["\\bU2AF2\\b                                                                                                                                             ",{"fg":0}]],"41":[["\\bWT1\\b                                                                                                                                               ",{"fg":0}]],"42":[["\\bZRSR2\\b                                                                                                                                             ",{"fg":0}]],"43":[["#=============================================================================                                                                        ",{"fg":0}]],"44":[["#   TRANSLOCATIONS (FUSIONS); INVERSIONS - GENES:                                                                                                     ",{"fg":0}]],"45":[["#=============================================================================                                                                        ",{"fg":0}]],"46":[["\\bCBFB\\b                                                                                                                                              ",{"fg":0}]],"47":[["\\bCIITA\\b                                                                                                                                             ",{"fg":0}]],"48":[["\\bDEK\\b                                                                                                                                               ",{"fg":0}]]}}],[4.104929,{"lines":{"0":[["\\bLOXL1\\b                                                                                                                                             ",{"fg":0}]],"1":[["\\bMLLT3\\b                                                                                                                                             ",{"fg":0}]],"2":[["\\bPIM3\\b                                                                                                                                              ",{"fg":0}]],"3":[["\\bPML\\b                                                                                                                                               ",{"fg":0}]],"4":[["\\bRAR/\\b                                                                                                                                              ",{"fg":0}]],"5":[["\\bRBM15\\b                                                                                                                                             ",{"fg":0}]],"6":[["\\bRPN1\\b                                                                                                                                              ",{"fg":0}]],"7":[["\\bSCO2\\b                                                                                                                                              ",{"fg":0}]],"8":[["#=============================================================================                                                                        ",{"fg":0}]],"9":[["#   TRANSLOCATIONS (FUSIONS); INVERSIONS - CYTOGENETIC:                                                                                               ",{"fg":0}]],"10":[["#=============================================================================                                                                        ",{"fg":0}]],"11":[["t(11;16)(q23;q13.3)                                                                                                                                   ",{"fg":0}]],"12":[["t(11;16) (q23;q13.3)                                                                                                                                  ",{"fg":0}]],"13":[["t(11;19)$                                                                                                                                             ",{"fg":0}]],"14":[["t(11;19)(q23;p13)                                                                                                                                     ",{"fg":0}]],"15":[["t(11;19) (q23;p13)                                                                                                                                    ",{"fg":0}]],"16":[["t(1;22)$                                                                                                                                              ",{"fg":0}]],"17":[["t(1;22)(p13;q13)                                                                                                                                      ",{"fg":0}]],"18":[["t(1;22) (p13;q13)                                                                                                                                     ",{"fg":0}]],"19":[["t(1;3)(p36.3;q21.1)                                                                                                                                   ",{"fg":0}]],"20":[["t(1;3) (p36.3;q21.1)                                                                                                                                  ",{"fg":0}]],"21":[["t(15;17)$                                                                                                                                             ",{"fg":0}]],"22":[["t(15;17)(q22;q12)                                                                                                                                     ",{"fg":0}]],"23":[["t(15;17) (q22;q12)                                                                                                                                    ",{"fg":0}]],"24":[["t(15;17)(q22;q21)                                                                                                                                     ",{"fg":0}]],"25":[["t(15;17) (q22;q21)                                                                                                                                    ",{"fg":0}]],"26":[["t(16;16)$                                                                                                                                             ",{"fg":0}]],"27":[["t(16;16)(p13.1;q22)                                                                                                                                   ",{"fg":0}]],"28":[["t(16;16) (p13.1;q22)                                                                                                                                  ",{"fg":0}]],"29":[["t(2;11)(p21;q23)                                                                                                                                      ",{"fg":0}]],"30":[["t(2;11) (p21;q23)                                                                                                                                     ",{"fg":0}]],"31":[["t(3;21)(q26.2;q22.1)                                                                                                                                  ",{"fg":0}]],"32":[["t(3;21) (q26.2;q22.1)                                                                                                                                 ",{"fg":0}]],"33":[["t(3:3)$                                                                                                                                               ",{"fg":0}]],"34":[["t(3;3)(q21;q26.2)                                                                                                                                     ",{"fg":0}]],"35":[["t(3;3) (q21;q26.2)                                                                                                                                    ",{"fg":0}]],"36":[["t(3;5)(q25;q34)                                                                                                                                       ",{"fg":0}]],"37":[["t(3;5) (q25;q34)                                                                                                                                      ",{"fg":0}]],"38":[["t(5;10)(q33;q21)                                                                                                                                      ",{"fg":0}]],"39":[["t(5;10) (q33;q21)                                                                                                                                     ",{"fg":0}]],"40":[["t(5;12)(q33;p12)                                                                                                                                      ",{"fg":0}]],"41":[["t(5;12) (q33;p12)                                                                                                                                     ",{"fg":0}]],"42":[["t(5;17)(q33;p13)                                                                                                                                      ",{"fg":0}]],"43":[["t(5;17) (q33;p13)                                                                                                                                     ",{"fg":0}]],"44":[["t(5;7)(q33;q11.2)                                                                                                                                     ",{"fg":0}]],"45":[["t(5;7) (q33;q11.2)                                                                                                                                    ",{"fg":0}]],"46":[["t(6;9)$                                                                                                                                               ",{"fg":0}]],"47":[["t(6;9)(p23;q34)                                                                                                                                       ",{"fg":0}]],"48":[["t(6;9) (p23;q34)                                                                                                                                      ",{"fg":0}]]}}],[4.710769,{"lines":{"0":[["t(6;9)(p23;q34)                                                                                                                                       ",{"fg":0}]],"1":[["t(6;9) (p23;q34)                                                                                                                                      ",{"fg":0}]],"2":[["t(6;9),t(v;11),(v;q23)                                                                                                                                ",{"fg":0}]],"3":[["t(6;9), t(v;11), (v;q23)                                                                                                                              ",{"fg":0}]],"4":[["t(8;21)(q22;q22)                                                                                                                                      ",{"fg":0}]],"5":[["t(8;21) (q22;q22)                                                                                                                                     ",{"fg":0}]],"6":[["t(9;11)$                                                                                                                                              ",{"fg":0}]],"7":[["t(9;11)(p22;q23)                                                                                                                                      ",{"fg":0}]],"8":[["t(9;11)( p22;q23)                                                                                                                                     ",{"fg":0}]],"9":[["t(9;11)(p22;q23)                                                                                                                                      ",{"fg":0}]],"10":[["t(9;11) (p22;q23)                                                                                                                                     ",{"fg":0}]],"11":[["t(9,22)$                                                                                                                                              ",{"fg":0}]],"12":[["t(v;11q23);MLL rearranged                                                                                                                             ",{"fg":0}]],"13":[["t(v;11q23); MLL rearranged                                                                                                                            ",{"fg":0}]],"14":[["#----------------------------------------                                                                                                             ",{"fg":0}]],"15":[["inv(16)$                                                                                                                                              ",{"fg":0}]],"16":[["inv(16)(p13.1q22)                                                                                                                                     ",{"fg":0}]],"17":[["inv(16) (p13.1q22)                                                                                                                                    ",{"fg":0}]],"18":[["inv(16)(p13q22)                                                                                                                                       ",{"fg":0}]],"19":[["inv(16) (p13q22)                                                                                                                                      ",{"fg":0}]],"20":[["inv(16)(p13q22)/t(16;16)(p13;q22)                                                                                                                     ",{"fg":0}]],"21":[["inv(16) (p13q22)/t(16;16) (p13;q22)                                                                                                                   ",{"fg":0}]],"22":[["inv(16) (p13q22)/ t(16;16) (p13;q22)                                                                                                                  ",{"fg":0}]],"23":[["inv(16) (p13q22) / t(16;16) (p13;q22)                                                                                                                 ",{"fg":0}]],"24":[["inv(3)$                                                                                                                                               ",{"fg":0}]],"25":[["inv(3)(q21q26.2)                                                                                                                                      ",{"fg":0}]],"26":[["inv(3) (q21q26.2)                                                                                                                                     ",{"fg":0}]],"27":[["inv(3)(q21q26)/t(3;3)(q21;q26)                                                                                                                        ",{"fg":0}]],"28":[["inv(3) (q21q26)/t(3;3) (q21;q26)                                                                                                                      ",{"fg":0}]],"29":[["inv(3) (q21q26)/ t(3;3) (q21;q26)                                                                                                                     ",{"fg":0}]],"30":[["inv(3) (q21q26) / t(3;3) (q21;q26)                                                                                                                    ",{"fg":0}]],"31":[["#----------------------------------------                                                                                                             ",{"fg":0}]],"32":[["del(11q)$                                                                                                                                             ",{"fg":0}]],"33":[["del(11q)$                                                                                                                                             ",{"fg":0}]],"34":[["del(12p)/t(12p)                                                                                                                                       ",{"fg":0}]],"35":[["del(12p) / t(12p)                                                                                                                                     ",{"fg":0}]],"36":[["del(12p)/ t(12p)                                                                                                                                      ",{"fg":0}]],"37":[["del(13q)$                                                                                                                                             ",{"fg":0}]],"38":[["del(16q)$                                                                                                                                             ",{"fg":0}]],"39":[["del(5q)$                                                                                                                                              ",{"fg":0}]],"40":[["del(5q)$                                                                                                                                              ",{"fg":0}]],"41":[["del(7q)$                                                                                                                                              ",{"fg":0}]],"42":[["del(7q)$                                                                                                                                              ",{"fg":0}]],"43":[["del(9q)$                                                                                                                                              ",{"fg":0}]],"44":[["del(9q)$                                                                                                                                              ",{"fg":0}]],"45":[["#----------------------------------------                                                                                                             ",{"fg":0}]],"46":[["idic(X)(q13)                                                                                                                                          ",{"fg":0}]],"47":[["idic(X) (q13)                                                                                                                                         ",{"fg":0}]],"48":[["#----------------------------------------                                                                                                             ",{"fg":0}]],"49":[["i(17q)/t(17p                                                                                                                                          ",{"fg":0}]]},"cursor":{"x":12}}],[2.5e-05,{"lines":{"0":[["t(6;9),t(v;11),(v;q23)                                                                                                                                ",{"fg":0}]],"1":[["t(6;9), t(v;11), (v;q23)                                                                                                                              ",{"fg":0}]],"2":[["t(8;21)(q22;q22)                                                                                                                                      ",{"fg":0}]],"3":[["t(8;21) (q22;q22)                                                                                                                                     ",{"fg":0}]],"4":[["t(9;11)$                                                                                                                                              ",{"fg":0}]],"5":[["t(9;11)(p22;q23)                                                                                                                                      ",{"fg":0}]],"6":[["t(9;11)( p22;q23)                                                                                                                                     ",{"fg":0}]],"8":[["t(9;11) (p22;q23)                                                                                                                                     ",{"fg":0}]],"9":[["t(9,22)$                                                                                                                                              ",{"fg":0}]],"10":[["t(v;11q23);MLL rearranged                                                                                                                             ",{"fg":0}]],"11":[["t(v;11q23); MLL rearranged                                                                                                                            ",{"fg":0}]],"12":[["#----------------------------------------                                                                                                             ",{"fg":0}]],"13":[["inv(16)$                                                                                                                                              ",{"fg":0}]],"14":[["inv(16)(p13.1q22)                                                                                                                                     ",{"fg":0}]],"15":[["inv(16) (p13.1q22)                                                                                                                                    ",{"fg":0}]],"16":[["inv(16)(p13q22)                                                                                                                                       ",{"fg":0}]],"17":[["inv(16) (p13q22)                                                                                                                                      ",{"fg":0}]],"18":[["inv(16)(p13q22)/t(16;16)(p13;q22)                                                                                                                     ",{"fg":0}]],"19":[["inv(16) (p13q22)/t(16;16) (p13;q22)                                                                                                                   ",{"fg":0}]],"20":[["inv(16) (p13q22)/ t(16;16) (p13;q22)                                                                                                                  ",{"fg":0}]],"21":[["inv(16) (p13q22) / t(16;16) (p13;q22)                                                                                                                 ",{"fg":0}]],"22":[["inv(3)$                                                                                                                                               ",{"fg":0}]],"23":[["inv(3)(q21q26.2)                                                                                                                                      ",{"fg":0}]],"24":[["inv(3) (q21q26.2)                                                                                                                                     ",{"fg":0}]],"25":[["inv(3)(q21q26)/t(3;3)(q21;q26)                                                                                                                        ",{"fg":0}]],"26":[["inv(3) (q21q26)/t(3;3) (q21;q26)                                                                                                                      ",{"fg":0}]],"27":[["inv(3) (q21q26)/ t(3;3) (q21;q26)                                                                                                                     ",{"fg":0}]],"28":[["inv(3) (q21q26) / t(3;3) (q21;q26)                                                                                                                    ",{"fg":0}]],"29":[["#----------------------------------------                                                                                                             ",{"fg":0}]],"30":[["del(11q)$                                                                                                                                             ",{"fg":0}]],"31":[["del(11q)$                                                                                                                                             ",{"fg":0}]],"32":[["del(12p)/t(12p)                                                                                                                                       ",{"fg":0}]],"33":[["del(12p) / t(12p)                                                                                                                                     ",{"fg":0}]],"34":[["del(12p)/ t(12p)                                                                                                                                      ",{"fg":0}]],"35":[["del(13q)$                                                                                                                                             ",{"fg":0}]],"36":[["del(16q)$                                                                                                                                             ",{"fg":0}]],"37":[["del(5q)$                                                                                                                                              ",{"fg":0}]],"38":[["del(5q)$                                                                                                                                              ",{"fg":0}]],"39":[["del(7q)$                                                                                                                                              ",{"fg":0}]],"40":[["del(7q)$                                                                                                                                              ",{"fg":0}]],"41":[["del(9q)$                                                                                                                                              ",{"fg":0}]],"42":[["del(9q)$                                                                                                                                              ",{"fg":0}]],"43":[["#----------------------------------------                                                                                                             ",{"fg":0}]],"44":[["idic(X)(q13)                                                                                                                                          ",{"fg":0}]],"45":[["idic(X) (q13)                                                                                                                                         ",{"fg":0}]],"46":[["#----------------------------------------                                                                                                             ",{"fg":0}]],"47":[["i(17q)/t(17p)                                                                                                                                         ",{"fg":0}]],"48":[["i(17q)/ t(17p)                                                                                                                                        ",{"fg":0}]],"49":[["--More--",{"fg":0,"inverse":true}],["                                                                                                                                              ",{"fg":0}]]},"cursor":{"x":8}}],[3.217117,{"lines":{"0":[["i(17q) / t(17p)                                                                                                                                       ",{"fg":0}]],"1":[["#----------------------------------------                                                                                                             ",{"fg":0}]],"2":[["\\b11q23, abnormal\\b                                                                                                                                   ",{"fg":0}]],"3":[["\\b11q23/KMT2A\\b                                                                                                                                       ",{"fg":0}]],"4":[["\\b11q23/MLL\\b                                                                                                                                         ",{"fg":0}]],"5":[["\\b11q23-non(t(9;11)\\b                                                                                                                                 ",{"fg":0}]],"6":[["\\b3q, abnormal\\b                                                                                                                                      ",{"fg":0}]],"7":[["#----------------------------------------                                                                                                             ",{"fg":0}]],"8":[["\\b[:\"SPACE ][-]5\\b                                                                                                                                    ",{"fg":0}]],"9":[["[:\"SPACE ]5q-                                                                                                                                         ",{"fg":0}]],"10":[["\\b[:\"SPACE ][-]7\\b                                                                                                                                    ",{"fg":0}]],"11":[["[:\"SPACE ]7q-                                                                                                                                         ",{"fg":0}]],"12":[["\\b[:\"SPACE ][+]8\\b                                                                                                                                    ",{"fg":0}]],"13":[["\\b[:\"SPACE ][+]21\\b                                                                                                                                   ",{"fg":0}]],"14":[["\\b[:\"SPACE ][+]22\\b                                                                                                                                   ",{"fg":0}]],"15":[["#=============================================================================                                                                        ",{"fg":0}]],"16":[["#   CHEMOTHERAPY:                                                                                                                                     ",{"fg":0}]],"17":[["#=============================================================================                                                                        ",{"fg":0}]],"18":[["all-trans retinoic acid                                                                                                                               ",{"fg":0}]],"19":[["all–trans retinoic acid                                                                                                                               ",{"fg":0}]],"20":[["all—trans retinoic acid                                                                                                                               ",{"fg":0}]],"21":[["all‒trans retinoic acid                                                                                                                               ",{"fg":0}]],"22":[["anthracycline                                                                                                                                         ",{"fg":0}]],"23":[["\\bAra-C\\b                                                                                                                                             ",{"fg":0}]],"24":[["\\bAra–C\\b                                                                                                                                             ",{"fg":0}]],"25":[["\\bAra—C\\b                                                                                                                                             ",{"fg":0}]],"26":[["\\bAra‒C\\b                                                                                                                                             ",{"fg":0}]],"27":[["arsenic trioxide                                                                                                                                      ",{"fg":0}]],"28":[["\\bAs2O3\\b                                                                                                                                             ",{"fg":0}]],"29":[["\\bATO\\b                                                                                                                                               ",{"fg":0}]],"30":[["\\bATRA\\b                                                                                                                                              ",{"fg":0}]],"31":[["\\bCeplene\\b                                                                                                                                           ",{"fg":0}]],"32":[["clofarabine                                                                                                                                           ",{"fg":0}]],"33":[["\\bCP-4055\\b                                                                                                                                           ",{"fg":0}]],"34":[["\\bCP–4055\\b                                                                                                                                           ",{"fg":0}]],"35":[["\\bCP—4055\\b                                                                                                                                           ",{"fg":0}]],"36":[["\\bCP‒4055\\b                                                                                                                                           ",{"fg":0}]],"37":[["\\bCPX351\\b                                                                                                                                            ",{"fg":0}]],"38":[["cytarabine                                                                                                                                            ",{"fg":0}]],"39":[["daunorubicin                                                                                                                                          ",{"fg":0}]],"40":[["#daunorubicine                                                                                                                                        ",{"fg":0}]],"41":[["elacytabine                                                                                                                                           ",{"fg":0}]],"42":[["flavopiridol                                                                                                                                          ",{"fg":0}]],"43":[["gemtuzumab                                                                                                                                            ",{"fg":0}]],"44":[["gemtuzumab ozogamicin                                                                                                                                 ",{"fg":0}]],"45":[["Gleevec                                                                                                                                               ",{"fg":0}]],"46":[["histamine dihydrochloride                                                                                                                             ",{"fg":0}]],"47":[["idarubicin                                                                                                                                            ",{"fg":0}]],"48":[["imatinib                                                                                                                                              ",{"fg":0}]]}}],[5.110944,{"lines":{"0":[["                                                                                                                                                      ",{"fg":0}]],"1":[["Let\\'s trick the system into reading the PMC XML files as UTF-8-encoded",{"fg":1}],["                                                                               ",{"fg":0}]],"2":[["                                                                                                                                                      ",{"fg":0}]],"3":[["First, let\\'s examine the default-encoded (pmc_result./xml) file header:",{"fg":6}],["                                                                              ",{"fg":0}]],"4":[["                                                                                                                                                      ",{"fg":0}]],"5":[["head -n1 \"pmc_result_AML.xml\"",{"fg":6}],["                                                                                                                         ",{"fg":0}]],"6":[["                                                                                                                                                      ",{"fg":0}]],"7":[["                                                                                                                                                      ",{"fg":0}]],"8":[["                                                                                                                                                      ",{"fg":0}]],"9":[["                                                                                                                                                      ",{"fg":0}]],"10":[["                                                                                                                                                      ",{"fg":0}]],"11":[["                                                                                                                                                      ",{"fg":0}]],"12":[["                                                                                                                                                      ",{"fg":0}]],"13":[["                                                                                                                                                      ",{"fg":0}]],"14":[["                                                                                                                                                      ",{"fg":0}]],"15":[["                                                                                                                                                      ",{"fg":0}]],"16":[["                                                                                                                                                      ",{"fg":0}]],"17":[["                                                                                                                                                      ",{"fg":0}]],"18":[["                                                                                                                                                      ",{"fg":0}]],"19":[["                                                                                                                                                      ",{"fg":0}]],"20":[["                                                                                                                                                      ",{"fg":0}]],"21":[["                                                                                                                                                      ",{"fg":0}]],"22":[["                                                                                                                                                      ",{"fg":0}]],"23":[["                                                                                                                                                      ",{"fg":0}]],"24":[["                                                                                                                                                      ",{"fg":0}]],"25":[["                                                                                                                                                      ",{"fg":0}]],"26":[["                                                                                                                                                      ",{"fg":0}]],"27":[["                                                                                                                                                      ",{"fg":0}]],"28":[["                                                                                                                                                      ",{"fg":0}]],"29":[["                                                                                                                                                      ",{"fg":0}]],"30":[["                                                                                                                                                      ",{"fg":0}]],"31":[["                                                                                                                                                      ",{"fg":0}]],"32":[["                                                                                                                                                      ",{"fg":0}]],"33":[["                                                                                                                                                      ",{"fg":0}]],"34":[["                                                                                                                                                      ",{"fg":0}]],"35":[["                                                                                                                                                      ",{"fg":0}]],"36":[["                                                                                                                                                      ",{"fg":0}]],"37":[["                                                                                                                                                      ",{"fg":0}]],"38":[["                                                                                                                                                      ",{"fg":0}]],"39":[["                                                                                                                                                      ",{"fg":0}]],"40":[["                                                                                                                                                      ",{"fg":0}]],"41":[["                                                                                                                                                      ",{"fg":0}]],"42":[["                                                                                                                                                      ",{"fg":0}]],"43":[["                                                                                                                                                      ",{"fg":0}]],"44":[["                                                                                                                                                      ",{"fg":0}]],"45":[["                                                                                                                                                      ",{"fg":0}]],"46":[["                                                                                                                                                      ",{"fg":0}]],"47":[["                                                                                                                                                      ",{"fg":0}]],"48":[["                                                                                                                                                      ",{"fg":0}]],"49":[["                                                                                                                                                      ",{"fg":0}]]},"cursor":{"x":0,"y":7}}],[0.012227,{"lines":{"7":[["<?xml version=\"1.0\" encoding=\"UTF-8\"?>",{}],["                                                                                                                ",{"fg":0}]],"9":[["    Note: the original PMC XML file starts (line 1) with",{"fg":2}],["                                                                                              ",{"fg":0}]],"11":[["        <?xml version=\\\"1.0\\\"?>",{}],["                                                                                                                       ",{"fg":0}]],"13":[["    but if the  has already been processed (e.g. this script) then it will appear as",{"fg":2}],["                                                                  ",{"fg":0}]],"15":[["        <?xml version=\\\"1.0\\\" encoding=\\\"UTF-8\\\"?>#{green} , above.",{}],["                                                                                   ",{"fg":0}]],"17":[["head -n1 \"pmc_result_cancer.xml\"",{"fg":6}],["                                                                                                                      ",{"fg":0}]],"19":[["<?xml version=\"1.0\" encoding=\"UTF-8\"?>",{}],["                                                                                                                ",{"fg":0}]],"21":[["    Ditto: the original (unprocessed) PMC XML file starts (line 1) with",{"fg":2}],["                                                                               ",{"fg":0}]],"23":[["        <?xml version=\"1.0\"?>",{}],["                                                                                                                         ",{"fg":0}]],"25":[["Press <Enter> key to continue ...",{"fg":1}],["                                                                                                                     ",{"fg":0}]]},"cursor":{"x":33,"y":25}}],[9.828657,{"lines":{"1":[["                                                                                                                                                      ",{"fg":0}]],"3":[["                                                                                                                                                      ",{"fg":0}]],"5":[["                                                                                                                                                      ",{"fg":0}]],"7":[["                                                                                                                                                      ",{"fg":0}]],"9":[["                                                                                                                                                      ",{"fg":0}]],"11":[["                                                                                                                                                      ",{"fg":0}]],"13":[["                                                                                                                                                      ",{"fg":0}]],"15":[["                                                                                                                                                      ",{"fg":0}]],"17":[["                                                                                                                                                      ",{"fg":0}]],"19":[["                                                                                                                                                      ",{"fg":0}]],"21":[["                                                                                                                                                      ",{"fg":0}]],"23":[["                                                                                                                                                      ",{"fg":0}]],"25":[["                                                                                                                                                      ",{"fg":0}]]},"cursor":{"x":0,"y":0}}],[0.001025,{"lines":{"1":[["Now, recode the headers (sed):",{"fg":1}],["                                                                                                                        ",{"fg":0}]],"3":[["    sed -i '1s/^.*$/<?xml version=\"1.0\" encoding=\"UTF-8\"?>/g' 'pmc_result_AML.xml'",{"fg":6}],["                                                                    ",{"fg":0}]]},"cursor":{"y":4}}],[2.234995,{"lines":{"5":[[" ... and ...",{}],["                                                                                                                                          ",{"fg":0}]],"7":[["    sed -i '1s/^.*$/<?xml version=\"1.0\" encoding=\"UTF-8\"?>/g' 'pmc_result_cancer.xml'",{"fg":6}],["                                                                 ",{"fg":0}]]},"cursor":{"y":8}}],[3.568107,{"lines":{"9":[["So, head -n1 \"pmc_result_AML.xml\" is now:",{"fg":6}],["                                                                                                             ",{"fg":0}]],"11":[["<?xml version=\"1.0\" encoding=\"UTF-8\"?>",{}],["                                                                                                                ",{"fg":0}]],"13":[["... and head -n1 \"pmc_result_cancer.xml\" is now:",{"fg":6}],["                                                                                                      ",{"fg":0}]]},"cursor":{"y":15}}],[0.003087,{"lines":{"15":[["<?xml version=\"1.0\" encoding=\"UTF-8\"?>",{}],["                                                                                                                ",{"fg":0}]],"17":[["Press <Enter> key to continue ...",{"fg":1}],["                                                                                                                     ",{"fg":0}]]},"cursor":{"x":33,"y":17}}],[4.496804,{"cursor":{"x":0,"y":18}}],[0.002388,{"lines":{"1":[["----------------------------------------                                                                                                              ",{"fg":0}]],"2":[["START PROCESSING THE 'RAW' XML FILE:",{"fg":1}],["                                                                                                                  ",{"fg":0}]],"3":[["----------------------------------------",{}],["                                                                                                              ",{"fg":0}]],"5":[["We'll begin by processing 'Set 2' (AML), followed by 'Set 3' (cancer)",{"fg":6}],["                                                                                 ",{"fg":0}]],"7":[["Here is ",{"fg":6}],["part",{"fg":1}],[" of an XML file",{"fg":6}],["                                                                                                                           ",{"fg":0}]],"9":[["    [ head -n150 pmc_result_AML.xml  | more ]",{}],["                                                                                                         ",{"fg":0}]],"11":[[" [ Press <Enter> key to continue ... ]",{"fg":1}],["                                                                                                                ",{"fg":0}]],"13":[["                                                                                                                                                      ",{"fg":0}]],"15":[["                                                                                                                                                      ",{"fg":0}]],"17":[["                                                                                                                                                      ",{"fg":0}]]},"cursor":{"x":38,"y":11}}],[3.685677,{"lines":{"1":[["                                                                                                                                                      ",{"fg":0}]],"2":[["                                                                                                                                                      ",{"fg":0}]],"3":[["                                                                                                                                                      ",{"fg":0}]],"5":[["                                                                                                                                                      ",{"fg":0}]],"7":[["                                                                                                                                                      ",{"fg":0}]],"9":[["                                                                                                                                                      ",{"fg":0}]],"11":[["                                                                                                                                                      ",{"fg":0}]]},"cursor":{"x":0,"y":1}}],[0.308206,{"lines":{"1":[["<?xml version=\"1.0\" encoding=\"UTF-8\"?>                                                                                                                ",{"fg":0}]],"2":[["<!DOCTYPE pmc-articleset PUBLIC \"-//NLM//DTD ARTICLE SET 2.0//EN\" \"http://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd\">                ",{"fg":0}]],"3":[["<pmc-articleset>                                                                                                                                      ",{"fg":0}]],"4":[["<article xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\">                   ",{"fg":0}]],"5":[["  <?properties open_access?>                                                                                                                          ",{"fg":0}]],"6":[["  <front>                                                                                                                                             ",{"fg":0}]],"7":[["    <journal-meta>                                                                                                                                    ",{"fg":0}]],"8":[["      <journal-id journal-id-type=\"nlm-ta\">PLoS One</journal-id>                                                                                      ",{"fg":0}]],"9":[["      <journal-id journal-id-type=\"iso-abbrev\">PLoS ONE</journal-id>                                                                                  ",{"fg":0}]],"10":[["      <journal-id journal-id-type=\"publisher-id\">plos</journal-id>                                                                                    ",{"fg":0}]],"11":[["      <journal-id journal-id-type=\"pmc\">plosone</journal-id>                                                                                          ",{"fg":0}]],"12":[["      <journal-title-group>                                                                                                                           ",{"fg":0}]],"13":[["        <journal-title>PLoS ONE</journal-title>                                                                                                       ",{"fg":0}]],"14":[["      </journal-title-group>                                                                                                                          ",{"fg":0}]],"15":[["      <issn pub-type=\"epub\">1932-6203</issn>                                                                                                          ",{"fg":0}]],"16":[["      <publisher>                                                                                                                                     ",{"fg":0}]],"17":[["        <publisher-name>Public Library of Science</publisher-name>                                                                                    ",{"fg":0}]],"18":[["        <publisher-loc>San Francisco, USA</publisher-loc>                                                                                             ",{"fg":0}]],"19":[["      </publisher>                                                                                                                                    ",{"fg":0}]],"20":[["    </journal-meta>                                                                                                                                   ",{"fg":0}]],"21":[["    <article-meta>                                                                                                                                    ",{"fg":0}]],"22":[["      <ar                                                                                                                                             ",{"fg":0}]]},"cursor":{"x":9,"y":22}}],[3.1e-05,{"lines":{"0":[["<?xml version=\"1.0\" encoding=\"UTF-8\"?>                                                                                                                ",{"fg":0}]],"1":[["<!DOCTYPE pmc-articleset PUBLIC \"-//NLM//DTD ARTICLE SET 2.0//EN\" \"http://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd\">                ",{"fg":0}]],"2":[["<pmc-articleset>                                                                                                                                      ",{"fg":0}]],"3":[["<article xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\">                   ",{"fg":0}]],"4":[["  <?properties open_access?>                                                                                                                          ",{"fg":0}]],"5":[["  <front>                                                                                                                                             ",{"fg":0}]],"6":[["    <journal-meta>                                                                                                                                    ",{"fg":0}]],"7":[["      <journal-id journal-id-type=\"nlm-ta\">PLoS One</journal-id>                                                                                      ",{"fg":0}]],"8":[["      <journal-id journal-id-type=\"iso-abbrev\">PLoS ONE</journal-id>                                                                                  ",{"fg":0}]],"9":[["      <journal-id journal-id-type=\"publisher-id\">plos</journal-id>                                                                                    ",{"fg":0}]],"10":[["      <journal-id journal-id-type=\"pmc\">plosone</journal-id>                                                                                          ",{"fg":0}]],"11":[["      <journal-title-group>                                                                                                                           ",{"fg":0}]],"12":[["        <journal-title>PLoS ONE</journal-title>                                                                                                       ",{"fg":0}]],"13":[["      </journal-title-group>                                                                                                                          ",{"fg":0}]],"14":[["      <issn pub-type=\"epub\">1932-6203</issn>                                                                                                          ",{"fg":0}]],"15":[["      <publisher>                                                                                                                                     ",{"fg":0}]],"16":[["        <publisher-name>Public Library of Science</publisher-name>                                                                                    ",{"fg":0}]],"17":[["        <publisher-loc>San Francisco, USA</publisher-loc>                                                                                             ",{"fg":0}]],"18":[["      </publisher>                                                                                                                                    ",{"fg":0}]],"19":[["    </journal-meta>                                                                                                                                   ",{"fg":0}]],"20":[["    <article-meta>                                                                                                                                    ",{"fg":0}]],"21":[["      <article-id pub-id-type=\"pmid\">23940586</article-id>                                                                                            ",{"fg":0}]],"22":[["      <article-id pub-id-type=\"pmc\">3734248</article-id>                                                                                              ",{"fg":0}]],"23":[["      <article-id pub-id-type=\"publisher-id\">PONE-D-12-37968</article-id>                                                                             ",{"fg":0}]],"24":[["      <article-id pub-id-type=\"doi\">10.1371/journal.pone.0070522</article-id>                                                                         ",{"fg":0}]],"25":[["      <article-categories>                                                                                                                            ",{"fg":0}]],"26":[["        <subj-group subj-group-type=\"heading\">                                                                                                        ",{"fg":0}]],"27":[["          <subject>Research Article</subject>                                                                                                         ",{"fg":0}]],"28":[["        </subj-group>                                                                                                                                 ",{"fg":0}]],"29":[["        <subj-group subj-group-type=\"Discipline-v2\">                                                                                                  ",{"fg":0}]],"30":[["          <subject>Medicine</subject>                                                                                                                 ",{"fg":0}]],"31":[["          <subj-group>                                                                                                                                ",{"fg":0}]],"32":[["            <subject>Clinical Immunology</subject>                                                                                                    ",{"fg":0}]],"33":[["            <subj-group>                                                                                                                              ",{"fg":0}]],"34":[["              <subject>Antigen Processing and Recognition</subject>                                                                                   ",{"fg":0}]],"35":[["              <subject>Immune Response</subject>                                                                                                      ",{"fg":0}]],"36":[["            </subj-group>                                                                                                                             ",{"fg":0}]],"37":[["          </subj-group>                                                                                                                               ",{"fg":0}]],"38":[["          <subj-group>                                                                                                                                ",{"fg":0}]],"39":[["            <subject>Hematology</subject>                                                                                                             ",{"fg":0}]],"40":[["            <subj-group>                                                                                                                              ",{"fg":0}]],"41":[["              <subject>Hematologic Cancers and Related Disorders</subject>                                                                            ",{"fg":0}]],"42":[["            </subj-group>                                                                                                                             ",{"fg":0}]],"43":[["          </subj-group>                                                                                                                               ",{"fg":0}]],"44":[["          <subj-group>                                                                                                                                ",{"fg":0}]],"45":[["            <subject>Oncology</subject>                                                                                                               ",{"fg":0}]],"46":[["            <subj-group>                                                                                                                              ",{"fg":0}]],"47":[["              <subject>Basic Cancer Research</subject>                                                                                                ",{"fg":0}]],"48":[["              <subject>Cancer Treatment</subject>                                                                                                     ",{"fg":0}]],"49":[["--More--",{"fg":0,"inverse":true}],["                                                                                                                                              ",{"fg":0}]]},"cursor":{"x":8,"y":49}}],[3.731964,{"lines":{"0":[["        <subj-group subj-group-type=\"heading\">                                                                                                        ",{"fg":0}]],"1":[["          <subject>Research Article</subject>                                                                                                         ",{"fg":0}]],"2":[["        </subj-group>                                                                                                                                 ",{"fg":0}]],"3":[["        <subj-group subj-group-type=\"Discipline-v2\">                                                                                                  ",{"fg":0}]],"4":[["          <subject>Medicine</subject>                                                                                                                 ",{"fg":0}]],"5":[["          <subj-group>                                                                                                                                ",{"fg":0}]],"6":[["            <subject>Clinical Immunology</subject>                                                                                                    ",{"fg":0}]],"7":[["            <subj-group>                                                                                                                              ",{"fg":0}]],"8":[["              <subject>Antigen Processing and Recognition</subject>                                                                                   ",{"fg":0}]],"9":[["              <subject>Immune Response</subject>                                                                                                      ",{"fg":0}]],"10":[["            </subj-group>                                                                                                                             ",{"fg":0}]],"11":[["          </subj-group>                                                                                                                               ",{"fg":0}]],"12":[["          <subj-group>                                                                                                                                ",{"fg":0}]],"13":[["            <subject>Hematology</subject>                                                                                                             ",{"fg":0}]],"14":[["            <subj-group>                                                                                                                              ",{"fg":0}]],"15":[["              <subject>Hematologic Cancers and Related Disorders</subject>                                                                            ",{"fg":0}]],"16":[["            </subj-group>                                                                                                                             ",{"fg":0}]],"17":[["          </subj-group>                                                                                                                               ",{"fg":0}]],"18":[["          <subj-group>                                                                                                                                ",{"fg":0}]],"19":[["            <subject>Oncology</subject>                                                                                                               ",{"fg":0}]],"20":[["            <subj-group>                                                                                                                              ",{"fg":0}]],"21":[["              <subject>Basic Cancer Research</subject>                                                                                                ",{"fg":0}]],"22":[["              <subject>Cancer Treatment</subject>                                                                                                     ",{"fg":0}]],"23":[["              <subject>Oncology Agents</subject>                                                                                                      ",{"fg":0}]],"24":[["            </subj-group>                                                                                                                             ",{"fg":0}]],"25":[["          </subj-group>                                                                                                                               ",{"fg":0}]],"26":[["        </subj-group>                                                                                                                                 ",{"fg":0}]],"27":[["      </article-categories>                                                                                                                           ",{"fg":0}]],"28":[["      <title-group>                                                                                                                                   ",{"fg":0}]],"29":[["        <article-title>Increased PRAME-Specific CTL Killing of Acute Myeloid Leukemia Cells by Either a Novel Histone Deacetylase Inhibitor Chidamide ",{"fg":0}]],"30":[["Alone or Combined Treatment with Decitabine</article-title>                                                                                           ",{"fg":0}]],"31":[["        <alt-title alt-title-type=\"running-head\">Chidamide Increases CTL Killing of AML Cells</alt-title>                                             ",{"fg":0}]],"32":[["      </title-group>                                                                                                                                  ",{"fg":0}]],"33":[["      <contrib-group>                                                                                                                                 ",{"fg":0}]],"34":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"35":[["          <name>                                                                                                                                      ",{"fg":0}]],"36":[["            <surname>Yao</surname>                                                                                                                    ",{"fg":0}]],"37":[["            <given-names>Yushi</given-names>                                                                                                          ",{"fg":0}]],"38":[["          </name>                                                                                                                                     ",{"fg":0}]],"39":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"40":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"41":[["          </xref>                                                                                                                                     ",{"fg":0}]],"42":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"43":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"44":[["          <name>                                                                                                                                      ",{"fg":0}]],"45":[["            <surname>Zhou</surname>                                                                                                                   ",{"fg":0}]],"46":[["            <given-names>Jihao</given-names>                                                                                                          ",{"fg":0}]],"47":[["          </name>                                                                                                                                     ",{"fg":0}]],"48":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"49":[["                                                                                                                                                      ",{"fg":0}]]},"cursor":{"x":9}}],[1.8e-05,{"lines":{"0":[["              <subject>Oncology Agents</subject>                                                                                                      ",{"fg":0}]],"1":[["            </subj-group>                                                                                                                             ",{"fg":0}]],"2":[["          </subj-group>                                                                                                                               ",{"fg":0}]],"3":[["        </subj-group>                                                                                                                                 ",{"fg":0}]],"4":[["      </article-categories>                                                                                                                           ",{"fg":0}]],"5":[["      <title-group>                                                                                                                                   ",{"fg":0}]],"6":[["        <article-title>Increased PRAME-Specific CTL Killing of Acute Myeloid Leukemia Cells by Either a Novel Histone Deacetylase Inhibitor Chidamide ",{"fg":0}]],"7":[["Alone or Combined Treatment with Decitabine</article-title>                                                                                           ",{"fg":0}]],"8":[["        <alt-title alt-title-type=\"running-head\">Chidamide Increases CTL Killing of AML Cells</alt-title>                                             ",{"fg":0}]],"9":[["      </title-group>                                                                                                                                  ",{"fg":0}]],"10":[["      <contrib-group>                                                                                                                                 ",{"fg":0}]],"11":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"12":[["          <name>                                                                                                                                      ",{"fg":0}]],"13":[["            <surname>Yao</surname>                                                                                                                    ",{"fg":0}]],"14":[["            <given-names>Yushi</given-names>                                                                                                          ",{"fg":0}]],"15":[["          </name>                                                                                                                                     ",{"fg":0}]],"16":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"17":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"18":[["          </xref>                                                                                                                                     ",{"fg":0}]],"19":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"20":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"21":[["          <name>                                                                                                                                      ",{"fg":0}]],"22":[["            <surname>Zhou</surname>                                                                                                                   ",{"fg":0}]],"23":[["            <given-names>Jihao</given-names>                                                                                                          ",{"fg":0}]],"24":[["          </name>                                                                                                                                     ",{"fg":0}]],"25":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"26":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"27":[["          </xref>                                                                                                                                     ",{"fg":0}]],"28":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"29":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"30":[["          <name>                                                                                                                                      ",{"fg":0}]],"31":[["            <surname>Wang</surname>                                                                                                                   ",{"fg":0}]],"32":[["            <given-names>Lixin</given-names>                                                                                                          ",{"fg":0}]],"33":[["          </name>                                                                                                                                     ",{"fg":0}]],"34":[["          <xref ref-type=\"aff\" rid=\"aff2\">                                                                                                            ",{"fg":0}]],"35":[["            <sup>2</sup>                                                                                                                              ",{"fg":0}]],"36":[["          </xref>                                                                                                                                     ",{"fg":0}]],"37":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"38":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"39":[["          <name>                                                                                                                                      ",{"fg":0}]],"40":[["            <surname>Gao</surname>                                                                                                                    ",{"fg":0}]],"41":[["            <given-names>Xiaoning</given-names>                                                                                                       ",{"fg":0}]],"42":[["          </name>                                                                                                                                     ",{"fg":0}]],"43":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"44":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"45":[["          </xref>                                                                                                                                     ",{"fg":0}]],"46":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"47":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"48":[["          <name>                                                                                                                                      ",{"fg":0}]],"49":[["--More--",{"fg":0,"inverse":true}],["                                                                                                                                              ",{"fg":0}]]},"cursor":{"x":8}}],[2.823979,{"lines":{"0":[["          </name>                                                                                                                                     ",{"fg":0}]],"1":[["          <xref ref-type=\"aff\" rid=\"aff2\">                                                                                                            ",{"fg":0}]],"2":[["            <sup>2</sup>                                                                                                                              ",{"fg":0}]],"3":[["          </xref>                                                                                                                                     ",{"fg":0}]],"4":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"5":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"6":[["          <name>                                                                                                                                      ",{"fg":0}]],"7":[["            <surname>Gao</surname>                                                                                                                    ",{"fg":0}]],"8":[["            <given-names>Xiaoning</given-names>                                                                                                       ",{"fg":0}]],"9":[["          </name>                                                                                                                                     ",{"fg":0}]],"10":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"11":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"12":[["          </xref>                                                                                                                                     ",{"fg":0}]],"13":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"14":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"15":[["          <name>                                                                                                                                      ",{"fg":0}]],"16":[["            <surname>Ning</surname>                                                                                                                   ",{"fg":0}]],"17":[["            <given-names>Qiaoyang</given-names>                                                                                                       ",{"fg":0}]],"18":[["          </name>                                                                                                                                     ",{"fg":0}]],"19":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"20":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"21":[["          </xref>                                                                                                                                     ",{"fg":0}]],"22":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"23":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"24":[["          <name>                                                                                                                                      ",{"fg":0}]],"25":[["            <surname>Jiang</surname>                                                                                                                  ",{"fg":0}]],"26":[["            <given-names>Mengmeng</given-names>                                                                                                       ",{"fg":0}]],"27":[["          </name>                                                                                                                                     ",{"fg":0}]],"28":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"29":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"30":[["          </xref>                                                                                                                                     ",{"fg":0}]],"31":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"32":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"33":[["          <name>                                                                                                                                      ",{"fg":0}]],"34":[["            <surname>Wang</surname>                                                                                                                   ",{"fg":0}]],"35":[["            <given-names>Jia</given-names>                                                                                                            ",{"fg":0}]],"36":[["          </name>                                                                                                                                     ",{"fg":0}]],"37":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"38":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"39":[["          </xref>                                                                                                                                     ",{"fg":0}]],"40":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"41":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"42":[["          <name>                                                                                                                                      ",{"fg":0}]],"43":[["            <surname>Wang</surname>                                                                                                                   ",{"fg":0}]],"44":[["            <given-names>Lili</given-names>                                                                                                           ",{"fg":0}]],"45":[["          </name>                                                                                                                                     ",{"fg":0}]],"46":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"47":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"48":[["          </xref>                                                                                                                                     ",{"fg":0}]],"49":[["        </contrib>                                                                                                                                    ",{"fg":0}]]},"cursor":{"x":18}}],[2e-05,{"lines":{"0":[["            <surname>Ning</surname>                                                                                                                   ",{"fg":0}]],"1":[["            <given-names>Qiaoyang</given-names>                                                                                                       ",{"fg":0}]],"2":[["          </name>                                                                                                                                     ",{"fg":0}]],"3":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"4":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"5":[["          </xref>                                                                                                                                     ",{"fg":0}]],"6":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"7":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"8":[["          <name>                                                                                                                                      ",{"fg":0}]],"9":[["            <surname>Jiang</surname>                                                                                                                  ",{"fg":0}]],"10":[["            <given-names>Mengmeng</given-names>                                                                                                       ",{"fg":0}]],"11":[["          </name>                                                                                                                                     ",{"fg":0}]],"12":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"13":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"14":[["          </xref>                                                                                                                                     ",{"fg":0}]],"15":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"16":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"17":[["          <name>                                                                                                                                      ",{"fg":0}]],"18":[["            <surname>Wang</surname>                                                                                                                   ",{"fg":0}]],"19":[["            <given-names>Jia</given-names>                                                                                                            ",{"fg":0}]],"20":[["          </name>                                                                                                                                     ",{"fg":0}]],"21":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"22":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"23":[["          </xref>                                                                                                                                     ",{"fg":0}]],"24":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"25":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"26":[["          <name>                                                                                                                                      ",{"fg":0}]],"27":[["            <surname>Wang</surname>                                                                                                                   ",{"fg":0}]],"28":[["            <given-names>Lili</given-names>                                                                                                           ",{"fg":0}]],"29":[["          </name>                                                                                                                                     ",{"fg":0}]],"30":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"31":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"32":[["          </xref>                                                                                                                                     ",{"fg":0}]],"33":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"34":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"35":[["          <name>                                                                                                                                      ",{"fg":0}]],"36":[["            <surname>Yu</surname>                                                                                                                     ",{"fg":0}]],"37":[["            <given-names>Li</given-names>                                                                                                             ",{"fg":0}]],"38":[["          </name>                                                                                                                                     ",{"fg":0}]],"39":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"40":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"41":[["          </xref>                                                                                                                                     ",{"fg":0}]],"42":[["          <xref ref-type=\"corresp\" rid=\"cor1\">                                                                                                        ",{"fg":0}]],"43":[["            <sup>*</sup>                                                                                                                              ",{"fg":0}]],"44":[["          </xref>                                                                                                                                     ",{"fg":0}]],"45":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"46":[["      </contrib-group>                                                                                                                                ",{"fg":0}]],"47":[["      <aff id=\"aff1\">                                                                                                                                 ",{"fg":0}]],"48":[["        <label>1</label>                                                                                                                              ",{"fg":0}]],"49":[["--More--",{"fg":0,"inverse":true}],["                                                                                                                                              ",{"fg":0}]]},"cursor":{"x":8}}],[2.159951,{"lines":{"0":[["          </name>                                                                                                                                     ",{"fg":0}]],"1":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"2":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"3":[["          </xref>                                                                                                                                     ",{"fg":0}]],"4":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"5":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"6":[["          <name>                                                                                                                                      ",{"fg":0}]],"7":[["            <surname>Wang</surname>                                                                                                                   ",{"fg":0}]],"8":[["            <given-names>Jia</given-names>                                                                                                            ",{"fg":0}]],"9":[["          </name>                                                                                                                                     ",{"fg":0}]],"10":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"11":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"12":[["          </xref>                                                                                                                                     ",{"fg":0}]],"13":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"14":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"15":[["          <name>                                                                                                                                      ",{"fg":0}]],"16":[["            <surname>Wang</surname>                                                                                                                   ",{"fg":0}]],"17":[["            <given-names>Lili</given-names>                                                                                                           ",{"fg":0}]],"18":[["          </name>                                                                                                                                     ",{"fg":0}]],"19":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"20":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"21":[["          </xref>                                                                                                                                     ",{"fg":0}]],"22":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"23":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"24":[["          <name>                                                                                                                                      ",{"fg":0}]],"25":[["            <surname>Yu</surname>                                                                                                                     ",{"fg":0}]],"26":[["            <given-names>Li</given-names>                                                                                                             ",{"fg":0}]],"27":[["          </name>                                                                                                                                     ",{"fg":0}]],"28":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"29":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"30":[["          </xref>                                                                                                                                     ",{"fg":0}]],"31":[["          <xref ref-type=\"corresp\" rid=\"cor1\">                                                                                                        ",{"fg":0}]],"32":[["            <sup>*</sup>                                                                                                                              ",{"fg":0}]],"33":[["          </xref>                                                                                                                                     ",{"fg":0}]],"34":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"35":[["      </contrib-group>                                                                                                                                ",{"fg":0}]],"36":[["      <aff id=\"aff1\">                                                                                                                                 ",{"fg":0}]],"37":[["        <label>1</label>                                                                                                                              ",{"fg":0}]],"38":[["        <addr-line>Department of Hematology and BMT Center, Chinese PLA General Hospital, Beijing, China</addr-line>                                  ",{"fg":0}]],"39":[["      </aff>                                                                                                                                          ",{"fg":0}]],"40":[["      <aff id=\"aff2\">                                                                                                                                 ",{"fg":0}]],"41":[["        <label>2</label>                                                                                                                              ",{"fg":0}]],"42":[["                                                                                                                                                      ",{"fg":0}]],"43":[["                                                                                                                                                      ",{"fg":0}]],"44":[["... and here is my ",{"fg":6}],[" XSLT stylesheet",{"fg":1}],[" (for processing that XML file)",{"fg":6}],["                                                                                    ",{"fg":0}]],"45":[["                                                                                                                                                      ",{}]],"46":[["    [ cat victoria-1.2.xsl | more ]                                                                                                                   ",{}]],"47":[["                                                                                                                                                      ",{}]],"48":[["                                                                                                                                                      ",{}]],"49":[["Press <Enter> key to continue ...",{"fg":1}],["                                                                                                                     ",{}]]},"cursor":{"x":33}}],[3.015771,{"lines":{"0":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"1":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"2":[["          </xref>                                                                                                                                     ",{"fg":0}]],"3":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"4":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"5":[["          <name>                                                                                                                                      ",{"fg":0}]],"6":[["            <surname>Wang</surname>                                                                                                                   ",{"fg":0}]],"7":[["            <given-names>Jia</given-names>                                                                                                            ",{"fg":0}]],"8":[["          </name>                                                                                                                                     ",{"fg":0}]],"9":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"10":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"11":[["          </xref>                                                                                                                                     ",{"fg":0}]],"12":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"13":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"14":[["          <name>                                                                                                                                      ",{"fg":0}]],"15":[["            <surname>Wang</surname>                                                                                                                   ",{"fg":0}]],"16":[["            <given-names>Lili</given-names>                                                                                                           ",{"fg":0}]],"17":[["          </name>                                                                                                                                     ",{"fg":0}]],"18":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"19":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"20":[["          </xref>                                                                                                                                     ",{"fg":0}]],"21":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"22":[["        <contrib contrib-type=\"author\">                                                                                                               ",{"fg":0}]],"23":[["          <name>                                                                                                                                      ",{"fg":0}]],"24":[["            <surname>Yu</surname>                                                                                                                     ",{"fg":0}]],"25":[["            <given-names>Li</given-names>                                                                                                             ",{"fg":0}]],"26":[["          </name>                                                                                                                                     ",{"fg":0}]],"27":[["          <xref ref-type=\"aff\" rid=\"aff1\">                                                                                                            ",{"fg":0}]],"28":[["            <sup>1</sup>                                                                                                                              ",{"fg":0}]],"29":[["          </xref>                                                                                                                                     ",{"fg":0}]],"30":[["          <xref ref-type=\"corresp\" rid=\"cor1\">                                                                                                        ",{"fg":0}]],"31":[["            <sup>*</sup>                                                                                                                              ",{"fg":0}]],"32":[["          </xref>                                                                                                                                     ",{"fg":0}]],"33":[["        </contrib>                                                                                                                                    ",{"fg":0}]],"34":[["      </contrib-group>                                                                                                                                ",{"fg":0}]],"35":[["      <aff id=\"aff1\">                                                                                                                                 ",{"fg":0}]],"36":[["        <label>1</label>                                                                                                                              ",{"fg":0}]],"37":[["        <addr-line>Department of Hematology and BMT Center, Chinese PLA General Hospital, Beijing, China</addr-line>                                  ",{"fg":0}]],"38":[["      </aff>                                                                                                                                          ",{"fg":0}]],"39":[["      <aff id=\"aff2\">                                                                                                                                 ",{"fg":0}]],"40":[["        <label>2</label>                                                                                                                              ",{"fg":0}]],"41":[["                                                                                                                                                      ",{"fg":0}]],"43":[["... and here is my ",{"fg":6}],[" XSLT stylesheet",{"fg":1}],[" (for processing that XML file)",{"fg":6}],["                                                                                    ",{"fg":0}]],"44":[["                                                                                                                                                      ",{}]],"45":[["    [ cat victoria-1.2.xsl | more ]                                                                                                                   ",{}]],"46":[["                                                                                                                                                      ",{}]],"48":[["Press <Enter> key to continue ...",{"fg":1}],["                                                                                                                     ",{}]],"49":[["                                                                                                                                                      ",{"fg":1}]]},"cursor":{"x":0}}],[0.003997,{"lines":{"0":[["<?xml version=\"1.0\" encoding=\"UTF-8\"?>                                                                                                                ",{"fg":0}]],"1":[["<xsl:stylesheet version=\"1.0\"                                                                                                                         ",{"fg":0}]],"2":[["    xmlns:xsl=\"http://www.w3.org/1999/XSL/Transform\">                                                                                                 ",{"fg":0}]],"3":[["                                                                                                                                                      ",{"fg":0}]],"4":[["<xsl:output encoding=\"utf-8\" method=\"text\"/>                                                                                                          ",{"fg":0}]],"5":[["                                                                                                                                                      ",{"fg":0}]],"6":[["<!-- To compress (completely wrap, as one line, the <body> section, include this code:                                                                ",{"fg":0}]],"7":[["    <xsl:strip-space elements=\"*\"/>                                                                                                                   ",{"fg":0}]],"8":[["... which will also strip a lot of white space: blank lines ...) -->                                                                                  ",{"fg":0}]],"9":[["                                                                                                                                                      ",{"fg":0}]],"10":[["<xsl:template match=\"pmc-articleset\">                                                                                                                 ",{"fg":0}]],"11":[["                                                                                                                                                      ",{"fg":0}]],"12":[["<!-- loop over the source document -->                                                                                                                ",{"fg":0}]],"13":[["<xsl:for-each select=\"article\">                                                                                                                       ",{"fg":0}]],"14":[["                                                                                                                                                      ",{"fg":0}]],"15":[["NEW_RECORD                                                                                                                                            ",{"fg":0}]],"16":[["PMCID_<xsl:value-of select=\"front/article-meta/article-id[@pub-id-type='pmc']\" />                                                                     ",{"fg":0}]],"17":[["TITLE: <xsl:value-of select=\"front/article-meta/title-group/article-title\"/>                                                                          ",{"fg":0}]],"18":[["                                                                                                                                                      ",{"fg":0}]],"19":[["AUTHORS: <xsl:for-each select=\"front/article-meta/contrib-group/contrib\">                                                                             ",{"fg":0}]],"20":[["<xsl:value-of select=\"name/surname\" />                                                                                                                ",{"fg":0}]],"21":[["<xsl:text>, </xsl:text>                                                                                                                               ",{"fg":0}]],"22":[["<xsl:value-of select=\"name/given-names\" />                                                                                                            ",{"fg":0}]],"23":[["<xsl:if test=\"not(position() = last())\"> | </xsl:if>                                                                                                  ",{"fg":0}]],"24":[["</xsl:for-each>                                                                                                                                       ",{"fg":0}]],"25":[["                                                                                                                                                      ",{"fg":0}]],"26":[["JOURNAL: <xsl:value-of select=\"front/journal-meta/journal-title-group/journal-title\"/>                                                                ",{"fg":0}]],"27":[["                                                                                                                                                      ",{"fg":0}]],"28":[["<xsl:for-each select=\"front/article-meta\">                                                                                                            ",{"fg":0}]],"29":[["PMCID: <xsl:value-of select=\"article-id[@pub-id-type='pmc']\" />                                                                                       ",{"fg":0}]],"30":[["PMID:  <xsl:value-of select=\"article-id[@pub-id-type='pmid']\" />                                                                                      ",{"fg":0}]],"31":[["<xsl:if test=\"not(position() = last())\">; </xsl:if>                                                                                                   ",{"fg":0}]],"32":[["</xsl:for-each>                                                                                                                                       ",{"fg":0}]],"33":[["                                                                                                                                                      ",{"fg":0}]],"34":[["<xsl:for-each select=\"front/article-meta/pub-date[@pub-type='collection']\">                                                                           ",{"fg":0}]],"35":[["YEAR: <xsl:value-of select=\"year\" />                                                                                                                  ",{"fg":0}]],"36":[["</xsl:for-each>                                                                                                                                       ",{"fg":0}]],"37":[["                                                                                                                                                      ",{"fg":0}]],"38":[["<xsl:for-each select=\"front/article-meta/pub-date[@pub-type='epub']\">                                                                                 ",{"fg":0}]],"39":[["MONTH: <xsl:value-of select=\"month\" />                                                                                                                ",{"fg":0}]],"40":[["</xsl:for-each>                                                                                                                                       ",{"fg":0}]],"42":[["<!-- <xsl:text>&#xa;</xsl:text> -->                                                                                                                   ",{"fg":0}]],"43":[["<xsl:text></xsl:text>                                                                                                                                 ",{"fg":0}]],"44":[["                                                                                                                                                      ",{"fg":0}]],"45":[["SUBJECTS (MeSH): <xsl:for-each select=\".//subject\">                                                                                                   ",{"fg":0}]],"46":[["<xsl:value-of select=\".\" />                                                                                                                           ",{"fg":0}]],"47":[["<xsl:if test=\"not(position() = last())\"> | </xsl:if>                                                                                                  ",{"fg":0}]],"48":[["</xsl:for-each>                                                                                                                                       ",{"fg":0}]],"49":[["--More--",{"fg":0,"inverse":true}],["                                                                                                                                              ",{"fg":0}]]},"cursor":{"x":8}}],[7.476269,{"lines":{"0":[["PMCID_<xsl:value-of select=\"front/article-meta/article-id[@pub-id-type='pmc']\" />                                                                     ",{"fg":0}]],"1":[["TITLE: <xsl:value-of select=\"front/article-meta/title-group/article-title\"/>                                                                          ",{"fg":0}]],"2":[["                                                                                                                                                      ",{"fg":0}]],"3":[["AUTHORS: <xsl:for-each select=\"front/article-meta/contrib-group/contrib\">                                                                             ",{"fg":0}]],"4":[["<xsl:value-of select=\"name/surname\" />                                                                                                                ",{"fg":0}]],"5":[["<xsl:text>, </xsl:text>                                                                                                                               ",{"fg":0}]],"6":[["<xsl:value-of select=\"name/given-names\" />                                                                                                            ",{"fg":0}]],"7":[["<xsl:if test=\"not(position() = last())\"> | </xsl:if>                                                                                                  ",{"fg":0}]],"8":[["</xsl:for-each>                                                                                                                                       ",{"fg":0}]],"10":[["JOURNAL: <xsl:value-of select=\"front/journal-meta/journal-title-group/journal-title\"/>                                                                ",{"fg":0}]],"12":[["<xsl:for-each select=\"front/article-meta\">                                                                                                            ",{"fg":0}]],"13":[["PMCID: <xsl:value-of select=\"article-id[@pub-id-type='pmc']\" />                                                                                       ",{"fg":0}]],"14":[["PMID:  <xsl:value-of select=\"article-id[@pub-id-type='pmid']\" />                                                                                      ",{"fg":0}]],"15":[["<xsl:if test=\"not(position() = last())\">; </xsl:if>                                                                                                   ",{"fg":0}]],"16":[["</xsl:for-each>                                                                                                                                       ",{"fg":0}]],"17":[["                                                                                                                                                      ",{"fg":0}]],"18":[["<xsl:for-each select=\"front/article-meta/pub-date[@pub-type='collection']\">                                                                           ",{"fg":0}]],"19":[["YEAR: <xsl:value-of select=\"year\" />                                                                                                                  ",{"fg":0}]],"20":[["</xsl:for-each>                                                                                                                                       ",{"fg":0}]],"21":[["                                                                                                                                                      ",{"fg":0}]],"22":[["<xsl:for-each select=\"front/article-meta/pub-date[@pub-type='epub']\">                                                                                 ",{"fg":0}]],"23":[["MONTH: <xsl:value-of select=\"month\" />                                                                                                                ",{"fg":0}]],"26":[["<!-- <xsl:text>&#xa;</xsl:text> -->                                                                                                                   ",{"fg":0}]],"27":[["<xsl:text></xsl:text>                                                                                                                                 ",{"fg":0}]],"28":[["                                                                                                                                                      ",{"fg":0}]],"29":[["SUBJECTS (MeSH): <xsl:for-each select=\".//subject\">                                                                                                   ",{"fg":0}]],"30":[["<xsl:value-of select=\".\" />                                                                                                                           ",{"fg":0}]],"31":[["<xsl:if test=\"not(position() = last())\"> | </xsl:if>                                                                                                  ",{"fg":0}]],"34":[["<xsl:text>&#xa;</xsl:text>                                                                                                                            ",{"fg":0}]],"35":[["ABSTRACT:                                                                                                                                             ",{"fg":0}]],"36":[["<xsl:value-of select=\"front/article-meta/abstract\"/>                                                                                                  ",{"fg":0}]],"38":[["BODY:                                                                                                                                                 ",{"fg":0}]],"39":[["<xsl:value-of select=\"body\"/>                                                                                                                         ",{"fg":0}]],"40":[["                                                                                                                                                      ",{"fg":0}]],"41":[["<!-- Add Acknowledgements, References:                                                                                                                ",{"fg":0}]],"42":[["    <back>                                                                                                                                            ",{"fg":0}]],"43":[["-->                                                                                                                                                   ",{"fg":0}]],"45":[["</xsl:for-each>                                                                                                                                       ",{"fg":0}]],"46":[["</xsl:template>                                                                                                                                       ",{"fg":0}]],"47":[["</xsl:stylesheet>                                                                                                                                     ",{"fg":0}]],"48":[["                                                                                                                                                      ",{"fg":0}]],"49":[["Press <Enter> key to continue ...",{"fg":1}],["                                                                                                                     ",{"fg":0}]]},"cursor":{"x":33}}],[5.455959,{"lines":{"0":[["                                                                                                                                                      ",{"fg":0}]],"1":[["----------------------------------------                                                                                                              ",{"fg":0}]],"3":[["                                                                                                                                                      ",{"fg":0}]],"4":[["                                                                                                                                                      ",{"fg":0}]],"5":[["                                                                                                                                                      ",{"fg":0}]],"6":[["                                                                                                                                                      ",{"fg":0}]],"7":[["                                                                                                                                                      ",{"fg":0}]],"8":[["                                                                                                                                                      ",{"fg":0}]],"10":[["                                                                                                                                                      ",{"fg":0}]],"12":[["                                                                                                                                                      ",{"fg":0}]],"13":[["                                                                                                                                                      ",{"fg":0}]],"14":[["                                                                                                                                                      ",{"fg":0}]],"15":[["                                                                                                                                                      ",{"fg":0}]],"16":[["                                                                                                                                                      ",{"fg":0}]],"18":[["                                                                                                                                                      ",{"fg":0}]],"19":[["                                                                                                                                                      ",{"fg":0}]],"20":[["                                                                                                                                                      ",{"fg":0}]],"22":[["                                                                                                                                                      ",{"fg":0}]],"23":[["                                                                                                                                                      ",{"fg":0}]],"24":[["                                                                                                                                                      ",{"fg":0}]],"26":[["                                                                                                                                                      ",{"fg":0}]],"27":[["                                                                                                                                                      ",{"fg":0}]],"29":[["                                                                                                                                                      ",{"fg":0}]],"30":[["                                                                                                                                                      ",{"fg":0}]],"31":[["                                                                                                                                                      ",{"fg":0}]],"32":[["                                                                                                                                                      ",{"fg":0}]],"34":[["                                                                                                                                                      ",{"fg":0}]],"35":[["                                                                                                                                                      ",{"fg":0}]],"36":[["                                                                                                                                                      ",{"fg":0}]],"38":[["                                                                                                                                                      ",{"fg":0}]],"39":[["                                                                                                                                                      ",{"fg":0}]],"41":[["                                                                                                                                                      ",{"fg":0}]],"42":[["                                                                                                                                                      ",{"fg":0}]],"43":[["                                                                                                                                                      ",{"fg":0}]],"45":[["                                                                                                                                                      ",{"fg":0}]],"46":[["                                                                                                                                                      ",{"fg":0}]],"47":[["                                                                                                                                                      ",{"fg":0}]],"49":[["                                                                                                                                                      ",{"fg":0}]]},"cursor":{"x":0,"y":2}}],[0.001768,{"lines":{"2":[["NOW, START PROCESSING THE \"AML\"",{"fg":1}],["                                                                                                                       ",{"fg":0}]],"3":[["XML FILE VIA THE XSLT STYLESHEET",{"fg":1}],["                                                                                                                      ",{"fg":0}]],"4":[["----------------------------------------",{}],["                                                                                                              ",{"fg":0}]],"6":[["xsltproc -o set2.txt victoria-1.2.xsl \"pmc_result_AML.xml\"",{"fg":6}],["                                                                                            ",{"fg":0}]]},"cursor":{"y":7}}],[9.378016000000001,{"lines":{"8":[["... removing lines that begin with spaces or tabs:",{"fg":6}],["                                                                                                    ",{"fg":0}]]},"cursor":{"y":10}}],[0.041229,{"lines":{"10":[["sed -i -e s/^[ t]*// set2.txt",{}],["                                                                                                                         ",{"fg":0}]]},"cursor":{"y":11}}],[0.462231,{"lines":{"12":[["... removing duplicate blank lines (sed -s):",{"fg":6}],["                                                                                                          ",{"fg":0}]],"14":[["cat -s set2.txt > tmp && cat tmp > set2.txt && rm -f tmp",{}],["                                                                                              ",{"fg":0}]]},"cursor":{"y":15}}],[2.634533,{"lines":{"16":[["... now, splitting the XML file into individual records (csplit):",{"fg":6}],["                                                                                     ",{"fg":0}]],"18":[["[   accomplished via \"NEW_RECORD\" flags that I insert into ]",{}],["                                                                                          ",{"fg":0}]],"19":[["[   the XML file via my XSLT stylesheet and xlstproc ]",{}],["                                                                                                ",{"fg":0}]],"21":[["csplit -n 3 -s -k -z -f pmc_record_ set3.txt \"/NEW_RECORD/-1\"  \"{*}\"",{}],["                                                                                  ",{"fg":0}]]},"cursor":{"y":22}}],[17.45222,{"lines":{"23":[["... renaming the individual records with their PMCID:",{"fg":6}],["                                                                                                 ",{"fg":0}]]},"cursor":{"y":25}}],[0.131776,{"lines":{"25":[["for i in pmc_record*; do mv -f $i `egrep -m1 -e PMCID_* $i | sed -e s/IDtag ID//`; done",{}],["                                                               ",{"fg":0}]]},"cursor":{"y":26}}],[67.86924,{"cursor":{"y":27}}],[10.93477,{"lines":{"28":[["... prepending each record file name with AML_ (Set 2) or cancer_ (Set 3):",{"fg":6}],["                                                                            ",{"fg":0}]],"30":[["for i in PMCID*; do mv \"$i\" \"AML_$i\"; done",{}],["                                                                                                            ",{"fg":0}]]},"cursor":{"y":31}}],[13.013025,{"lines":{"32":[["Press <Enter> key to continue ...",{"fg":1}],["                                                                                                                     ",{"fg":0}]]},"cursor":{"x":33,"y":32}}],[0.002104,{"lines":{"2":[["NOW PROCESSING Set 3 (silent) ...",{"fg":1}],["                                                                                                                     ",{"fg":0}]],"3":[["----------------------------------------",{}],["                                                                                                              ",{"fg":0}]],"4":[["                                                                                                                                                      ",{"fg":0}]],"5":[["    Processing PMC XML file via xsltproc & XSLT stylesheet ...",{"fg":6}],["                                                                                        ",{"fg":0}]],"6":[["                                                                                                                                                      ",{"fg":0}]],"8":[["                                                                                                                                                      ",{"fg":0}]],"10":[["                                                                                                                                                      ",{"fg":0}]],"12":[["                                                                                                                                                      ",{"fg":0}]],"14":[["                                                                                                                                                      ",{"fg":0}]],"16":[["                                                                                                                                                      ",{"fg":0}]],"18":[["                                                                                                                                                      ",{"fg":0}]],"19":[["                                                                                                                                                      ",{"fg":0}]],"21":[["                                                                                                                                                      ",{"fg":0}]],"23":[["                                                                                                                                                      ",{"fg":0}]],"25":[["                                                                                                                                                      ",{"fg":0}]],"28":[["                                                                                                                                                      ",{"fg":0}]],"30":[["                                                                                                                                                      ",{"fg":0}]],"32":[["                                                                                                                                                      ",{"fg":0}]]},"cursor":{"x":0,"y":6}}],[6.170863,{"lines":{"6":[["    ... removing lines beginning with space or tab ...",{}],["                                                                                                ",{"fg":0}]]},"cursor":{"y":7}}],[0.603028,{"lines":{"7":[["    ... removing duplicate blank lines ...",{}],["                                                                                                            ",{"fg":0}]]},"cursor":{"y":8}}],[0.908981,{"lines":{"8":[["    ... splitting XML file into individual records ...",{}],["                                                                                                ",{"fg":0}]]},"cursor":{"y":9}}],[5.695988,{"lines":{"9":[["    ... renaming each file with it's PMCID UI ...",{}],["                                                                                                     ",{"fg":0}]]},"cursor":{"y":10}}],[60.883222,{"lines":{"10":[["    ... prepending each file with \"cancer_\" ...",{}],["                                                                                                       ",{"fg":0}]]},"cursor":{"y":11}}],[14.612792,{"lines":{"12":[["Done!  : - )  Press <Enter> key to continue ...",{"fg":1}],["                                                                                                       ",{"fg":0}]]},"cursor":{"x":47,"y":12}}],[1.08199,{"cursor":{"x":0,"y":13}}],[0.001371,{"lines":{"1":[["So, how many files (records) do we have?",{"fg":1}],["                                                                                                              ",{"fg":0}]],"2":[["                                                                                                                                                      ",{"fg":0}]],"3":[["AML: ls -l AML_PMCID* | wc -l",{}],["                                                                                                                         ",{"fg":0}]],"5":[["                                                                                                                                                      ",{"fg":0}]],"6":[["                                                                                                                                                      ",{"fg":0}]],"7":[["                                                                                                                                                      ",{"fg":0}]],"8":[["                                                                                                                                                      ",{"fg":0}]],"9":[["                                                                                                                                                      ",{"fg":0}]],"10":[["                                                                                                                                                      ",{"fg":0}]],"12":[["                                                                                                                                                      ",{"fg":0}]]},"cursor":{"y":4}}],[0.120641,{"lines":{"4":[["395",{}],["                                                                                                                                                   ",{"fg":0}]],"6":[["cancer: ls -l cancer_PMCID* | wc -l",{}],["                                                                                                                   ",{"fg":0}]]},"cursor":{"y":7}}],[0.007900000000000001,{"lines":{"7":[["392",{}],["                                                                                                                                                   ",{"fg":0}]],"9":[["-------------------",{}],["                                                                                                                                   ",{"fg":0}]],"11":[["Now, let's search our AML-related patterns over those PMC records,",{"fg":6}],["                                                                                    ",{"fg":0}]],"12":[["using the \"patterns-1.6\" file and grep:",{"fg":6}],["                                                                                                               ",{"fg":0}]],"14":[["    grep -il -f patterns-1.6 *PMCID* > out-l",{}],["                                                                                                          ",{"fg":0}]]},"cursor":{"y":16}}],[10.445101,{"lines":{"17":[["    -i : ignore case",{"fg":2}],["                                                                                                                                  ",{"fg":0}]],"18":[["    -l : output matching files, not lines",{"fg":2}],["                                                                                                             ",{"fg":0}]],"19":[["    -f : read a PATTERNS file",{"fg":2}],["                                                                                                                         ",{"fg":0}]],"21":[["[ Hence, \"out-l\" is a file containing a list of matched file names. ]",{"fg":6}],["                                                                                 ",{"fg":0}]],"23":[["Number of pattern-matched files ( cat out-l | wc -l ):",{}],["                                                                                                ",{"fg":0}]]},"cursor":{"y":24}}],[0.010267,{"lines":{"24":[["501",{}],["                                                                                                                                                   ",{"fg":0}]],"26":[["Press <Enter> key to continue ...",{"fg":1}],["                                                                                                                     ",{"fg":0}]]},"cursor":{"x":33,"y":26}}],[5.734914,{"cursor":{"x":0,"y":27}}],[0.014865,{"lines":{"28":[["-------------------                                                                                                                                   ",{"fg":0}]],"30":[["Pattern-matched PMCID records in output file \"out-l\" :",{"fg":6}],["                                                                                                ",{"fg":0}]],"32":[["    grep -i aml_pmcid* out-l | wc -l",{"fg":6}],["                                                                                                                  ",{"fg":0}]],"34":[["    [ note - could also use: cat out-l | grep -i aml_pmcid | wc -l ]",{}],["                                                                                  ",{"fg":0}]],"36":[["395",{}],["                                                                                                                                                   ",{"fg":0}]],"38":[["    grep -i cancer_PMCID* out-l | wc -l",{"fg":6}],["                                                                                                               ",{"fg":0}]],"40":[["    [ note - could also use: cat out-l | grep -i cancer_pmcid | wc -l ]",{}],["                                                                               ",{"fg":0}]],"42":[["106",{}],["                                                                                                                                                   ",{"fg":0}]]},"cursor":{"y":44}}],[0.002266,{"lines":{"44":[["Press <Enter> key to continue ...",{"fg":1}],["                                                                                                                     ",{"fg":0}]]},"cursor":{"x":33}}],[6.149777,{"cursor":{"x":0,"y":46}}],[0.001263,{"lines":{"1":[["----------------------------------------                                                                                                              ",{"fg":0}]],"2":[["LASTLY, FOR REASSURANCE LET's",{"fg":1}],["                                                                                                                         ",{"fg":0}]],"3":[["EXAMINE THE ACTUAL PATTERN MATCHING:",{"fg":1}],["                                                                                                                  ",{"fg":0}]],"4":[["----------------------------------------",{}],["                                                                                                              ",{"fg":0}]],"6":[["\\033[0;36m    grep -i --color=always -f patterns-1.6  AML_PMCID* | more\\033[0m",{}],["                                                                        ",{"fg":0}]],"7":[["                                                                                                                                                      ",{"fg":0}]],"9":[["                                                                                                                                                      ",{"fg":0}]],"11":[["                                                                                                                                                      ",{"fg":0}]],"12":[["                                                                                                                                                      ",{"fg":0}]],"14":[["                                                                                                                                                      ",{"fg":0}]],"17":[["                                                                                                                                                      ",{"fg":0}]],"18":[["                                                                                                                                                      ",{"fg":0}]],"19":[["                                                                                                                                                      ",{"fg":0}]],"21":[["                                                                                                                                                      ",{"fg":0}]],"23":[["                                                                                                                                                      ",{"fg":0}]],"24":[["                                                                                                                                                      ",{"fg":0}]],"26":[["                                                                                                                                                      ",{"fg":0}]],"28":[["                                                                                                                                                      ",{"fg":0}]],"30":[["                                                                                                                                                      ",{"fg":0}]],"32":[["                                                                                                                                                      ",{"fg":0}]],"34":[["                                                                                                                                                      ",{"fg":0}]],"36":[["                                                                                                                                                      ",{"fg":0}]],"38":[["                                                                                                                                                      ",{"fg":0}]],"40":[["                                                                                                                                                      ",{"fg":0}]],"42":[["                                                                                                                                                      ",{"fg":0}]],"44":[["                                                                                                                                                      ",{"fg":0}]]},"cursor":{"y":7}}],[0.175674,{"lines":{"7":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["TITLE: Incidence of ",{}],["leukemias",{"fg":1,"bold":true}],[" in children from El Salvador and Mexico City between 1996 and 2000: P                                 ",{}]],"8":[["opulation-based data",{}],["                                                                                                                                  ",{"fg":0}]],"9":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["There are very few studies that report the incidence of acute ",{}],["leukemias",{"fg":1,"bold":true}],[" in children in Latin Americ                                 ",{}]],"10":[["a. This work assesses the incidence of acute ",{}],["leukemias",{"fg":1,"bold":true}],[", between 1996 and 2000, in children from 0–14 years old who were attended at the M             ",{}]],"11":[["exican Social Security Institute in Mexico City and in children from 0–11 years old in El Salvador.",{}],["                                                   ",{"fg":0}]],"12":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Design: Population-based data. Hospitals: In San Salvador, El Salvador, Hospital Nacional de Niños \"Benjamín Blo                    ",{}]],"13":[["om\", the only center in El Salvador which attends all children, younger than 12 years, with oncologic disease. The Pediatric Hospital and the General ",{}]],"14":[["Hospital of the Mexican Social Security Institute in Mexico City, the only centers in Mexico City w",{}],["                                                   ",{"fg":0}]]},"cursor":{"x":99,"y":14}}],[5.4e-05,{"lines":{"14":[["Hospital of the Mexican Social Security Institute in Mexico City, the only centers in Mexico City which attend all those children with acute ",{}],["         ",{"fg":1,"bold":true}]],"15":[["leukemia ",{"fg":1,"bold":true}],["who have a right to this service. Diagnosis: All patients were diagnosed by bone marrow smear and were divided into acute lymphoid leukem    ",{}]],"16":[["ia (ALL), acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],["), chronic myeloid leukemia (CML), and unspecified ",{}],["leukemias",{"fg":1,"bold":true}],[" (UL). The annual incidence                          ",{}]],"17":[[" rate (AIR) and average annual incidence rate (AAIR) were calculated per million children. Cases were stratified by age and assigned to one of four ag",{}]],"18":[["e strata: 1) <1 year; 2) 1–4 years; 3) 5–9 years, or 4) 10–14 or 10–11 years, for Mexico City and El Salvador, respectively.",{}],["                          ",{"fg":0}]],"19":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["The number of cases was 375 and 238 in El Salvador and Mexico City, respectively. AAIRs in Mexico City were 44.9                    ",{}]],"20":[[", 10.6, 2.5, 0.5, and 58.4 per million children for ALL, ",{}],["AML",{"fg":1,"bold":true}],[", CML, UL, and total ",{}],["leukemias",{"fg":1,"bold":true}],[", respectively. The AAIRs in El Sa                          ",{}]],"21":[["lvador could not be calculated because the fourth age stratum in El Salvador included children only from 0–11 years old. The incidence rates for the S",{}]],"22":[["alvadoran group of 0–11 year olds were 34.2, 7.1, 0.6, 0.2, and 43.2 per million children for ALL, ",{}],["AML",{"fg":1,"bold":true}],[", CML, UL, and total ",{}],["leuke                      ",{"fg":1,"bold":true}]],"23":[["mias",{"fg":1,"bold":true}],[", respectively.                                                                                                                                   ",{}]],"24":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Leukemias",{"fg":1,"bold":true}],[" are the most frequent type of cancer in childhood [1], the incidence of which varies depe                                 ",{}]],"25":[["nding on the area of the world where they are studied [2]. An elevated frequency of acute ",{}],["leukemias",{"fg":1,"bold":true}],[" has been reported in populations of H             ",{}]],"26":[["ispanic origin [3-5]. For example, in Costa Rica, the highest incidence rate in the world for acute ",{}],["leukemias",{"fg":1,"bold":true}],[" has been reported: 56 per m             ",{}]],"27":[["illion of children under the age of 15 years [5]. In California and Texas, two states of the U.S. which have a Hispanic component predominately of Mex",{}]],"28":[["ican origin [3], the incidence rates for ALL and for AL in general have been found to be greater than those previously reported for Mexico City [6-8].",{}]],"29":[[" However, because the studies carried out in Mexico City have been retrospective, it is possible that a under-register of the infirmity may have exist",{}]],"30":[["ed in Mexico City. In Florida, the state with the highest predominance of Hispanics of Caribbean and Central American origin, the incidence rate of AL",{}]],"31":[["L was higher than that reported for the Caucasian population and similarly elevated to that reported for Costa Rica. For the Central American country ",{}]],"32":[["of El Salvador, there is no prior information on the incidence of acute ",{}],["leukemias",{"fg":1,"bold":true}],[".                                                                    ",{}]],"33":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["In developing countries, there are few data on the frequency of ",{}],["leukemias",{"fg":1,"bold":true}],[" during childhood [5,9] be                                 ",{}]],"34":[["cause these countries have not had the infrastructure required to keep reliable records. Some international studies have produced information from som",{}]],"35":[["e developing countries, particularly in Latin America [10]; however, this information has certain constraints with respect to its validity and coverag",{}]]},"cursor":{"x":0,"y":36}}],[0.09593699999999999,{"lines":{"36":[["e in representing the populations [11-15] Of the studies carried out in Mexico City, an important increase in the incidence of ALL, but not of ",{}],["       ",{"fg":0}]],"37":[["AML",{"fg":1,"bold":true}],[", has been reported. In 1991, an incidence of 22.2 per million of children under 15 years of age was reported [6]. From the data from the Ins      ",{}]],"38":[["tituto Mexicano del Seguro Social, the Medical Center having the greatest coverage of the population in the whole of the country, an incidence rate wa",{}]],"39":[["s reported of 29.1 per million of children under 15 years of age who were residents of Mexico City and who had the right to receive attention from thi",{}]],"40":[["s Institution [7]. Given the retrospective nature of these studies, it is possible that there was underestimation of the incidence rate of ALL. On the",{}]],"41":[[" other hand, when taken into account that, in the different states in the U.S. which have a high component of Hispanics of Mexican origin, the inciden",{}]],"42":[["ce rate of acute ",{}],["leukemias",{"fg":1,"bold":true}],[" is the highest in the world, one may consider it important to pe                                                           ",{}]]},"cursor":{"x":91,"y":42}}],[2.5e-05,{"lines":{"0":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["TITLE: Incidence of ",{}],["leukemias",{"fg":1,"bold":true}],[" in children from El Salvador and Mexico City between 1996 and 2000: P                                 ",{}]],"1":[["opulation-based data",{}],["                                                                                                                                  ",{"fg":0}]],"2":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["There are very few studies that report the incidence of acute ",{}],["leukemias",{"fg":1,"bold":true}],[" in children in Latin Americ                                 ",{}]],"3":[["a. This work assesses the incidence of acute ",{}],["leukemias",{"fg":1,"bold":true}],[", between 1996 and 2000, in children from 0–14 years old who were attended at the M             ",{}]],"4":[["exican Social Security Institute in Mexico City and in children from 0–11 years old in El Salvador.",{}],["                                                   ",{"fg":0}]],"5":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Design: Population-based data. Hospitals: In San Salvador, El Salvador, Hospital Nacional de Niños \"Benjamín Blo                    ",{}]],"6":[["om\", the only center in El Salvador which attends all children, younger than 12 years, with oncologic disease. The Pediatric Hospital and the General ",{}]],"7":[["Hospital of the Mexican Social Security Institute in Mexico City, the only centers in Mexico City which attend all those children with acute ",{}],["         ",{"fg":1,"bold":true}]],"8":[["leukemia ",{"fg":1,"bold":true}],["who have a right to this service. Diagnosis: All patients were diagnosed by bone marrow smear and were divided into acute lymphoid leukem    ",{}]],"9":[["ia (ALL), acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],["), chronic myeloid leukemia (CML), and unspecified ",{}],["leukemias",{"fg":1,"bold":true}],[" (UL). The annual incidence                          ",{}]],"10":[[" rate (AIR) and average annual incidence rate (AAIR) were calculated per million children. Cases were stratified by age and assigned to one of four ag",{}]],"11":[["e strata: 1) <1 year; 2) 1–4 years; 3) 5–9 years, or 4) 10–14 or 10–11 years, for Mexico City and El Salvador, respectively.",{}],["                          ",{"fg":0}]],"12":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["The number of cases was 375 and 238 in El Salvador and Mexico City, respectively. AAIRs in Mexico City were 44.9                    ",{}]],"13":[[", 10.6, 2.5, 0.5, and 58.4 per million children for ALL, ",{}],["AML",{"fg":1,"bold":true}],[", CML, UL, and total ",{}],["leukemias",{"fg":1,"bold":true}],[", respectively. The AAIRs in El Sa                          ",{}]],"14":[["lvador could not be calculated because the fourth age stratum in El Salvador included children only from 0–11 years old. The incidence rates for the S",{}]],"15":[["alvadoran group of 0–11 year olds were 34.2, 7.1, 0.6, 0.2, and 43.2 per million children for ALL, ",{}],["AML",{"fg":1,"bold":true}],[", CML, UL, and total ",{}],["leuke                      ",{"fg":1,"bold":true}]],"16":[["mias",{"fg":1,"bold":true}],[", respectively.                                                                                                                                   ",{}]],"17":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Leukemias",{"fg":1,"bold":true}],[" are the most frequent type of cancer in childhood [1], the incidence of which varies depe                                 ",{}]],"18":[["nding on the area of the world where they are studied [2]. An elevated frequency of acute ",{}],["leukemias",{"fg":1,"bold":true}],[" has been reported in populations of H             ",{}]],"19":[["ispanic origin [3-5]. For example, in Costa Rica, the highest incidence rate in the world for acute ",{}],["leukemias",{"fg":1,"bold":true}],[" has been reported: 56 per m             ",{}]],"20":[["illion of children under the age of 15 years [5]. In California and Texas, two states of the U.S. which have a Hispanic component predominately of Mex",{}]],"21":[["ican origin [3], the incidence rates for ALL and for AL in general have been found to be greater than those previously reported for Mexico City [6-8].",{}]],"22":[[" However, because the studies carried out in Mexico City have been retrospective, it is possible that a under-register of the infirmity may have exist",{}]],"23":[["ed in Mexico City. In Florida, the state with the highest predominance of Hispanics of Caribbean and Central American origin, the incidence rate of AL",{}]],"24":[["L was higher than that reported for the Caucasian population and similarly elevated to that reported for Costa Rica. For the Central American country ",{}]],"25":[["of El Salvador, there is no prior information on the incidence of acute ",{}],["leukemias",{"fg":1,"bold":true}],[".                                                                    ",{}]],"26":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["In developing countries, there are few data on the frequency of ",{}],["leukemias",{"fg":1,"bold":true}],[" during childhood [5,9] be                                 ",{}]],"27":[["cause these countries have not had the infrastructure required to keep reliable records. Some international studies have produced information from som",{}]],"28":[["e developing countries, particularly in Latin America [10]; however, this information has certain constraints with respect to its validity and coverag",{}]],"29":[["e in representing the populations [11-15] Of the studies carried out in Mexico City, an important increase in the incidence of ALL, but not of ",{}],["       ",{"fg":0}]],"30":[["AML",{"fg":1,"bold":true}],[", has been reported. In 1991, an incidence of 22.2 per million of children under 15 years of age was reported [6]. From the data from the Ins      ",{}]],"31":[["tituto Mexicano del Seguro Social, the Medical Center having the greatest coverage of the population in the whole of the country, an incidence rate wa",{}]],"32":[["s reported of 29.1 per million of children under 15 years of age who were residents of Mexico City and who had the right to receive attention from thi",{}]],"33":[["s Institution [7]. Given the retrospective nature of these studies, it is possible that there was underestimation of the incidence rate of ALL. On the",{}]],"34":[[" other hand, when taken into account that, in the different states in the U.S. which have a high component of Hispanics of Mexican origin, the inciden",{}]],"35":[["ce rate of acute ",{}],["leukemias",{"fg":1,"bold":true}],[" is the highest in the world, one may consider it important to perform a prospective population-based study in              ",{}]],"36":[["Mexico City that would determine if Mexican children, residing in this City, had an incidence rate similar to those reported for Texas and California ",{}]],"37":[["[3].",{}],["                                                                                                                                                  ",{"fg":0}]],"38":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Prospective records of those children treated for ",{}],["leukemia ",{"fg":1,"bold":true}],["was initiated in El Salvador in 1994 and                                 ",{}]],"39":[[" in Mexico City in 1996 [16,17]. In Mexico City, the record was kept in the hospitals of the Instituto Mexicano del Seguro Social (IMSS), an instituti",{}]],"40":[["on that attends about 50% of the population inhabiting Mexico City [7]. Because the IMSS keeps a register of the population that has a right to receiv",{}]],"41":[["e medical attention at its facilities, the base population is known and it is feasible to obtain the incidence rate for the population under 15 years ",{}]],"42":[["of age. In El Salvador, because the record was kept by the Hospital Nacional de Niños \"Benjamín Bloom\" (BB), the only center in the country which atte",{}]],"43":[["nds all children, younger than 12 years with oncologic disease, data on the population base which was necessary for calculating the incidence rate was",{}]],"44":[[" available. Treatment of children with ",{}],["leukemia ",{"fg":1,"bold":true}],["is completely free of charge both in El Salvador and at the IMSS in Mexico City, thus all             ",{}]],"45":[["owing a greater coverage for children with this disease [16,17].                                                                                      ",{}]],"46":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["This work presents the incidence of ",{}],["leukemia ",{"fg":1,"bold":true}],["in children younger than 12 years, because this is the                                 ",{}]],"47":[[" age range admitted in the BB and data for children younger than 15 is used for Mexico City. In this report, for purposes of analysis, the data from 1",{}]],"48":[["996–2000 were used, with 1996 being the first year of record keeping in Mexico City and 2000 being the most recent year for data reported from El Salv",{}]],"49":[["--More--",{"inverse":true}],["                                                                                                                                              ",{}]]},"cursor":{"x":8,"y":49}}],[1.360962,{"lines":{"0":[["Hospital of the Mexican Social Security Institute in Mexico City, the only centers in Mexico City which attend all those children with acute ",{}],["         ",{"fg":1,"bold":true}]],"1":[["leukemia ",{"fg":1,"bold":true}],["who have a right to this service. Diagnosis: All patients were diagnosed by bone marrow smear and were divided into acute lymphoid leukem    ",{}]],"2":[["ia (ALL), acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],["), chronic myeloid leukemia (CML), and unspecified ",{}],["leukemias",{"fg":1,"bold":true}],[" (UL). The annual incidence                          ",{}]],"3":[[" rate (AIR) and average annual incidence rate (AAIR) were calculated per million children. Cases were stratified by age and assigned to one of four ag",{}]],"4":[["e strata: 1) <1 year; 2) 1–4 years; 3) 5–9 years, or 4) 10–14 or 10–11 years, for Mexico City and El Salvador, respectively.",{}],["                          ",{"fg":0}]],"5":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["The number of cases was 375 and 238 in El Salvador and Mexico City, respectively. AAIRs in Mexico City were 44.9                    ",{}]],"6":[[", 10.6, 2.5, 0.5, and 58.4 per million children for ALL, ",{}],["AML",{"fg":1,"bold":true}],[", CML, UL, and total ",{}],["leukemias",{"fg":1,"bold":true}],[", respectively. The AAIRs in El Sa                          ",{}]],"7":[["lvador could not be calculated because the fourth age stratum in El Salvador included children only from 0–11 years old. The incidence rates for the S",{}]],"8":[["alvadoran group of 0–11 year olds were 34.2, 7.1, 0.6, 0.2, and 43.2 per million children for ALL, ",{}],["AML",{"fg":1,"bold":true}],[", CML, UL, and total ",{}],["leuke                      ",{"fg":1,"bold":true}]],"9":[["mias",{"fg":1,"bold":true}],[", respectively.                                                                                                                                   ",{}]],"10":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Leukemias",{"fg":1,"bold":true}],[" are the most frequent type of cancer in childhood [1], the incidence of which varies depe                                 ",{}]],"11":[["nding on the area of the world where they are studied [2]. An elevated frequency of acute ",{}],["leukemias",{"fg":1,"bold":true}],[" has been reported in populations of H             ",{}]],"12":[["ispanic origin [3-5]. For example, in Costa Rica, the highest incidence rate in the world for acute ",{}],["leukemias",{"fg":1,"bold":true}],[" has been reported: 56 per m             ",{}]],"13":[["illion of children under the age of 15 years [5]. In California and Texas, two states of the U.S. which have a Hispanic component predominately of Mex",{}]],"14":[["ican origin [3], the incidence rates for ALL and for AL in general have been found to be greater than those previously reported for Mexico City [6-8].",{}]],"15":[[" However, because the studies carried out in Mexico City have been retrospective, it is possible that a under-register of the infirmity may have exist",{}]],"16":[["ed in Mexico City. In Florida, the state with the highest predominance of Hispanics of Caribbean and Central American origin, the incidence rate of AL",{}]],"17":[["L was higher than that reported for the Caucasian population and similarly elevated to that reported for Costa Rica. For the Central American country ",{}]],"18":[["of El Salvador, there is no prior information on the incidence of acute ",{}],["leukemias",{"fg":1,"bold":true}],[".                                                                    ",{}]],"19":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["In developing countries, there are few data on the frequency of ",{}],["leukemias",{"fg":1,"bold":true}],[" during childhood [5,9] be                                 ",{}]],"20":[["cause these countries have not had the infrastructure required to keep reliable records. Some international studies have produced information from som",{}]],"21":[["e developing countries, particularly in Latin America [10]; however, this information has certain constraints with respect to its validity and coverag",{}]],"22":[["e in representing the populations [11-15] Of the studies carried out in Mexico City, an important increase in the incidence of ALL, but not of ",{}],["       ",{"fg":0}]],"23":[["AML",{"fg":1,"bold":true}],[", has been reported. In 1991, an incidence of 22.2 per million of children under 15 years of age was reported [6]. From the data from the Ins      ",{}]],"24":[["tituto Mexicano del Seguro Social, the Medical Center having the greatest coverage of the population in the whole of the country, an incidence rate wa",{}]],"25":[["s reported of 29.1 per million of children under 15 years of age who were residents of Mexico City and who had the right to receive attention from thi",{}]],"26":[["s Institution [7]. Given the retrospective nature of these studies, it is possible that there was underestimation of the incidence rate of ALL. On the",{}]],"27":[[" other hand, when taken into account that, in the different states in the U.S. which have a high component of Hispanics of Mexican origin, the inciden",{}]],"28":[["ce rate of acute ",{}],["leukemias",{"fg":1,"bold":true}],[" is the highest in the world, one may consider it important to perform a prospective population-based study in              ",{}]],"29":[["Mexico City that would determine if Mexican children, residing in this City, had an incidence rate similar to those reported for Texas and California ",{}]],"30":[["[3].",{}],["                                                                                                                                                  ",{"fg":0}]],"31":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Prospective records of those children treated for ",{}],["leukemia ",{"fg":1,"bold":true}],["was initiated in El Salvador in 1994 and                                 ",{}]],"32":[[" in Mexico City in 1996 [16,17]. In Mexico City, the record was kept in the hospitals of the Instituto Mexicano del Seguro Social (IMSS), an instituti",{}]],"33":[["on that attends about 50% of the population inhabiting Mexico City [7]. Because the IMSS keeps a register of the population that has a right to receiv",{}]],"34":[["e medical attention at its facilities, the base population is known and it is feasible to obtain the incidence rate for the population under 15 years ",{}]],"35":[["of age. In El Salvador, because the record was kept by the Hospital Nacional de Niños \"Benjamín Bloom\" (BB), the only center in the country which atte",{}]],"36":[["nds all children, younger than 12 years with oncologic disease, data on the population base which was necessary for calculating the incidence rate was",{}]],"37":[[" available. Treatment of children with ",{}],["leukemia ",{"fg":1,"bold":true}],["is completely free of charge both in El Salvador and at the IMSS in Mexico City, thus all             ",{}]],"38":[["owing a greater coverage for children with this disease [16,17].                                                                                      ",{}]],"39":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["This work presents the incidence of ",{}],["leukemia ",{"fg":1,"bold":true}],["in children younger than 12 years, because this is the                                 ",{}]],"40":[[" age range admitted in the BB and data for children younger than 15 is used for Mexico City. In this report, for purposes of analysis, the data from 1",{}]],"41":[["996–2000 were used, with 1996 being the first year of record keeping in Mexico City and 2000 being the most recent year for data reported from El Salv",{}]],"42":[["ador.                                                                                                                                                 ",{}]],"43":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["The Hospital Nacional de Niños \"Benjamín Bloom\" (BB), located in San Salvador, capital of El Salvador; is a tert                    ",{}]],"44":[["iary care center and is the only hospital in that country that has a pediatric hematology-oncology service with pediatric hematology staff. Being the ",{}]],"45":[["only domestic reference center for pediatric oncologic diseases, it is the only hospital to which children with presumed ",{}],["leukemia ",{"fg":1,"bold":true}],["diagnos             ",{}]],"46":[["is are referred for treatment. For this reason and because treatment is completely free of charge [16], no case of presumed childhood ",{}],["leukemi         ",{"fg":1,"bold":true}]],"47":[["a ",{"fg":1,"bold":true}],["should be missing from the records. Children from other countries (Nicaragua, Honduras, etc) were excluded from the numerator.                      ",{}]],"48":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["The types of ",{}],["leukemia ",{"fg":1,"bold":true}],["were divided according to the five-group morphological classification of the                                  ",{}]],"49":[["international classification of childhood cancer. Only four of the types were found in th                                                             ",{}]]},"cursor":{"x":89}}],[0.001028,{"lines":{"0":[["ador.                                                                                                                                                 ",{}]],"1":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["The Hospital Nacional de Niños \"Benjamín Bloom\" (BB), located in San Salvador, capital of El Salvador; is a tert                    ",{}]],"2":[["iary care center and is the only hospital in that country that has a pediatric hematology-oncology service with pediatric hematology staff. Being the ",{}]],"3":[["only domestic reference center for pediatric oncologic diseases, it is the only hospital to which children with presumed ",{}],["leukemia ",{"fg":1,"bold":true}],["diagnos             ",{}]],"4":[["is are referred for treatment. For this reason and because treatment is completely free of charge [16], no case of presumed childhood ",{}],["leukemi         ",{"fg":1,"bold":true}]],"5":[["a ",{"fg":1,"bold":true}],["should be missing from the records. Children from other countries (Nicaragua, Honduras, etc) were excluded from the numerator.                      ",{}]],"6":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["The types of ",{}],["leukemia ",{"fg":1,"bold":true}],["were divided according to the five-group morphological classification of the                                  ",{}]],"7":[["international classification of childhood cancer. Only four of the types were found in this study: a) Acute lymphoid leukemia (ALL) (9820–9827, 9850);",{}]],"8":[[" b) acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],["), the preferred terminology instead of \"acute nonlymphocytic leukemia\" [18] (9840, 9841, 9861, 9864, 9866             ",{}]],"9":[[", 9867, 9891, 9894, 9910); c) chronic myeloid leukemia (CML) (9863, 9868); and e) unspecified ",{}],["leukemias",{"fg":1,"bold":true}],[" (UL) (9800–9804) (International C             ",{}]],"10":[["lassification of Disease for Oncology, ICD-O2; 1990) [19]. The codes were reviewed with the Child-Check program [19] to corroborate that there were no",{}]],"11":[[" duplicate records or inconsistent data. A database was generated to record age, sex, residency, year of diagnosis, and clinical manifestation of the ",{}]],"12":[["patients.                                                                                                                                             ",{}]],"13":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["During the study period, there were 375 children diagnosed with ",{}],["leukemia ",{"fg":1,"bold":true}],["in El Salvador and 238 in                                  ",{}]],"14":[["Mexico City. Of total ",{}],["leukemias",{"fg":1,"bold":true}],[" in El Salvador and in Mexico City, ALL represented 80.5% and 76.9%; ",{}],["AML",{"fg":1,"bold":true}],[", 16.8% and 18.1%; CM                          ",{}]],"15":[["L, 1.6% and 4.2%; and UL, 1.1 and 0.8%, respectively.                                                                                                 ",{}]],"16":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["The standardized rate by age of all ",{}],["leukemias",{"fg":1,"bold":true}],[" in both countries was higher in boys than in girls, w                                 ",{}]],"17":[["ith a more marked male:female ratio in El Salvador than in Mexico City: 1.18 (46.8 per million children:39.5 per million children) vs. 1.01 (58.8 per ",{}]],"18":[["million children:58.1 per million children). Whereas standardized rates by age in El Salvador revealed that all types of ",{}],["leukemias",{"fg":1,"bold":true}],[" were m             ",{}]],"19":[["ore frequent in boys, this was not observed in ",{}],["AML",{"fg":1,"bold":true}],[" or CML in Mexico City, where the frequency of both ",{}],["leukemias",{"fg":1,"bold":true}],[" was higher f                          ",{}]],"20":[["or girls than that reported for boys (Tables I and II).                                                                                               ",{}]],"21":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["The low incidence of ALL in youngsters less than 1 year old found in El Salvador is notable, as is the fact that                    ",{}]],"22":[[" no case of ",{}],["AML",{"fg":1,"bold":true}],[" in this age group was found in Mexico City.                                                                                           ",{}]],"23":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Among the subtypes of ",{}],["AML",{"fg":1,"bold":true}],[", the most frequent in Mexico City was ",{}],["AML",{"fg":1,"bold":true}],[" M3 (01B9866) with                                               ",{}]],"24":[["nine cases, giving a frequency of 20.9% and an AAIR of 2.21 per million children. It is noteworthy that all these ",{}],["AML",{"fg":1,"bold":true}],[" M3 cases were femal             ",{}]],"25":[["es. Unfortunately, in El Salvador, the frequency of ",{}],["AML",{"fg":1,"bold":true}],[" M3 could not be assessed, as the major part of ",{}],["AML",{"fg":1,"bold":true}],[" was classified on                          ",{}]],"26":[["ly in the general category 01B9861.                                                                                                                   ",{}]],"27":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Because there are only two important reviews that summarize the high incidence rates of ",{}],["leukemias",{"fg":1,"bold":true}],[" i                                 ",{}]],"28":[["n children reported in the world up to 1999 [1,10], it has been very difficult to obtain reliable data on the incidence of cancer in children, includi",{}]],"29":[["ng ",{}],["leukemias",{"fg":1,"bold":true}],[", in developing countries. In fact, the review of Parkin et al., carried out in 1999, did not include data from either El Sal             ",{}]],"30":[["vador or Mexico City because there were no reliable data from these areas at the time (1980 to 1989) at which they performed their study [10].        ",{}]],"31":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["There are some issues of the present study that must be emphasized. In this study, statistics were not performed                    ",{}]],"32":[[" to compare the rates in Mexico City with the rates in El Salvador over time, because this was not the aim. The inclusion of the aforementioned instit",{}]],"33":[["utions helped guarantee that all children diagnosed with ",{}],["leukemia ",{"fg":1,"bold":true}],["during the studied period were included. This is due to the fact that,              ",{}]],"34":[["because BB is the only hospital in El Salvador that attends children with leukemia, any child with presumed ",{}],["leukemia ",{"fg":1,"bold":true}],["is referred to that              ",{}]],"35":[["institution [16]. Similarly, in Mexico City, HP and HG are the only hospitals of the IMSS that attend the children with ",{}],["leukemia ",{"fg":1,"bold":true}],["whose pa             ",{}]],"36":[["rents have rights to receive medical services from IMSS [17].                                                                                         ",{}]],"37":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Even if there had been an under-registration of cases because some could not be diagnosed (e.g., patients dying                     ",{}]],"38":[["before ",{}],["leukemia ",{"fg":1,"bold":true}],["diagnosis is confirmed), the incidence rates in children of 0–11 years old found in El Salvador are similar to those repo             ",{}]],"39":[["rted in North America, which range from 36 to 45 , and with rates from South and Central America, which range from 29.0 to 57.9 per million children [",{}]],"40":[["10].                                                                                                                                                  ",{}]],"41":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["In Mexico City, there are various institutions outside the IMSS system that can attend children with cancer, par                    ",{}]],"42":[["ticularly leukemia. However, such private institutions represent an economic burden for the family of the patient, in that the treatment for patients ",{}]],"43":[["with ",{}],["leukemia ",{"fg":1,"bold":true}],["lasts several years, with the possibility of expenses totaling almost $65,000 USD [22]. Therefore, it is less probable that             ",{}]],"44":[[" the family of a child with ",{}],["leukemia ",{"fg":1,"bold":true}],["would turn down access to the free service offered by HP and HG, opting instead for a costly private             ",{}]],"45":[[" institution. For this reason, we think that cases in Mexico would not be underestimated due to patients being treated outside the IMSS system.       ",{}]],"46":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Mexico is a developing country with a high rate of child mortality in general. The absence of ",{}],["AML",{"fg":1,"bold":true}],[" c                                 ",{}]],"47":[["ases in infants of less than 1 year in Mexico City is notable because this is the peak age for ",{}],["AML",{"fg":1,"bold":true}],[" in most developed countries [1,23], an             ",{}]],"48":[["d suggests the probability that children younger than 1 year with ",{}],["AML",{"fg":1,"bold":true}],[" die before being diagnosed. In contrast to ALL, ",{}],["AML",{"fg":1,"bold":true}],[" se                          ",{}]],"49":[["--More--",{"inverse":true}],["                                                                                                                                              ",{}]]},"cursor":{"x":8}}],[0.878049,{"lines":{"0":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["The types of ",{}],["leukemia ",{"fg":1,"bold":true}],["were divided according to the five-group morphological classification of the                                  ",{}]],"1":[["international classification of childhood cancer. Only four of the types were found in this study: a) Acute lymphoid leukemia (ALL) (9820–9827, 9850);",{}]],"2":[[" b) acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],["), the preferred terminology instead of \"acute nonlymphocytic leukemia\" [18] (9840, 9841, 9861, 9864, 9866             ",{}]],"3":[[", 9867, 9891, 9894, 9910); c) chronic myeloid leukemia (CML) (9863, 9868); and e) unspecified ",{}],["leukemias",{"fg":1,"bold":true}],[" (UL) (9800–9804) (International C             ",{}]],"4":[["lassification of Disease for Oncology, ICD-O2; 1990) [19]. The codes were reviewed with the Child-Check program [19] to corroborate that there were no",{}]],"5":[[" duplicate records or inconsistent data. A database was generated to record age, sex, residency, year of diagnosis, and clinical manifestation of the ",{}]],"6":[["patients.                                                                                                                                             ",{}]],"7":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["During the study period, there were 375 children diagnosed with ",{}],["leukemia ",{"fg":1,"bold":true}],["in El Salvador and 238 in                                  ",{}]],"8":[["Mexico City. Of total ",{}],["leukemias",{"fg":1,"bold":true}],[" in El Salvador and in Mexico City, ALL represented 80.5% and 76.9%; ",{}],["AML",{"fg":1,"bold":true}],[", 16.8% and 18.1%; CM                          ",{}]],"9":[["L, 1.6% and 4.2%; and UL, 1.1 and 0.8%, respectively.                                                                                                 ",{}]],"10":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["The standardized rate by age of all ",{}],["leukemias",{"fg":1,"bold":true}],[" in both countries was higher in boys than in girls, w                                 ",{}]],"11":[["ith a more marked male:female ratio in El Salvador than in Mexico City: 1.18 (46.8 per million children:39.5 per million children) vs. 1.01 (58.8 per ",{}]],"12":[["million children:58.1 per million children). Whereas standardized rates by age in El Salvador revealed that all types of ",{}],["leukemias",{"fg":1,"bold":true}],[" were m             ",{}]],"13":[["ore frequent in boys, this was not observed in ",{}],["AML",{"fg":1,"bold":true}],[" or CML in Mexico City, where the frequency of both ",{}],["leukemias",{"fg":1,"bold":true}],[" was higher f                          ",{}]],"14":[["or girls than that reported for boys (Tables I and II).                                                                                               ",{}]],"15":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["The low incidence of ALL in youngsters less than 1 year old found in El Salvador is notable, as is the fact that                    ",{}]],"16":[[" no case of ",{}],["AML",{"fg":1,"bold":true}],[" in this age group was found in Mexico City.                                                                                           ",{}]],"17":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Among the subtypes of ",{}],["AML",{"fg":1,"bold":true}],[", the most frequent in Mexico City was ",{}],["AML",{"fg":1,"bold":true}],[" M3 (01B9866) with                                               ",{}]],"18":[["nine cases, giving a frequency of 20.9% and an AAIR of 2.21 per million children. It is noteworthy that all these ",{}],["AML",{"fg":1,"bold":true}],[" M3 cases were femal             ",{}]],"19":[["es. Unfortunately, in El Salvador, the frequency of ",{}],["AML",{"fg":1,"bold":true}],[" M3 could not be assessed, as the major part of ",{}],["AML",{"fg":1,"bold":true}],[" was classified on                          ",{}]],"20":[["ly in the general category 01B9861.                                                                                                                   ",{}]],"21":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Because there are only two important reviews that summarize the high incidence rates of ",{}],["leukemias",{"fg":1,"bold":true}],[" i                                 ",{}]],"22":[["n children reported in the world up to 1999 [1,10], it has been very difficult to obtain reliable data on the incidence of cancer in children, includi",{}]],"23":[["ng ",{}],["leukemias",{"fg":1,"bold":true}],[", in developing countries. In fact, the review of Parkin et al., carried out in 1999, did not include data from either El Sal             ",{}]],"24":[["vador or Mexico City because there were no reliable data from these areas at the time (1980 to 1989) at which they performed their study [10].        ",{}]],"25":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["There are some issues of the present study that must be emphasized. In this study, statistics were not performed                    ",{}]],"26":[[" to compare the rates in Mexico City with the rates in El Salvador over time, because this was not the aim. The inclusion of the aforementioned instit",{}]],"27":[["utions helped guarantee that all children diagnosed with ",{}],["leukemia ",{"fg":1,"bold":true}],["during the studied period were included. This is due to the fact that,              ",{}]],"28":[["because BB is the only hospital in El Salvador that attends children with leukemia, any child with presumed ",{}],["leukemia ",{"fg":1,"bold":true}],["is referred to that              ",{}]],"29":[["institution [16]. Similarly, in Mexico City, HP and HG are the only hospitals of the IMSS that attend the children with ",{}],["leukemia ",{"fg":1,"bold":true}],["whose pa             ",{}]],"30":[["rents have rights to receive medical services from IMSS [17].                                                                                         ",{}]],"31":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Even if there had been an under-registration of cases because some could not be diagnosed (e.g., patients dying                     ",{}]],"32":[["before ",{}],["leukemia ",{"fg":1,"bold":true}],["diagnosis is confirmed), the incidence rates in children of 0–11 years old found in El Salvador are similar to those repo             ",{}]],"33":[["rted in North America, which range from 36 to 45 , and with rates from South and Central America, which range from 29.0 to 57.9 per million children [",{}]],"34":[["10].                                                                                                                                                  ",{}]],"35":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["In Mexico City, there are various institutions outside the IMSS system that can attend children with cancer, par                    ",{}]],"36":[["ticularly leukemia. However, such private institutions represent an economic burden for the family of the patient, in that the treatment for patients ",{}]],"37":[["with ",{}],["leukemia ",{"fg":1,"bold":true}],["lasts several years, with the possibility of expenses totaling almost $65,000 USD [22]. Therefore, it is less probable that             ",{}]],"38":[[" the family of a child with ",{}],["leukemia ",{"fg":1,"bold":true}],["would turn down access to the free service offered by HP and HG, opting instead for a costly private             ",{}]],"39":[[" institution. For this reason, we think that cases in Mexico would not be underestimated due to patients being treated outside the IMSS system.       ",{}]],"40":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["Mexico is a developing country with a high rate of child mortality in general. The absence of ",{}],["AML",{"fg":1,"bold":true}],[" c                                 ",{}]],"41":[["ases in infants of less than 1 year in Mexico City is notable because this is the peak age for ",{}],["AML",{"fg":1,"bold":true}],[" in most developed countries [1,23], an             ",{}]],"42":[["d suggests the probability that children younger than 1 year with ",{}],["AML",{"fg":1,"bold":true}],[" die before being diagnosed. In contrast to ALL, ",{}],["AML",{"fg":1,"bold":true}],[" se                          ",{}]],"43":[["ems to have no worse prognosis in children younger than 1 year [24,25], indicating that all children with ",{}],["AML",{"fg":1,"bold":true}],[", regardless of age, run the             ",{}]],"44":[[" same risk of not being diagnosed. This increases the possibility of an apparently different pattern of age of ",{}],["AML",{"fg":1,"bold":true}],[" onset in Mexico City.              ",{}]],"45":[["Little can be argued about the delay of diagnosis in these diseases, due to fast evolution of the disease and short-term mortality when no prompt mana",{}]],"46":[["gement is provided; thus, acute ",{}],["leukemias",{"fg":1,"bold":true}],[" are considered as the reference point for time of diagnosis [26].                                           ",{}]],"47":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["It is noteworthy that the AAIR of the age peak of ALL in boys in Mexico City is very high (82.4 per million in b                    ",{}]],"48":[["oys), an is higher than that reported for Costa Rica (76 per million in boys) and by SEER (76.7 per million in both sexs) [5,30]. However, the AAIR re",{}]],"49":[["ported for Hispanics in general in Florida for the 0–4 year-old age group is 87.6 per million, which to our knowledge i                               ",{}]]},"cursor":{"x":119}}],[0.00198,{"lines":{"0":[["ems to have no worse prognosis in children younger than 1 year [24,25], indicating that all children with ",{}],["AML",{"fg":1,"bold":true}],[", regardless of age, run the             ",{}]],"1":[[" same risk of not being diagnosed. This increases the possibility of an apparently different pattern of age of ",{}],["AML",{"fg":1,"bold":true}],[" onset in Mexico City.              ",{}]],"2":[["Little can be argued about the delay of diagnosis in these diseases, due to fast evolution of the disease and short-term mortality when no prompt mana",{}]],"3":[["gement is provided; thus, acute ",{}],["leukemias",{"fg":1,"bold":true}],[" are considered as the reference point for time of diagnosis [26].                                           ",{}]],"4":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["It is noteworthy that the AAIR of the age peak of ALL in boys in Mexico City is very high (82.4 per million in b                    ",{}]],"5":[["oys), an is higher than that reported for Costa Rica (76 per million in boys) and by SEER (76.7 per million in both sexs) [5,30]. However, the AAIR re",{}]],"6":[["ported for Hispanics in general in Florida for the 0–4 year-old age group is 87.6 per million, which to our knowledge is the highest AAIR reported in ",{}]],"7":[["the literature [4]. This finding is important because this peak in age is related with the higher frequency of ALL with the B-cell precursor immunophe",{}]],"8":[["notype. Although such data were not reported in this study, this immunophenotype is thought to be more frequent in developed countries [1] and, in add",{}]],"9":[["ition, is related with genetic rearrangements such as TEL/",{}],["AML1",{"fg":1,"bold":true}],[" that occur in the child during the intrauterine stage [31].                            ",{}]],"10":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["The frequency of ",{}],["AML",{"fg":1,"bold":true}],[" M3 in the Hispanic population has been reported to be higher than those for ot                                 ",{}]],"11":[["her populations [37]. This has been observed both for children and for adults [3,37-39] (Table 4). In the present study, it was found that, in Mexico ",{}]],"12":[["City, the frequency was 21%, a value consistent with the data that the frequency of ",{}],["AML",{"fg":1,"bold":true}],[" M3 is higher in a population of Hispanic origin.              ",{}]],"13":[["The present study has the advantage over other studies that were carried out in Latin America because it is population-based. One study has proposed t",{}]],"14":[["hat the elevated frequency of ",{}],["AML",{"fg":1,"bold":true}],[" in the Hispanic population may be related not only genetic factors but also nutritional ones [38].                  ",{}]],"15":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["It is important to emphasize that, despite recent data published on the incidence of ",{}],["leukemias",{"fg":1,"bold":true}],[" in L                                 ",{}]],"16":[["atin America [5,40] or in Hispanics from the USA [29], those study periods were prior to those analyzed here. Finally, it can be stated that the rates",{}]],"17":[[" here presented are similar to those reported for Latin America, thereby supporting the reliability of these results. This is the start of a project t",{}]],"18":[["hat intends to join efforts in Mexico City, El Salvador, Honduras, Guatemala, Costa Rica, and Nicaragua to keep records of cancer in children, which w",{}]],"19":[["ill be highly reliable and which, therefore, can provide valid and timely data on the great concern that child cancer represents in the Latin American",{}]],"20":[[" countries.                                                                                                                                           ",{}]],"21":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["TITLE: Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid                             ",{}]],"22":[["leukemia ",{"fg":1,"bold":true}],["blasts                                                                                                                                       ",{}]],"23":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["To determine, whether caspase activation can predict the chemosensitivity, we investigated enzyme activation of                     ",{}]],"24":[["caspase-3, a key executioner caspase and correlated these data with chemosensitivity profiles of acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],[") blasts.                 ",{}]],"25":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["It is generally accepted that cytotoxic drugs eliminate malignant cells by inducing apoptosis (programmed cell d                    ",{}]],"26":[["eath) [18,19]. This process starts, as it was shown in ",{}],["hematopoietic",{"fg":1,"bold":true}],[" tumor cell lines, within hours of exposure to cytotoxic drugs [20].              ",{}]],"27":[["Thus, quantification of a surrogate marker of apoptosis might be a suitable method for a fast ex-vivo chemosensitivity assay. The appearance of phosph",{}]],"28":[["olipids like phosphatidylserine at the cell surface is a common marker for apoptosis which can be detected by Annexin V using flow cytometry [21,22]. ",{}]],"29":[["Apoptosis may also be quantified by changes of the mitochondrial electrochemical transmembrane potential using DiOC6 or JC-1 [21,23], by detection of ",{}]],"30":[["DNA- respectively nuclear-fragmentation using the TdT-assay [23], gel-electrophoresis or acridine orange [21,24-26]. Further apoptotic markers are the",{}]],"31":[[" cleaved forms of poly (ADP-ribose) polymerase (PARP) and caspase-3 which both are detectable by specific antibodies [24,25,27-29].                   ",{}]],"32":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["Most of these methods allow some grade of automation and a reasonable number of samples to be processed, which i                    ",{}]],"33":[["s needed for the clinical use of an ex-vivo chemosensitivity assay as well as for the identification of new agents. A development allowing more automa",{}]],"34":[["tion and larger sample sizes might be the detection of activated caspase-3, the main effector caspase in the apoptotic enzyme cascade, by using fluoro",{}]],"35":[["genic substrates and detection of enzyme activation in microplate readers [30]. To evaluate the usefulness and accuracy of such a procedure, we invest",{}]],"36":[["igated the ex-vivo chemosensitivity assessed by measuring caspase-3 activation and, also, compared these data to results obtained by DiSC assay in    ",{}]],"37":[["AML",{"fg":1,"bold":true}],[" blasts.                                                                                                                                           ",{}]],"38":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["Bone marrow (BM) or peripheral blood (PB) were taken from adult patients with acute myeloid leukemia (",{}],["A                             ",{"fg":1,"bold":true}]],"39":[["ML",{"fg":1,"bold":true}],[") with informed consent during routine diagnostic BM aspiration and/or phlebotomy before treatment was started. Samples were collected in hepari    ",{}]],"40":[["nized tubes from patients treated at our institution.                                                                                                 ",{}]],"41":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["For establishing the caspase-3 assay the ",{}],["AML",{"fg":1,"bold":true}],[" cell lines THP-1, HEL and KG-1 were used.                                              ",{}]],"42":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["Drugs were dissolved according to manufacturers' instructions and diluted in RPMI 1640 culture medium (Gibco, Pa                    ",{}]],"43":[["isley, UK). In order to induce cytotoxicity levels ex vivo comparable with those induced in vivo, the drugs were used at concentrations encompassing t",{}]],"44":[["he range of clinically relevant plasma levels, as previously reported [31]. ",{}],["Cytarabine",{"fg":1,"bold":true}],[" (Ara-cell™, cell-pharm, Hannover, Germany) was use             ",{}]],"45":[["d at final concentrations in the range from 0.06 μg/ml to 5 μg/ml in the DiSC-Assay and from 0.06 to 20 μg/ml in the caspase-3 assay. ",{}],["Daunoru         ",{"fg":1,"bold":true}]],"46":[["bicin",{"fg":1,"bold":true}],[" (Daunoblastin™, Pharmacia, Erlangen, Germany) was tested at final concentrations ranging from 0.008 μg/ml to 2 μg/ml and from 0.008 μg/ml to    ",{}]],"47":[[" 5 μg/ml, mitoxantrone (Novantron™, Lederle, Münster, Germany) from 0.006 μg/ml to 0.5 μg/ml and from 0.006 μg/ml to 20 μg/ml in the DiSC-assay and th",{}]],"48":[["e caspase-3 assay, respectively. The drugs were tested in duplicate samples at 5 different concentrations in the DiSC-Assay and in triplicate samples ",{}]],"49":[["--More--",{"inverse":true}],["                                                                                                                                              ",{}]]},"cursor":{"x":8}}],[0.950012,{"lines":{"0":[["the literature [4]. This finding is important because this peak in age is related with the higher frequency of ALL with the B-cell precursor immunophe",{}]],"1":[["notype. Although such data were not reported in this study, this immunophenotype is thought to be more frequent in developed countries [1] and, in add",{}]],"2":[["ition, is related with genetic rearrangements such as TEL/",{}],["AML1",{"fg":1,"bold":true}],[" that occur in the child during the intrauterine stage [31].                            ",{}]],"3":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["The frequency of ",{}],["AML",{"fg":1,"bold":true}],[" M3 in the Hispanic population has been reported to be higher than those for ot                                 ",{}]],"4":[["her populations [37]. This has been observed both for children and for adults [3,37-39] (Table 4). In the present study, it was found that, in Mexico ",{}]],"5":[["City, the frequency was 21%, a value consistent with the data that the frequency of ",{}],["AML",{"fg":1,"bold":true}],[" M3 is higher in a population of Hispanic origin.              ",{}]],"6":[["The present study has the advantage over other studies that were carried out in Latin America because it is population-based. One study has proposed t",{}]],"7":[["hat the elevated frequency of ",{}],["AML",{"fg":1,"bold":true}],[" in the Hispanic population may be related not only genetic factors but also nutritional ones [38].                  ",{}]],"8":[["AML_PMCID_1090561",{"fg":5}],[":",{"fg":6}],["It is important to emphasize that, despite recent data published on the incidence of ",{}],["leukemias",{"fg":1,"bold":true}],[" in L                                 ",{}]],"9":[["atin America [5,40] or in Hispanics from the USA [29], those study periods were prior to those analyzed here. Finally, it can be stated that the rates",{}]],"10":[[" here presented are similar to those reported for Latin America, thereby supporting the reliability of these results. This is the start of a project t",{}]],"11":[["hat intends to join efforts in Mexico City, El Salvador, Honduras, Guatemala, Costa Rica, and Nicaragua to keep records of cancer in children, which w",{}]],"12":[["ill be highly reliable and which, therefore, can provide valid and timely data on the great concern that child cancer represents in the Latin American",{}]],"13":[[" countries.                                                                                                                                           ",{}]],"14":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["TITLE: Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid                             ",{}]],"15":[["leukemia ",{"fg":1,"bold":true}],["blasts                                                                                                                                       ",{}]],"16":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["To determine, whether caspase activation can predict the chemosensitivity, we investigated enzyme activation of                     ",{}]],"17":[["caspase-3, a key executioner caspase and correlated these data with chemosensitivity profiles of acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],[") blasts.                 ",{}]],"18":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["It is generally accepted that cytotoxic drugs eliminate malignant cells by inducing apoptosis (programmed cell d                    ",{}]],"19":[["eath) [18,19]. This process starts, as it was shown in ",{}],["hematopoietic",{"fg":1,"bold":true}],[" tumor cell lines, within hours of exposure to cytotoxic drugs [20].              ",{}]],"20":[["Thus, quantification of a surrogate marker of apoptosis might be a suitable method for a fast ex-vivo chemosensitivity assay. The appearance of phosph",{}]],"21":[["olipids like phosphatidylserine at the cell surface is a common marker for apoptosis which can be detected by Annexin V using flow cytometry [21,22]. ",{}]],"22":[["Apoptosis may also be quantified by changes of the mitochondrial electrochemical transmembrane potential using DiOC6 or JC-1 [21,23], by detection of ",{}]],"23":[["DNA- respectively nuclear-fragmentation using the TdT-assay [23], gel-electrophoresis or acridine orange [21,24-26]. Further apoptotic markers are the",{}]],"24":[[" cleaved forms of poly (ADP-ribose) polymerase (PARP) and caspase-3 which both are detectable by specific antibodies [24,25,27-29].                   ",{}]],"25":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["Most of these methods allow some grade of automation and a reasonable number of samples to be processed, which i                    ",{}]],"26":[["s needed for the clinical use of an ex-vivo chemosensitivity assay as well as for the identification of new agents. A development allowing more automa",{}]],"27":[["tion and larger sample sizes might be the detection of activated caspase-3, the main effector caspase in the apoptotic enzyme cascade, by using fluoro",{}]],"28":[["genic substrates and detection of enzyme activation in microplate readers [30]. To evaluate the usefulness and accuracy of such a procedure, we invest",{}]],"29":[["igated the ex-vivo chemosensitivity assessed by measuring caspase-3 activation and, also, compared these data to results obtained by DiSC assay in    ",{}]],"30":[["AML",{"fg":1,"bold":true}],[" blasts.                                                                                                                                           ",{}]],"31":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["Bone marrow (BM) or peripheral blood (PB) were taken from adult patients with acute myeloid leukemia (",{}],["A                             ",{"fg":1,"bold":true}]],"32":[["ML",{"fg":1,"bold":true}],[") with informed consent during routine diagnostic BM aspiration and/or phlebotomy before treatment was started. Samples were collected in hepari    ",{}]],"33":[["nized tubes from patients treated at our institution.                                                                                                 ",{}]],"34":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["For establishing the caspase-3 assay the ",{}],["AML",{"fg":1,"bold":true}],[" cell lines THP-1, HEL and KG-1 were used.                                              ",{}]],"35":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["Drugs were dissolved according to manufacturers' instructions and diluted in RPMI 1640 culture medium (Gibco, Pa                    ",{}]],"36":[["isley, UK). In order to induce cytotoxicity levels ex vivo comparable with those induced in vivo, the drugs were used at concentrations encompassing t",{}]],"37":[["he range of clinically relevant plasma levels, as previously reported [31]. ",{}],["Cytarabine",{"fg":1,"bold":true}],[" (Ara-cell™, cell-pharm, Hannover, Germany) was use             ",{}]],"38":[["d at final concentrations in the range from 0.06 μg/ml to 5 μg/ml in the DiSC-Assay and from 0.06 to 20 μg/ml in the caspase-3 assay. ",{}],["Daunoru         ",{"fg":1,"bold":true}]],"39":[["bicin",{"fg":1,"bold":true}],[" (Daunoblastin™, Pharmacia, Erlangen, Germany) was tested at final concentrations ranging from 0.008 μg/ml to 2 μg/ml and from 0.008 μg/ml to    ",{}]],"40":[[" 5 μg/ml, mitoxantrone (Novantron™, Lederle, Münster, Germany) from 0.006 μg/ml to 0.5 μg/ml and from 0.006 μg/ml to 20 μg/ml in the DiSC-assay and th",{}]],"41":[["e caspase-3 assay, respectively. The drugs were tested in duplicate samples at 5 different concentrations in the DiSC-Assay and in triplicate samples ",{}]],"42":[["at six different concentrations in the caspase-3 assay.                                                                                               ",{}]],"43":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["In this study, we examined 42 ",{}],["AML",{"fg":1,"bold":true}],["-specimens. Patient characteristics are shown in Table 1. The diag                                 ",{}]],"44":[["nosis and classification of ",{}],["AML",{"fg":1,"bold":true}],[" was confirmed by central review of bone marrow slides, at our institution patients were treated according             ",{}]],"45":[[" to treatment protocols of the ",{}],["AML",{"fg":1,"bold":true}],["-Cooperative Group (AMLCG, Germany).                                                                                ",{}]],"46":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["For defining an optimal incubation period to allow time for all drugs studied to exert their apoptotic effect an                    ",{}]],"47":[["d, also, to find stable caspase-3 activity rates we performed time course experiments. The ",{}],["AML",{"fg":1,"bold":true}],[" cell lines HEL, THP-1 and KG-1 were incuba             ",{}]],"48":[["ted with ",{}],["daunorubicin",{"fg":1,"bold":true}],[" (0.03 – 5 μg/ml) and ",{}],["cytarabine",{"fg":1,"bold":true}],[" (0.19 – 20 μg/ml). The incubation was stopped after every two hours up                          ",{}]],"49":[[" to 24 hours. Plotting the fluorescence signal in dependence upon incubatio                                                                           ",{}]]},"cursor":{"x":75}}],[0.000194,{"lines":{"0":[["at six different concentrations in the caspase-3 assay.                                                                                               ",{}]],"1":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["In this study, we examined 42 ",{}],["AML",{"fg":1,"bold":true}],["-specimens. Patient characteristics are shown in Table 1. The diag                                 ",{}]],"2":[["nosis and classification of ",{}],["AML",{"fg":1,"bold":true}],[" was confirmed by central review of bone marrow slides, at our institution patients were treated according             ",{}]],"3":[[" to treatment protocols of the ",{}],["AML",{"fg":1,"bold":true}],["-Cooperative Group (AMLCG, Germany).                                                                                ",{}]],"4":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["For defining an optimal incubation period to allow time for all drugs studied to exert their apoptotic effect an                    ",{}]],"5":[["d, also, to find stable caspase-3 activity rates we performed time course experiments. The ",{}],["AML",{"fg":1,"bold":true}],[" cell lines HEL, THP-1 and KG-1 were incuba             ",{}]],"6":[["ted with ",{}],["daunorubicin",{"fg":1,"bold":true}],[" (0.03 – 5 μg/ml) and ",{}],["cytarabine",{"fg":1,"bold":true}],[" (0.19 – 20 μg/ml). The incubation was stopped after every two hours up                          ",{}]],"7":[[" to 24 hours. Plotting the fluorescence signal in dependence upon incubation time, maximum values were observed at different time points corresponding",{}]],"8":[[" to different drug concentrations. Usually, the highest drug concentrations achieved their maximum of relative fluorescence (compared to controls) aft",{}]],"9":[["er 8 to 12 hours of incubation in contrast to lower concentrations with 12 to 14 hours. Generally, higher fluorescence levels were obtained by higher ",{}]],"10":[["drug concentrations.                                                                                                                                  ",{}]],"11":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["The Km as a marker for the cytotoxic efficacy of a specific drug was determined according to the Michaelis-equat                    ",{}]],"12":[["ion as described above. Stable Km-values were achieved during incubation with ",{}],["daunorubicin",{"fg":1,"bold":true}],[" within 14 hours and with ",{}],["cytarabine                        ",{"fg":1,"bold":true}]],"13":[[" within 12 hours (Figure 2). In order to have reliably stable rates of apoptosis we chose an incubation time of 16 hours.                             ",{}]],"14":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["In 37 of 42 ",{}],["AML",{"fg":1,"bold":true}],[" samples (88%) the DiSC-assay was successfully performed. In 5 cases the assay faile                                 ",{}]],"15":[["d due to bacterial contamination. All chemotherapeutic drugs tested – ",{}],["ara-C",{"fg":1,"bold":true}],[", ",{}],["daunorubicin",{"fg":1,"bold":true}],[" and mitoxantrone – induced cell de                          ",{}]],"16":[["ath in a dose-dependent manner (Figure 1). The sensitivities of the ",{}],["AML",{"fg":1,"bold":true}],[" cells expressed as LC90s showed variability between the patients              ",{}]],"17":[["from as much as 22-fold below (for ",{}],["ara-C",{"fg":1,"bold":true}],[") to 105-fold above (also for ",{}],["ara-C",{"fg":1,"bold":true}],[") the median value (Table 2). For each drug, a ra                          ",{}]],"18":[["nge of sensitivities was observed, ranging from very sensitive to very resistant [11,36]. These individual patient drug sensitivity profiles reflect t",{}]],"19":[["he patient heterogeneity seen in the clinic [37]. If more than 90% of the tumor cells were already killed by the lowest drug concentration, the LC90-v",{}]],"20":[["alue was set equal to the corresponding lowest drug concentration [13]. This was observed in seven cases after incubation with ",{}],["cytarabine",{"fg":1,"bold":true}],["             ",{}]],"21":[[".                                                                                                                                                     ",{}]],"22":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["The Casp3-test was successful in all 42 ",{}],["AML",{"fg":1,"bold":true}],[" samples in terms of measurable caspase activity. But as                                 ",{}]],"23":[[" far as the various cytotoxic drugs – ",{}],["ara-C",{"fg":1,"bold":true}],[", ",{}],["daunorubicin",{"fg":1,"bold":true}],[" and mitoxantrone – are concerned apoptosis could be demonstrated i                          ",{}]],"24":[["n a dose-dependent manner only in a subset of 116 of 126 tests (92%) (Figure 1). The sensitivities of the ",{}],["AML",{"fg":1,"bold":true}],[" blasts expressed as Km show             ",{}]],"25":[["ed extreme variability between the patients from as much as 40-fold below (for ",{}],["daunorubicin",{"fg":1,"bold":true}],[") to 6,3 × 108-fold above (for ",{}],["ara-C                       ",{"fg":1,"bold":true}]],"26":[[") the median value (Table 2). In 14 cases Km-values were less than the lowest concentration of ",{}],["ara-C",{"fg":1,"bold":true}],[" used in the assay, hence the Km-v                ",{}]],"27":[["alues was set equal to the lowest ",{}],["ara-C",{"fg":1,"bold":true}],[" concentration tested in these cases.                                                                          ",{}]],"28":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["Both assays were simultaneously performed on each of the 42 ",{}],["AML",{"fg":1,"bold":true}],[" samples. Correlation between the tw                                 ",{}]],"29":[["o tests was possible for ",{}],["cytarabine",{"fg":1,"bold":true}],[" in 33 cases, for ",{}],["daunorubicin",{"fg":1,"bold":true}],[" in 36 cases and for mitoxantrone in 33 cases.                                       ",{}]],"30":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["For each drug tested the Km-values by the Casp3-test showed an extreme variability as compared to the LC90-value                    ",{}]],"31":[["s by the DiSC-assay, although the median values were quite similar (Table 2). LC90-values did not correlate with corresponding Km-values of ",{}],["c         ",{"fg":1,"bold":true}]],"32":[["ytarabine",{"fg":1,"bold":true}],[" (R2 = 0.38, p = 0.491), ",{}],["daunorubicin",{"fg":1,"bold":true}],[" (R2 = 0.001, p = 0.964) or mitoxantrone (R2 = 0.005, p = 0.544) according to the regre                 ",{}]],"33":[["ssion after Spearman-Rho. The associations of LC90-values with Km-values of the three drugs are shown in Figure 3.                                    ",{}]],"34":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["The major goal of this study was to determine whether the ex-vivo drug resistance in fresh leukemic cells from p                    ",{}]],"35":[["atients with ",{}],["AML",{"fg":1,"bold":true}],[" is reliably assessed by a short-time apoptosis-assay that measures caspase-3 activation. To this end, we compared the Ca             ",{}]],"36":[["sp3-test with established methods like the differential staining cytotoxicity (DiSC)-assay that measures reliably the overall rate of cell death induc",{}]],"37":[["ed by anticancer drugs [6,8,11,34,37,38]. The cytotoxic drugs ",{}],["cytarabine",{"fg":1,"bold":true}],[", ",{}],["daunorubicin",{"fg":1,"bold":true}],[" and mitoxantrone, commonly used in th                          ",{}]],"38":[["e treatment of ",{}],["AML",{"fg":1,"bold":true}],[" were tested in both assays.                                                                                                        ",{}]],"39":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["In the Casp3-test, the activation of proteases that recognize the DEVD peptide motif (DEVD-ases), especially cas                    ",{}]],"40":[["pase-3 was detected by measuring a fluorescence signal generated by a fluorogenic dye upon cleavage by caspase-3. It has been repeatedly demonstrated ",{}]],"41":[["that apoptosis usually is the dominant mode of tumor cell death promoted by chemotherapy [19,39,40], and caspase-3 is a major effector protease in thi",{}]],"42":[["s process [41-44]. Our results indicate, however, that levels of caspase-3 activation, i.e. DEVD-ases, do not correlate with sensitivity or resistance",{}]],"43":[[" to commonly employed anticancer drugs in ",{}],["AML",{"fg":1,"bold":true}],[" blasts. Even though apoptosis is the main pathway for drug-induced cell death caspase-3 act             ",{}]],"44":[["ivities fail to predict the response to chemotherapy as determined by measuring ex-vivo chemosensitivity by the DiSC-assay. There was no association b",{}]],"45":[["etween LC90-values (DiSC-assay) and corresponding Km-values (Casp3-test) of ",{}],["cytarabine",{"fg":1,"bold":true}],[" (p = 0.491), ",{}],["daunorubicin",{"fg":1,"bold":true}],[" (p = 0.964)                          ",{}]],"46":[[" or mitoxantrone (p = 0.544).                                                                                                                         ",{}]],"47":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["The DiSC-assay measures total cell death and, therefore, integrates apoptotic and non-apoptotic death induced by                    ",{}]],"48":[[" chemotherapy. Moreover, the DiSC-assay was shown to identify response to therapy and also long-term survival in various hematological neoplastic dise",{}]],"49":[["--More--",{"inverse":true}],["                                                                                                                                              ",{}]]},"cursor":{"x":8}}],[1.224813,{"lines":{"0":[["ted with ",{}],["daunorubicin",{"fg":1,"bold":true}],[" (0.03 – 5 μg/ml) and ",{}],["cytarabine",{"fg":1,"bold":true}],[" (0.19 – 20 μg/ml). The incubation was stopped after every two hours up                          ",{}]],"1":[[" to 24 hours. Plotting the fluorescence signal in dependence upon incubation time, maximum values were observed at different time points corresponding",{}]],"2":[[" to different drug concentrations. Usually, the highest drug concentrations achieved their maximum of relative fluorescence (compared to controls) aft",{}]],"3":[["er 8 to 12 hours of incubation in contrast to lower concentrations with 12 to 14 hours. Generally, higher fluorescence levels were obtained by higher ",{}]],"4":[["drug concentrations.                                                                                                                                  ",{}]],"5":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["The Km as a marker for the cytotoxic efficacy of a specific drug was determined according to the Michaelis-equat                    ",{}]],"6":[["ion as described above. Stable Km-values were achieved during incubation with ",{}],["daunorubicin",{"fg":1,"bold":true}],[" within 14 hours and with ",{}],["cytarabine                        ",{"fg":1,"bold":true}]],"7":[[" within 12 hours (Figure 2). In order to have reliably stable rates of apoptosis we chose an incubation time of 16 hours.                             ",{}]],"8":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["In 37 of 42 ",{}],["AML",{"fg":1,"bold":true}],[" samples (88%) the DiSC-assay was successfully performed. In 5 cases the assay faile                                 ",{}]],"9":[["d due to bacterial contamination. All chemotherapeutic drugs tested – ",{}],["ara-C",{"fg":1,"bold":true}],[", ",{}],["daunorubicin",{"fg":1,"bold":true}],[" and mitoxantrone – induced cell de                          ",{}]],"10":[["ath in a dose-dependent manner (Figure 1). The sensitivities of the ",{}],["AML",{"fg":1,"bold":true}],[" cells expressed as LC90s showed variability between the patients              ",{}]],"11":[["from as much as 22-fold below (for ",{}],["ara-C",{"fg":1,"bold":true}],[") to 105-fold above (also for ",{}],["ara-C",{"fg":1,"bold":true}],[") the median value (Table 2). For each drug, a ra                          ",{}]],"12":[["nge of sensitivities was observed, ranging from very sensitive to very resistant [11,36]. These individual patient drug sensitivity profiles reflect t",{}]],"13":[["he patient heterogeneity seen in the clinic [37]. If more than 90% of the tumor cells were already killed by the lowest drug concentration, the LC90-v",{}]],"14":[["alue was set equal to the corresponding lowest drug concentration [13]. This was observed in seven cases after incubation with ",{}],["cytarabine",{"fg":1,"bold":true}],["             ",{}]],"15":[[".                                                                                                                                                     ",{}]],"16":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["The Casp3-test was successful in all 42 ",{}],["AML",{"fg":1,"bold":true}],[" samples in terms of measurable caspase activity. But as                                 ",{}]],"17":[[" far as the various cytotoxic drugs – ",{}],["ara-C",{"fg":1,"bold":true}],[", ",{}],["daunorubicin",{"fg":1,"bold":true}],[" and mitoxantrone – are concerned apoptosis could be demonstrated i                          ",{}]],"18":[["n a dose-dependent manner only in a subset of 116 of 126 tests (92%) (Figure 1). The sensitivities of the ",{}],["AML",{"fg":1,"bold":true}],[" blasts expressed as Km show             ",{}]],"19":[["ed extreme variability between the patients from as much as 40-fold below (for ",{}],["daunorubicin",{"fg":1,"bold":true}],[") to 6,3 × 108-fold above (for ",{}],["ara-C                       ",{"fg":1,"bold":true}]],"20":[[") the median value (Table 2). In 14 cases Km-values were less than the lowest concentration of ",{}],["ara-C",{"fg":1,"bold":true}],[" used in the assay, hence the Km-v                ",{}]],"21":[["alues was set equal to the lowest ",{}],["ara-C",{"fg":1,"bold":true}],[" concentration tested in these cases.                                                                          ",{}]],"22":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["Both assays were simultaneously performed on each of the 42 ",{}],["AML",{"fg":1,"bold":true}],[" samples. Correlation between the tw                                 ",{}]],"23":[["o tests was possible for ",{}],["cytarabine",{"fg":1,"bold":true}],[" in 33 cases, for ",{}],["daunorubicin",{"fg":1,"bold":true}],[" in 36 cases and for mitoxantrone in 33 cases.                                       ",{}]],"24":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["For each drug tested the Km-values by the Casp3-test showed an extreme variability as compared to the LC90-value                    ",{}]],"25":[["s by the DiSC-assay, although the median values were quite similar (Table 2). LC90-values did not correlate with corresponding Km-values of ",{}],["c         ",{"fg":1,"bold":true}]],"26":[["ytarabine",{"fg":1,"bold":true}],[" (R2 = 0.38, p = 0.491), ",{}],["daunorubicin",{"fg":1,"bold":true}],[" (R2 = 0.001, p = 0.964) or mitoxantrone (R2 = 0.005, p = 0.544) according to the regre                 ",{}]],"27":[["ssion after Spearman-Rho. The associations of LC90-values with Km-values of the three drugs are shown in Figure 3.                                    ",{}]],"28":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["The major goal of this study was to determine whether the ex-vivo drug resistance in fresh leukemic cells from p                    ",{}]],"29":[["atients with ",{}],["AML",{"fg":1,"bold":true}],[" is reliably assessed by a short-time apoptosis-assay that measures caspase-3 activation. To this end, we compared the Ca             ",{}]],"30":[["sp3-test with established methods like the differential staining cytotoxicity (DiSC)-assay that measures reliably the overall rate of cell death induc",{}]],"31":[["ed by anticancer drugs [6,8,11,34,37,38]. The cytotoxic drugs ",{}],["cytarabine",{"fg":1,"bold":true}],[", ",{}],["daunorubicin",{"fg":1,"bold":true}],[" and mitoxantrone, commonly used in th                          ",{}]],"32":[["e treatment of ",{}],["AML",{"fg":1,"bold":true}],[" were tested in both assays.                                                                                                        ",{}]],"33":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["In the Casp3-test, the activation of proteases that recognize the DEVD peptide motif (DEVD-ases), especially cas                    ",{}]],"34":[["pase-3 was detected by measuring a fluorescence signal generated by a fluorogenic dye upon cleavage by caspase-3. It has been repeatedly demonstrated ",{}]],"35":[["that apoptosis usually is the dominant mode of tumor cell death promoted by chemotherapy [19,39,40], and caspase-3 is a major effector protease in thi",{}]],"36":[["s process [41-44]. Our results indicate, however, that levels of caspase-3 activation, i.e. DEVD-ases, do not correlate with sensitivity or resistance",{}]],"37":[[" to commonly employed anticancer drugs in ",{}],["AML",{"fg":1,"bold":true}],[" blasts. Even though apoptosis is the main pathway for drug-induced cell death caspase-3 act             ",{}]],"38":[["ivities fail to predict the response to chemotherapy as determined by measuring ex-vivo chemosensitivity by the DiSC-assay. There was no association b",{}]],"39":[["etween LC90-values (DiSC-assay) and corresponding Km-values (Casp3-test) of ",{}],["cytarabine",{"fg":1,"bold":true}],[" (p = 0.491), ",{}],["daunorubicin",{"fg":1,"bold":true}],[" (p = 0.964)                          ",{}]],"40":[[" or mitoxantrone (p = 0.544).                                                                                                                         ",{}]],"41":[["AML_PMCID_1164407",{"fg":5}],[":",{"fg":6}],["The DiSC-assay measures total cell death and, therefore, integrates apoptotic and non-apoptotic death induced by                    ",{}]],"42":[[" chemotherapy. Moreover, the DiSC-assay was shown to identify response to therapy and also long-term survival in various hematological neoplastic dise",{}]],"43":[["ases [8,35]. This assay has been extensively evaluated in B-CLL, ",{}],["AML",{"fg":1,"bold":true}],[" and, also, ALL [8,11,36-38,45]. In a large series of ",{}],["AML                         ",{"fg":1,"bold":true}]],"44":[[" patients, we have recently shown an overall predictive accuracy for the DiSC-assay of 98.2% concerning treatment response and proofed the ex-vivo ch ",{}]],"45":[["emosensitivity evaluated by the DiSC-assay as one of the strongest prognostic factors [34]. For the DiSC-assay, it has also been demonstrated that it ",{}]],"46":[["runs more reliable than colony-forming assays that measure clonogenic growth and that results obtained by DiSC-assay are equivalent to both, the colon",{}]],"47":[["y-forming assay and the colorimetric MTT-assay [32,36]. Based on this background, the DiSC-assay serves as an established standard method to evaluate ",{}]],"48":[["the individual ex-vivo chemosensitivity and, also, as an appropriate reference method to evaluate and establish new ex-vivo chemosensitivity assays. F",{}]],"49":[["urthermore, the DiSC-assay has also been used to study various parameters influencing the apoptotic pro                                               ",{}]]},"cursor":{"x":103}}],[0.000968,{"lines":{"0":[["ases [8,35]. This assay has been extensively evaluated in B-CLL, ",{}],["AML",{"fg":1,"bold":true}],[" and, also, ALL [8,11,36-38,45]. In a large series of ",{}],["AML                         ",{"fg":1,"bold":true}]],"1":[[" patients, we have recently shown an overall predictive accuracy for the DiSC-assay of 98.2% concerning treatment response and proofed the ex-vivo ch ",{}]],"2":[["emosensitivity evaluated by the DiSC-assay as one of the strongest prognostic factors [34]. For the DiSC-assay, it has also been demonstrated that it ",{}]],"3":[["runs more reliable than colony-forming assays that measure clonogenic growth and that results obtained by DiSC-assay are equivalent to both, the colon",{}]],"4":[["y-forming assay and the colorimetric MTT-assay [32,36]. Based on this background, the DiSC-assay serves as an established standard method to evaluate ",{}]],"5":[["the individual ex-vivo chemosensitivity and, also, as an appropriate reference method to evaluate and establish new ex-vivo chemosensitivity assays. F",{}]],"6":[["urthermore, the DiSC-assay has also been used to study various parameters influencing the apoptotic process [46,47].                                  ",{}]],"7":[["AML_PMCID_1469755",{"fg":5}],[":",{"fg":6}],["TITLE: ",{}],["Leukemia ",{"fg":1,"bold":true}],["mortality by cell type in petroleum workers with potential exposure to benzene.                                     ",{}]],"8":[["AML_PMCID_1469755",{"fg":5}],[":",{"fg":6}],["Workers in the petroleum industry are potentially exposed to a variety of petrochemicals, including benzene or b                    ",{}]],"9":[["enzene-containing liquids. Although a large number of studies of petroleum workers have been conducted to examine ",{}],["leukemia ",{"fg":1,"bold":true}],["and other canc             ",{}]],"10":[["er risks, few existing studies have investigated cell-type-specific ",{}],["leukemias",{"fg":1,"bold":true}],[". One of the major reasons for the lack of cell-type-specifi             ",{}]],"11":[["c analysis was the small number of deaths by cell type in individual studies. In the present investigation, all cohort studies of petroleum workers in",{}]],"12":[[" the United States and the United Kingdom were combined into a single database for cell-type-specific ",{}],["leukemia ",{"fg":1,"bold":true}],["analysis. The majority of              ",{}]],"13":[["these workers were petroleum refinery employees, but production, pipeline, and distribution workers in the petroleum industry were also included. The ",{}]],"14":[["combined cohort consisted of more than 208,000 petroleum workers, who contributed more than 4.6 million person-years of observation. Based on a meta-a",{}]],"15":[["nalysis of the combined data, cell-type-specific ",{}],["leukemia ",{"fg":1,"bold":true}],["risks were expressed in terms of standardized mortality ratios (meta-SMRs). The             ",{}]],"16":[[" meta-SMR for acute myeloid ",{}],["leukemia ",{"fg":1,"bold":true}],["was 0.96. The lack of an increase of acute myeloid ",{}],["leukemia ",{"fg":1,"bold":true}],["was attributed to the low l                          ",{}]],"17":[["evels of benzene exposure in the petroleum industry, particularly in comparison to benzene exposure levels in some previous studies of workers in othe",{}]],"18":[["r industries, who had been found to experience an increased risk of acute myeloid leukemia. Similarly, no increase in chronic myeloid, acute lymphocyt",{}]],"19":[["ic, or chronic lymphocytic ",{}],["leukemias",{"fg":1,"bold":true}],[" was found in petroleum workers (meta-SMRs of 0.89, 1.16, and 0.84, respectively). Stratified meta-an             ",{}]],"20":[["alyses restricted to refinery studies or to studies with at least 15 years of follow-up yielded similar results. The findings of the present investiga",{}]],"21":[["tion are consistent with those from several recent case-control studies of cell-type-specific leukemia. Patterns and levels of benzene exposure in the",{}]],"22":[[" petroleum industry are reviewed. The results of the present epidemiologic investigation are discussed in conjunction with recent advances in leukemog",{}]],"23":[["enesis from other scientific disciplines.                                                                                                             ",{}]],"24":[["AML_PMCID_1469763",{"fg":5}],[":",{"fg":6}],["Chronic exposure of humans to benzene (BZ) causes acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],["). Both BZ and therapy                                 ",{}]],"25":[["-related secondary ",{}],["AML",{"fg":1,"bold":true}],[" are characterized by chromosomal translocations that may occur by inappropriate recombinational events. DNA topois             ",{}]],"26":[["omerase II (topo II) is an essential sulfhydryl (SH)-dependent endonuclease required for replication, recombination, chromosome segregation, and chrom",{}]],"27":[["osome structure. Topo II cleaves DNA at purine(R)/pyrimidine(Y) repeat sequences that have been shown to be highly recombinogenic in vivo. Certain ant",{}]],"28":[["ineoplastic drugs stabilize topo II-DNA cleavage complexes at RY repeat sequences, which leads to translocations of the type observed in leukemia. Hyd",{}]],"29":[["roquinone (HQ) is metabolized to p-benzoquinone (BQ) in a peroxidase-mediated reaction in myeloid progenitor cells. BQ interacts wit SH groups of SH-d",{}]],"30":[["ependent enzymes. Consequently, the aims of this research were to determine whether HQ and BQ are topo II inhibitors. The ability of the compounds to ",{}]],"31":[["inhibit the activity of topo III was tested using an assay system that depends on the conversion, by homogeneous human topo II, of catenated kinetopla",{}]],"32":[["st DNA into open and/or nicked open circular DNA that can be separated from the catenated DNA by electrophoresis in a 1% agarose-ethidium bromide gel.",{}]],"33":[[" We provide preliminary data that indicate that both HQ and BQ cause a time and concentration (microM)-dependent inhibition of topo II activity. These",{}]],"34":[[" compounds, which potentially can form adducts with DNA, have no effect on the migration of the supercoiled and open circular forms in the electrophor",{}]],"35":[["etic gradient, and BQ-adducted KDNA can be decatenated by topo II. Using a pRYG plasmid DNA with a single RY repeat as a cleavage site, it was determi",{}]],"36":[["ned that BQ does not stimulate the production of linear DNA indicative of an inhibition of topo II religation of strand breaks by stabilization of the",{}]],"37":[[" covalent topo III-DNA cleavage complex. Rather, BQ most probably inhibits the SH-dependent topo II by binding to an essential SH group. The inhibitio",{}]],"38":[["n of topo II by BQ has implications for the formation of deleterious translocations that may be involved in BZ-induced initiation of leukemogenesis.  ",{}]],"39":[["AML_PMCID_1568109",{"fg":5}],[":",{"fg":6}],["TITLE: Consistencies and inconsistencies underlying the quantitative assessment of ",{}],["leukemia ",{"fg":1,"bold":true}],["risk fr                                 ",{}]],"40":[["om benzene exposure.                                                                                                                                  ",{}]],"41":[["AML_PMCID_1568109",{"fg":5}],[":",{"fg":6}],["This paper examines recent risk assessments for benzene and observes a number of inconsistencies within the stud                    ",{}]],"42":[["y and consistencies between studies that should effect the quantitative determination of the risk from benzene exposure. Comparisons across studies sh",{}]],"43":[["ow that only acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],[") is found to be consistently in excess with significant benzene exposure. The data from the Plio             ",{}]],"44":[["film study that forms the basis of most quantitative assessments reveal that all the ",{}],["AML",{"fg":1,"bold":true}],[" cases came from only one of the three studied pl             ",{}]],"45":[["ants and that all the benzene exposure data came from the other plants. Hematological data from the 1940s from the plant from which almost all of the ",{}]],"46":[["industrial hygiene exposure data come do not correlate well with the originally published exposure estimates but do correlate well with an alternative",{}]],"47":[[" set of exposure estimates that are much greater than those estimates originally published. Temporal relationships within the study are not consistent",{}]],"48":[[" with those of other studies. The dose-response relationship is strongly nonlinear. Other data suggest that the leukemogenic effect of benzene is nonl",{}]],"49":[["--More--",{"inverse":true}],["                                                                                                                                              ",{}]]},"cursor":{"x":8}}],[0.942034,{"lines":{"0":[["AML_PMCID_1469755",{"fg":5}],[":",{"fg":6}],["TITLE: ",{}],["Leukemia ",{"fg":1,"bold":true}],["mortality by cell type in petroleum workers with potential exposure to benzene.                                     ",{}]],"1":[["AML_PMCID_1469755",{"fg":5}],[":",{"fg":6}],["Workers in the petroleum industry are potentially exposed to a variety of petrochemicals, including benzene or b                    ",{}]],"2":[["enzene-containing liquids. Although a large number of studies of petroleum workers have been conducted to examine ",{}],["leukemia ",{"fg":1,"bold":true}],["and other canc             ",{}]],"3":[["er risks, few existing studies have investigated cell-type-specific ",{}],["leukemias",{"fg":1,"bold":true}],[". One of the major reasons for the lack of cell-type-specifi             ",{}]],"4":[["c analysis was the small number of deaths by cell type in individual studies. In the present investigation, all cohort studies of petroleum workers in",{}]],"5":[[" the United States and the United Kingdom were combined into a single database for cell-type-specific ",{}],["leukemia ",{"fg":1,"bold":true}],["analysis. The majority of              ",{}]],"6":[["these workers were petroleum refinery employees, but production, pipeline, and distribution workers in the petroleum industry were also included. The ",{}]],"7":[["combined cohort consisted of more than 208,000 petroleum workers, who contributed more than 4.6 million person-years of observation. Based on a meta-a",{}]],"8":[["nalysis of the combined data, cell-type-specific ",{}],["leukemia ",{"fg":1,"bold":true}],["risks were expressed in terms of standardized mortality ratios (meta-SMRs). The             ",{}]],"9":[[" meta-SMR for acute myeloid ",{}],["leukemia ",{"fg":1,"bold":true}],["was 0.96. The lack of an increase of acute myeloid ",{}],["leukemia ",{"fg":1,"bold":true}],["was attributed to the low l                          ",{}]],"10":[["evels of benzene exposure in the petroleum industry, particularly in comparison to benzene exposure levels in some previous studies of workers in othe",{}]],"11":[["r industries, who had been found to experience an increased risk of acute myeloid leukemia. Similarly, no increase in chronic myeloid, acute lymphocyt",{}]],"12":[["ic, or chronic lymphocytic ",{}],["leukemias",{"fg":1,"bold":true}],[" was found in petroleum workers (meta-SMRs of 0.89, 1.16, and 0.84, respectively). Stratified meta-an             ",{}]],"13":[["alyses restricted to refinery studies or to studies with at least 15 years of follow-up yielded similar results. The findings of the present investiga",{}]],"14":[["tion are consistent with those from several recent case-control studies of cell-type-specific leukemia. Patterns and levels of benzene exposure in the",{}]],"15":[[" petroleum industry are reviewed. The results of the present epidemiologic investigation are discussed in conjunction with recent advances in leukemog",{}]],"16":[["enesis from other scientific disciplines.                                                                                                             ",{}]],"17":[["AML_PMCID_1469763",{"fg":5}],[":",{"fg":6}],["Chronic exposure of humans to benzene (BZ) causes acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],["). Both BZ and therapy                                 ",{}]],"18":[["-related secondary ",{}],["AML",{"fg":1,"bold":true}],[" are characterized by chromosomal translocations that may occur by inappropriate recombinational events. DNA topois             ",{}]],"19":[["omerase II (topo II) is an essential sulfhydryl (SH)-dependent endonuclease required for replication, recombination, chromosome segregation, and chrom",{}]],"20":[["osome structure. Topo II cleaves DNA at purine(R)/pyrimidine(Y) repeat sequences that have been shown to be highly recombinogenic in vivo. Certain ant",{}]],"21":[["ineoplastic drugs stabilize topo II-DNA cleavage complexes at RY repeat sequences, which leads to translocations of the type observed in leukemia. Hyd",{}]],"22":[["roquinone (HQ) is metabolized to p-benzoquinone (BQ) in a peroxidase-mediated reaction in myeloid progenitor cells. BQ interacts wit SH groups of SH-d",{}]],"23":[["ependent enzymes. Consequently, the aims of this research were to determine whether HQ and BQ are topo II inhibitors. The ability of the compounds to ",{}]],"24":[["inhibit the activity of topo III was tested using an assay system that depends on the conversion, by homogeneous human topo II, of catenated kinetopla",{}]],"25":[["st DNA into open and/or nicked open circular DNA that can be separated from the catenated DNA by electrophoresis in a 1% agarose-ethidium bromide gel.",{}]],"26":[[" We provide preliminary data that indicate that both HQ and BQ cause a time and concentration (microM)-dependent inhibition of topo II activity. These",{}]],"27":[[" compounds, which potentially can form adducts with DNA, have no effect on the migration of the supercoiled and open circular forms in the electrophor",{}]],"28":[["etic gradient, and BQ-adducted KDNA can be decatenated by topo II. Using a pRYG plasmid DNA with a single RY repeat as a cleavage site, it was determi",{}]],"29":[["ned that BQ does not stimulate the production of linear DNA indicative of an inhibition of topo II religation of strand breaks by stabilization of the",{}]],"30":[[" covalent topo III-DNA cleavage complex. Rather, BQ most probably inhibits the SH-dependent topo II by binding to an essential SH group. The inhibitio",{}]],"31":[["n of topo II by BQ has implications for the formation of deleterious translocations that may be involved in BZ-induced initiation of leukemogenesis.  ",{}]],"32":[["AML_PMCID_1568109",{"fg":5}],[":",{"fg":6}],["TITLE: Consistencies and inconsistencies underlying the quantitative assessment of ",{}],["leukemia ",{"fg":1,"bold":true}],["risk fr                                 ",{}]],"33":[["om benzene exposure.                                                                                                                                  ",{}]],"34":[["AML_PMCID_1568109",{"fg":5}],[":",{"fg":6}],["This paper examines recent risk assessments for benzene and observes a number of inconsistencies within the stud                    ",{}]],"35":[["y and consistencies between studies that should effect the quantitative determination of the risk from benzene exposure. Comparisons across studies sh",{}]],"36":[["ow that only acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],[") is found to be consistently in excess with significant benzene exposure. The data from the Plio             ",{}]],"37":[["film study that forms the basis of most quantitative assessments reveal that all the ",{}],["AML",{"fg":1,"bold":true}],[" cases came from only one of the three studied pl             ",{}]],"38":[["ants and that all the benzene exposure data came from the other plants. Hematological data from the 1940s from the plant from which almost all of the ",{}]],"39":[["industrial hygiene exposure data come do not correlate well with the originally published exposure estimates but do correlate well with an alternative",{}]],"40":[[" set of exposure estimates that are much greater than those estimates originally published. Temporal relationships within the study are not consistent",{}]],"41":[[" with those of other studies. The dose-response relationship is strongly nonlinear. Other data suggest that the leukemogenic effect of benzene is nonl",{}]],"42":[["inear and may derive from a threshold toxicity.                                                                                                       ",{}]],"43":[["AML_PMCID_1638019",{"fg":5}],[":",{"fg":6}],["Cigarette smoking is associated with an increased risk of leukemia; benzene, an established leukemogen, is prese                    ",{}]],"44":[["nt in cigarette smoke. By combining epidemiologic data on the health effects of smoking with risk assessment techniques for low-dose extrapolation, we",{}]],"45":[[" assessed the proportion of smoking-induced total ",{}],["leukemia ",{"fg":1,"bold":true}],["and acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],[") attributable to the benzene in c                          ",{}]],"46":[["igarette smoke. We fit both linear and quadratic models to data from two benzene-exposed occupational cohorts to estimate the leukemogenic potency of ",{}]],"47":[["benzene. Using multiple-decrement life tables, we calculated lifetime risks of total ",{}],["leukemia ",{"fg":1,"bold":true}],["and ",{}],["AML",{"fg":1,"bold":true}],[" deaths for never, ligh                          ",{}]],"48":[["t, and heavy smokers. We repeated these calculations, removing the effect of benzene in cigarettes based on the estimated potencies. From these life t",{}]],"49":[["ables we determined smoking-attributab                                                                                                                ",{}]]},"cursor":{"x":38}}],[0.001973,{"lines":{"0":[["inear and may derive from a threshold toxicity.                                                                                                       ",{}]],"1":[["AML_PMCID_1638019",{"fg":5}],[":",{"fg":6}],["Cigarette smoking is associated with an increased risk of leukemia; benzene, an established leukemogen, is prese                    ",{}]],"2":[["nt in cigarette smoke. By combining epidemiologic data on the health effects of smoking with risk assessment techniques for low-dose extrapolation, we",{}]],"3":[[" assessed the proportion of smoking-induced total ",{}],["leukemia ",{"fg":1,"bold":true}],["and acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],[") attributable to the benzene in c                          ",{}]],"4":[["igarette smoke. We fit both linear and quadratic models to data from two benzene-exposed occupational cohorts to estimate the leukemogenic potency of ",{}]],"5":[["benzene. Using multiple-decrement life tables, we calculated lifetime risks of total ",{}],["leukemia ",{"fg":1,"bold":true}],["and ",{}],["AML",{"fg":1,"bold":true}],[" deaths for never, ligh                          ",{}]],"6":[["t, and heavy smokers. We repeated these calculations, removing the effect of benzene in cigarettes based on the estimated potencies. From these life t",{}]],"7":[["ables we determined smoking-attributable risks and benzene-attributable risks. The ratio of the latter to the former constitutes the proportion of smo",{}]],"8":[["king-induced cases attributable to benzene. Based on linear potency models, the benzene in cigarette smoke contributed from 8 to 48% of smoking-induce",{}]],"9":[["d total ",{}],["leukemia ",{"fg":1,"bold":true}],["deaths [95% upper confidence limit (UCL), 20-66%], and from 12 to 58% of smoking-induced ",{}],["AML",{"fg":1,"bold":true}],[" deaths (95% UC                          ",{}]],"10":[["L, 19-121%). The inclusion of a quadratic term yielded results that were comparable; however, potency models with only quadratic terms resulted in muc",{}]],"11":[["h lower attributable fractions--all < 1%. Thus, benzene is estimated to be responsible for approximately one-tenth to one-half of smoking-induced tota",{}]],"12":[["l ",{}],["leukemia ",{"fg":1,"bold":true}],["mortality and up to three-fifths of smoking-related ",{}],["AML",{"fg":1,"bold":true}],[" mortality. In contrast to theoretical arguments that line                          ",{}]],"13":[["ar models substantially overestimate low-dose risk, linear extrapolations from empirical data over a dose range of 10- to 100-fold resulted in plausib",{}]],"14":[["le predictions.                                                                                                                                       ",{}]],"15":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["TITLE: Text-derived concept profiles support assessment of DNA microarray data for acute myeloid ",{}],["leukem                             ",{"fg":1,"bold":true}]],"16":[["ia ",{"fg":1,"bold":true}],["and for androgen receptor stimulation                                                                                                              ",{}]],"17":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["The experimental validation was done in two steps. We first applied our method on a controlled test set. After t                    ",{}]],"18":[["his proved to be successful the datasets from two DNA microarray experiments were analyzed in the same way and the results were evaluated by domain ex",{}]],"19":[["perts. The first dataset was a gene-expression profile that characterizes the cancer cells of a group of acute myeloid ",{}],["leukemia ",{"fg":1,"bold":true}],["patients.             ",{}]],"20":[[" For this group of patients the biological background of the cancer cells is largely unknown. Using our methodology we found an association of these c",{}]],"21":[["ells to monocytes, which agreed with other experimental evidence. The second data set consisted of differentially expressed genes following androgen r",{}]],"22":[["eceptor stimulation in a prostate cancer cell line. Based on the analysis we put forward a hypothesis about the biological processes induced in these ",{}]],"23":[["studied cells: secretory lysosomes are involved in the production of prostatic fluid and their development and/or secretion are androgen-regulated pro",{}]],"24":[["cesses.                                                                                                                                               ",{}]],"25":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["DNA microarray dataset 1: Gene expression profiles of acute myeloid ",{}],["leukemia ",{"fg":1,"bold":true}],["patients                                               ",{}]],"26":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["Based on gene-expression profiles of leukemic cells, 285 acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],[") patients were                                 ",{}]],"27":[[" separated into 16 groups [23]. Several of these groups coincided with known classes of ",{}],["AML",{"fg":1,"bold":true}],[" patients. ",{}],["AML",{"fg":1,"bold":true}],[" cases are classifi                          ",{}]],"28":[["ed by the occurrence of genomic aberrations in the leukemic cells. According to the report, group 5, one of the larger groups with 61 patients, does n",{}]],"29":[["ot associate with a known karyotypic abnormality and little is known about the background of the leukemic cells in this cluster [23]. The set of genes",{}]],"30":[[" that characterize this patient group were analyzed with the literature-based clustering provided by Anni. We sought to find shared processes and othe",{}]],"31":[["r associations that could be indicative for the background of the leukemic cells.                                                                     ",{}]],"32":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["Also within several other clusters genes were found to have an association with monocytes in their concept profi                    ",{}]],"33":[["le. Several of these genes indeed had a functional relationship with monocytes. A cluster of chemokines and chemokine receptors is associated with che",{}]],"34":[["motaxis and macrophage inflammatory proteins. From this cluster CCR1 and CCR2 are involved in monocyte chemotaxis [27]. A cluster associated with anti",{}]],"35":[["gens contained Cluster Differentiation genes, and CD14 is a monocyte lineage specific marker. The immunologic receptor cluster contained a number of g",{}]],"36":[["enes strongly associated with monocytes. One of these, LILRB4 (ILT3) is a cell surface molecule selectively expressed by the myeloid antigen presentin",{}]],"37":[["g cells of the monocytic lineage [28]. As we did not find clusters characteristic for other myeloid cell-types, such as erythrocyte precursors, we pos",{}]],"38":[["tulate that ",{}],["AML",{"fg":1,"bold":true}],[" patient group 5 is associated with precursor cells from the monocytic lineage.                                                        ",{}]],"39":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["The first DNA microarray data set we analyzed, was the gene expression profile of the leukemic cells of a group                     ",{}]],"40":[["of ",{}],["AML",{"fg":1,"bold":true}],[" patients as identified in [23]. Little is known about the background of the leukemic cells in this cluster. With the Anni annotati             ",{}]],"41":[["on and the underlying literature it was possible to identify several groups of genes and individual genes in the profile that indicate an association ",{}]],"42":[["of the leukemic cells to cells of the monocytic lineage. This finding was in concordance with the morphological classification of the cells. The secon",{}]],"43":[["d data set consisted of a list of differentially expressed genes following the agonistic stimulation of the androgen receptor in a prostate cancer cel",{}]],"44":[["l line. The Anni annotation revealed a cluster associated with, amongst others, melanosomes and secretory vesicles. Based on this finding and the unde",{}]],"45":[["rlying literature we formulated a hypothesis about the role of secretory lysosomes in prostate function. We conclude that Anni can be successfully use",{}]],"46":[["d by molecular biologists studying DNA microarray datasets as a tool to automatically use the explicit and implicit information in literature.        ",{}]],"47":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["The first set consisted of data from a recent study about prognostically useful gene-expression profiles in                         ",{}]],"48":[["AML",{"fg":1,"bold":true}],[" [23]. Gene expression in leukemic blast cells from 285 patients was measured. Clustering of the gene expression data resulted in 16 group         ",{}]],"49":[["--More--",{"inverse":true}],["                                                                                                                                              ",{}]]},"cursor":{"x":8}}],[0.942016,{"lines":{"0":[["king-induced cases attributable to benzene. Based on linear potency models, the benzene in cigarette smoke contributed from 8 to 48% of smoking-induce",{}]],"1":[["d total ",{}],["leukemia ",{"fg":1,"bold":true}],["deaths [95% upper confidence limit (UCL), 20-66%], and from 12 to 58% of smoking-induced ",{}],["AML",{"fg":1,"bold":true}],[" deaths (95% UC                          ",{}]],"2":[["L, 19-121%). The inclusion of a quadratic term yielded results that were comparable; however, potency models with only quadratic terms resulted in muc",{}]],"3":[["h lower attributable fractions--all < 1%. Thus, benzene is estimated to be responsible for approximately one-tenth to one-half of smoking-induced tota",{}]],"4":[["l ",{}],["leukemia ",{"fg":1,"bold":true}],["mortality and up to three-fifths of smoking-related ",{}],["AML",{"fg":1,"bold":true}],[" mortality. In contrast to theoretical arguments that line                          ",{}]],"5":[["ar models substantially overestimate low-dose risk, linear extrapolations from empirical data over a dose range of 10- to 100-fold resulted in plausib",{}]],"6":[["le predictions.                                                                                                                                       ",{}]],"7":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["TITLE: Text-derived concept profiles support assessment of DNA microarray data for acute myeloid ",{}],["leukem                             ",{"fg":1,"bold":true}]],"8":[["ia ",{"fg":1,"bold":true}],["and for androgen receptor stimulation                                                                                                              ",{}]],"9":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["The experimental validation was done in two steps. We first applied our method on a controlled test set. After t                    ",{}]],"10":[["his proved to be successful the datasets from two DNA microarray experiments were analyzed in the same way and the results were evaluated by domain ex",{}]],"11":[["perts. The first dataset was a gene-expression profile that characterizes the cancer cells of a group of acute myeloid ",{}],["leukemia ",{"fg":1,"bold":true}],["patients.             ",{}]],"12":[[" For this group of patients the biological background of the cancer cells is largely unknown. Using our methodology we found an association of these c",{}]],"13":[["ells to monocytes, which agreed with other experimental evidence. The second data set consisted of differentially expressed genes following androgen r",{}]],"14":[["eceptor stimulation in a prostate cancer cell line. Based on the analysis we put forward a hypothesis about the biological processes induced in these ",{}]],"15":[["studied cells: secretory lysosomes are involved in the production of prostatic fluid and their development and/or secretion are androgen-regulated pro",{}]],"16":[["cesses.                                                                                                                                               ",{}]],"17":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["DNA microarray dataset 1: Gene expression profiles of acute myeloid ",{}],["leukemia ",{"fg":1,"bold":true}],["patients                                               ",{}]],"18":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["Based on gene-expression profiles of leukemic cells, 285 acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],[") patients were                                 ",{}]],"19":[[" separated into 16 groups [23]. Several of these groups coincided with known classes of ",{}],["AML",{"fg":1,"bold":true}],[" patients. ",{}],["AML",{"fg":1,"bold":true}],[" cases are classifi                          ",{}]],"20":[["ed by the occurrence of genomic aberrations in the leukemic cells. According to the report, group 5, one of the larger groups with 61 patients, does n",{}]],"21":[["ot associate with a known karyotypic abnormality and little is known about the background of the leukemic cells in this cluster [23]. The set of genes",{}]],"22":[[" that characterize this patient group were analyzed with the literature-based clustering provided by Anni. We sought to find shared processes and othe",{}]],"23":[["r associations that could be indicative for the background of the leukemic cells.                                                                     ",{}]],"24":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["Also within several other clusters genes were found to have an association with monocytes in their concept profi                    ",{}]],"25":[["le. Several of these genes indeed had a functional relationship with monocytes. A cluster of chemokines and chemokine receptors is associated with che",{}]],"26":[["motaxis and macrophage inflammatory proteins. From this cluster CCR1 and CCR2 are involved in monocyte chemotaxis [27]. A cluster associated with anti",{}]],"27":[["gens contained Cluster Differentiation genes, and CD14 is a monocyte lineage specific marker. The immunologic receptor cluster contained a number of g",{}]],"28":[["enes strongly associated with monocytes. One of these, LILRB4 (ILT3) is a cell surface molecule selectively expressed by the myeloid antigen presentin",{}]],"29":[["g cells of the monocytic lineage [28]. As we did not find clusters characteristic for other myeloid cell-types, such as erythrocyte precursors, we pos",{}]],"30":[["tulate that ",{}],["AML",{"fg":1,"bold":true}],[" patient group 5 is associated with precursor cells from the monocytic lineage.                                                        ",{}]],"31":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["The first DNA microarray data set we analyzed, was the gene expression profile of the leukemic cells of a group                     ",{}]],"32":[["of ",{}],["AML",{"fg":1,"bold":true}],[" patients as identified in [23]. Little is known about the background of the leukemic cells in this cluster. With the Anni annotati             ",{}]],"33":[["on and the underlying literature it was possible to identify several groups of genes and individual genes in the profile that indicate an association ",{}]],"34":[["of the leukemic cells to cells of the monocytic lineage. This finding was in concordance with the morphological classification of the cells. The secon",{}]],"35":[["d data set consisted of a list of differentially expressed genes following the agonistic stimulation of the androgen receptor in a prostate cancer cel",{}]],"36":[["l line. The Anni annotation revealed a cluster associated with, amongst others, melanosomes and secretory vesicles. Based on this finding and the unde",{}]],"37":[["rlying literature we formulated a hypothesis about the role of secretory lysosomes in prostate function. We conclude that Anni can be successfully use",{}]],"38":[["d by molecular biologists studying DNA microarray datasets as a tool to automatically use the explicit and implicit information in literature.        ",{}]],"39":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["The first set consisted of data from a recent study about prognostically useful gene-expression profiles in                         ",{}]],"40":[["AML",{"fg":1,"bold":true}],[" [23]. Gene expression in leukemic blast cells from 285 patients was measured. Clustering of the gene expression data resulted in 16 group         ",{}]],"41":[["s of patients with distinct profiles. For each cluster a profile of genes with the most distinguishing gene expression patterns was made with the sign",{}]],"42":[["ificance analysis of microarray (SAM) method. For our analysis genes with a SAM score higher than 4 or lower than -4 were selected. Data acquisition a",{}]],"43":[["nd processing are described in detail in the original paper.                                                                                          ",{}]],"44":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["AML",{"fg":1,"bold":true}],[" Acute Myeloid Leukemia                                                                                                          ",{}]],"45":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["TITLE: Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and ",{}],["                             ",{"fg":1,"bold":true}]],"46":[["Flt3",{"fg":1,"bold":true}],[" in acute myeloid ",{}],["leukemia ",{"fg":1,"bold":true}],["cells                                                                                                                  ",{}]],"47":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],[") cells are characterized by non-mutated ",{}],["TP53",{"fg":1,"bold":true}],[", high levels                                               ",{}]],"48":[["of Hdm2, and frequent mutation of the ",{}],["Flt3",{"fg":1,"bold":true}],[" receptor tyrosine kinase. The juxtamembrane mutation of ",{}],["FLT3",{"fg":1,"bold":true}],[" is the strongest ind                          ",{}]],"49":[["ependent marker                                                                                                                                       ",{}]]},"cursor":{"x":15}}],[0.001987,{"lines":{"0":[["s of patients with distinct profiles. For each cluster a profile of genes with the most distinguishing gene expression patterns was made with the sign",{}]],"1":[["ificance analysis of microarray (SAM) method. For our analysis genes with a SAM score higher than 4 or lower than -4 were selected. Data acquisition a",{}]],"2":[["nd processing are described in detail in the original paper.                                                                                          ",{}]],"3":[["AML_PMCID_1784107",{"fg":5}],[":",{"fg":6}],["AML",{"fg":1,"bold":true}],[" Acute Myeloid Leukemia                                                                                                          ",{}]],"4":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["TITLE: Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and ",{}],["                             ",{"fg":1,"bold":true}]],"5":[["Flt3",{"fg":1,"bold":true}],[" in acute myeloid ",{}],["leukemia ",{"fg":1,"bold":true}],["cells                                                                                                                  ",{}]],"6":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],[") cells are characterized by non-mutated ",{}],["TP53",{"fg":1,"bold":true}],[", high levels                                               ",{}]],"7":[["of Hdm2, and frequent mutation of the ",{}],["Flt3",{"fg":1,"bold":true}],[" receptor tyrosine kinase. The juxtamembrane mutation of ",{}],["FLT3",{"fg":1,"bold":true}],[" is the strongest ind                          ",{}]],"8":[["ependent marker for disease relapse and is associated with elevated Bcl-2 protein and p53 hyper-phosphorylation in ",{}],["AML",{"fg":1,"bold":true}],[". DNA damage forms              ",{}]],"9":[["the basic mechanism of cancer cell eradication in current therapy of ",{}],["AML",{"fg":1,"bold":true}],[".                                                                             ",{}]],"10":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Hdm2 and pro-apoptotic Bcl-2 members are among the most intensely induced genes immediately after chemotherapy a                    ",{}]],"11":[["nd Hdm2 is proposed a role in receptor tyrosine kinase regulation. Thus we examined the DNA damage related modulation of these proteins in relation to",{}]],"12":[[" ",{}],["FLT3",{"fg":1,"bold":true}],[" mutational status and induction of apoptosis.                                                                                                   ",{}]],"13":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Within one hour after exposure to ionizing radiation (IR), the ",{}],["AML",{"fg":1,"bold":true}],[" cells (NB4, MV4-11, HL-60, prima                                 ",{}]],"14":[["ry ",{}],["AML",{"fg":1,"bold":true}],[" cells) showed an increase in ",{}],["Flt3",{"fg":1,"bold":true}],[" protein independent of mRNA levels, while the Hdm2 protein decreased. The ",{}],["                                   ",{"fg":1,"bold":true}]],"15":[["FLT3",{"fg":1,"bold":true}],[" mutant MV4-11 cells were resistant to IR accompanied by presence of both Mcl-1 and Hdm2 protein three hours after IR. In contrast, the           ",{}]],"16":[["FLT3",{"fg":1,"bold":true}],[" wild type NB4 cells responded to IR with apoptosis and pre-apoptotic Mcl-1 down regulation. ",{}],["Daunorubicin",{"fg":1,"bold":true}],[" (DNR) induced contin                    ",{}]],"17":[["uing down regulation of Hdm2 and Mcl-1 in both cell lines followed by apoptosis.                                                                      ",{}]],"18":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Both IR and DNR treatment resulted in concerted protein modulations of Mcl-1, Hdm2 and ",{}],["Flt3",{"fg":1,"bold":true}],[". Cell d                                 ",{}]],"19":[["eath induction was associated with persistent attenuation of Mcl-1 and Hdm2. These observations suggest that defining the pathway(s) modulating       ",{}]],"20":[["Flt3",{"fg":1,"bold":true}],[", Hdm2 and Mcl-1 may propose new strategies to optimize therapy for the relapse prone ",{}],["FLT3",{"fg":1,"bold":true}],[" mutated ",{}],["AML",{"fg":1,"bold":true}],[" patients.                                  ",{}]],"21":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Anthracycline",{"fg":1,"bold":true}],["s like ",{}],["daunorubicin",{"fg":1,"bold":true}],[" (DNR) are used in the induction treatment of acute my                                              ",{}]],"22":[["eloid leukemia (",{}],["AML",{"fg":1,"bold":true}],["), obtaining short time complete hematological remission for more than 65% of adult ",{}],["AML",{"fg":1,"bold":true}],[" patients with de                           ",{}]],"23":[["novo ",{}],["AML",{"fg":1,"bold":true}],[" [1]. Successful hematological remission after only one induction cycle is a favorable prognostic parameter and is associated wit             ",{}]],"24":[["h decreased risk of later ",{}],["AML",{"fg":1,"bold":true}],[" relapse [1,2]. Induction therapy causes rapid activation of the tumor suppressor p53 followed by dominating             ",{}]],"25":[[" p53-targeted gene expression in vivo [3]. A major mechanism for this p53 induction is DNA damage through ",{}],["anthracycline",{"fg":1,"bold":true}],["-stabilization of              ",{}]],"26":[["the DNA:topoisomerase II complex [4], but cell death induction by ",{}],["anthracycline",{"fg":1,"bold":true}],["s may also involve other molecular targets independent of              ",{}]],"27":[["p53 [4-7].                                                                                                                                            ",{}]],"28":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Ionizing radiation (IR) is frequently used in the treatment of solid cancers, in the conditional treatment befor                    ",{}]],"29":[["e allotransplantation of ",{}],["leukemia ",{"fg":1,"bold":true}],["patients and in radioisotope-conjugated therapeutic antibodies directed against ",{}],["AML",{"fg":1,"bold":true}],[" cells                           ",{}]],"30":[["[8,9]. IR and ",{}],["anthracycline",{"fg":1,"bold":true}],["s induce growth arrest and cell death through DNA-damage, but also involve cell membrane-related effects in re             ",{}]],"31":[["gulation of apoptosis [4-7,10]. We have previously reported that ",{}],["AML",{"fg":1,"bold":true}],[" patient cells respond with varying sensitivity to IR-induced prolife             ",{}]],"32":[["ration arrest [11], and it may therefore be of interest to determine molecular mechanisms for radioresistance in more detail.                         ",{}]],"33":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["The strongest molecular predictor for ",{}],["AML",{"fg":1,"bold":true}],[" relapse is internal tandem duplications in the juxtamembr                                 ",{}]],"34":[["ane domain of the receptor tyrosine kinase ",{}],["Flt3",{"fg":1,"bold":true}],[" (",{}],["Flt3",{"fg":1,"bold":true}],["-ITD). These mutations are present in approximately one third of the pa                          ",{}]],"35":[["tients [12]. ",{}],["Flt3",{"fg":1,"bold":true}],["-ITD are associated with increased DNA repair [13], an observation suggesting that these cells are able to recover from              ",{}]],"36":[["DNA damage caused by topoisomerase II blockage and thus have a more drug-resistant phenotype. The expression of anti-apoptotic Bcl-2 protein family me",{}]],"37":[["mbers is also influenced by the mutational status of ",{}],["Flt3",{"fg":1,"bold":true}],[" [14]. We have recently shown that a duplication of Y591 in ",{}],["Flt3",{"fg":1,"bold":true}],["-IT                          ",{}]],"38":[["Ds is associated with elevated Bcl-2 protein and hyper-phosphorylated wild type (wt) p53 in ",{}],["AML",{"fg":1,"bold":true}],[", proposing a mechanism for inactivation o             ",{}]],"39":[["f p53 [14].                                                                                                                                           ",{}]],"40":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Mcl-1 is an anti-apoptotic member of the Bcl-2 family of proteins. High levels of Mcl-1 have been detected in ce                    ",{}]],"41":[["lls from patients with relapsed ",{}],["AML",{"fg":1,"bold":true}],[" [15]. Therapeutic targeting of Bcl-2 family proteins seems to depend on Mcl-1 to trigger apoptosis [1             ",{}]],"42":[["6]. It may therefore be of particular interest to examine the Mcl-1 modulation in DNA damage therapy.                                                 ",{}]],"43":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["In contrast to solid tumors, more than 90% of the ",{}],["AML",{"fg":1,"bold":true}],[" cases comprise wild type p53 [17,18]. On the                                  ",{}]],"44":[["other hand, the E3 ubiquitin ligase Hdm2 is usually strongly expressed in ",{}],["AML",{"fg":1,"bold":true}],[", contributing to block the growth inhibitory and pro-apopto             ",{}]],"45":[["tic effect of p53 [19]. IR induces DNA damage and rapid down regulation of Hdm2 through induction of auto-ubiquitination and subsequent proteasomal de",{}]],"46":[["gradation [20]. Recent reports indicate that Hdm2 have important p53-independent activities, including regulation of cell membrane receptors like insu",{}]],"47":[["lin-like growth factor (IGF) 1 receptor and β2-adrenergic receptor through ubiquitination [21]. However, it is not known whether the ",{}],["Flt3",{"fg":1,"bold":true}],["             ",{}]],"48":[[" receptor is regulated by Hdm2.                                                                                                                       ",{}]],"49":[["--More--",{"inverse":true}],["                                                                                                                                              ",{}]]},"cursor":{"x":8}}],[0.814008,{"lines":{"49":[["                                                                                                                                                      ",{}]]},"cursor":{"x":0}}],[0.240951,{"lines":{"0":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["TITLE: Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and ",{}],["                             ",{"fg":1,"bold":true}]],"1":[["Flt3",{"fg":1,"bold":true}],[" in acute myeloid ",{}],["leukemia ",{"fg":1,"bold":true}],["cells                                                                                                                  ",{}]],"2":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],[") cells are characterized by non-mutated ",{}],["TP53",{"fg":1,"bold":true}],[", high levels                                               ",{}]],"3":[["of Hdm2, and frequent mutation of the ",{}],["Flt3",{"fg":1,"bold":true}],[" receptor tyrosine kinase. The juxtamembrane mutation of ",{}],["FLT3",{"fg":1,"bold":true}],[" is the strongest ind                          ",{}]],"4":[["ependent marker for disease relapse and is associated with elevated Bcl-2 protein and p53 hyper-phosphorylation in ",{}],["AML",{"fg":1,"bold":true}],[". DNA damage forms              ",{}]],"5":[["the basic mechanism of cancer cell eradication in current therapy of ",{}],["AML",{"fg":1,"bold":true}],[".                                                                             ",{}]],"6":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Hdm2 and pro-apoptotic Bcl-2 members are among the most intensely induced genes immediately after chemotherapy a                    ",{}]],"7":[["nd Hdm2 is proposed a role in receptor tyrosine kinase regulation. Thus we examined the DNA damage related modulation of these proteins in relation to",{}]],"8":[[" ",{}],["FLT3",{"fg":1,"bold":true}],[" mutational status and induction of apoptosis.                                                                                                   ",{}]],"9":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Within one hour after exposure to ionizing radiation (IR), the ",{}],["AML",{"fg":1,"bold":true}],[" cells (NB4, MV4-11, HL-60, prima                                 ",{}]],"10":[["ry ",{}],["AML",{"fg":1,"bold":true}],[" cells) showed an increase in ",{}],["Flt3",{"fg":1,"bold":true}],[" protein independent of mRNA levels, while the Hdm2 protein decreased. The ",{}],["                                   ",{"fg":1,"bold":true}]],"11":[["FLT3",{"fg":1,"bold":true}],[" mutant MV4-11 cells were resistant to IR accompanied by presence of both Mcl-1 and Hdm2 protein three hours after IR. In contrast, the           ",{}]],"12":[["FLT3",{"fg":1,"bold":true}],[" wild type NB4 cells responded to IR with apoptosis and pre-apoptotic Mcl-1 down regulation. ",{}],["Daunorubicin",{"fg":1,"bold":true}],[" (DNR) induced contin                    ",{}]],"13":[["uing down regulation of Hdm2 and Mcl-1 in both cell lines followed by apoptosis.                                                                      ",{}]],"14":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Both IR and DNR treatment resulted in concerted protein modulations of Mcl-1, Hdm2 and ",{}],["Flt3",{"fg":1,"bold":true}],[". Cell d                                 ",{}]],"15":[["eath induction was associated with persistent attenuation of Mcl-1 and Hdm2. These observations suggest that defining the pathway(s) modulating       ",{}]],"16":[["Flt3",{"fg":1,"bold":true}],[", Hdm2 and Mcl-1 may propose new strategies to optimize therapy for the relapse prone ",{}],["FLT3",{"fg":1,"bold":true}],[" mutated ",{}],["AML",{"fg":1,"bold":true}],[" patients.                                  ",{}]],"17":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Anthracycline",{"fg":1,"bold":true}],["s like ",{}],["daunorubicin",{"fg":1,"bold":true}],[" (DNR) are used in the induction treatment of acute my                                              ",{}]],"18":[["eloid leukemia (",{}],["AML",{"fg":1,"bold":true}],["), obtaining short time complete hematological remission for more than 65% of adult ",{}],["AML",{"fg":1,"bold":true}],[" patients with de                           ",{}]],"19":[["novo ",{}],["AML",{"fg":1,"bold":true}],[" [1]. Successful hematological remission after only one induction cycle is a favorable prognostic parameter and is associated wit             ",{}]],"20":[["h decreased risk of later ",{}],["AML",{"fg":1,"bold":true}],[" relapse [1,2]. Induction therapy causes rapid activation of the tumor suppressor p53 followed by dominating             ",{}]],"21":[[" p53-targeted gene expression in vivo [3]. A major mechanism for this p53 induction is DNA damage through ",{}],["anthracycline",{"fg":1,"bold":true}],["-stabilization of              ",{}]],"22":[["the DNA:topoisomerase II complex [4], but cell death induction by ",{}],["anthracycline",{"fg":1,"bold":true}],["s may also involve other molecular targets independent of              ",{}]],"23":[["p53 [4-7].                                                                                                                                            ",{}]],"24":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Ionizing radiation (IR) is frequently used in the treatment of solid cancers, in the conditional treatment befor                    ",{}]],"25":[["e allotransplantation of ",{}],["leukemia ",{"fg":1,"bold":true}],["patients and in radioisotope-conjugated therapeutic antibodies directed against ",{}],["AML",{"fg":1,"bold":true}],[" cells                           ",{}]],"26":[["[8,9]. IR and ",{}],["anthracycline",{"fg":1,"bold":true}],["s induce growth arrest and cell death through DNA-damage, but also involve cell membrane-related effects in re             ",{}]],"27":[["gulation of apoptosis [4-7,10]. We have previously reported that ",{}],["AML",{"fg":1,"bold":true}],[" patient cells respond with varying sensitivity to IR-induced prolife             ",{}]],"28":[["ration arrest [11], and it may therefore be of interest to determine molecular mechanisms for radioresistance in more detail.                         ",{}]],"29":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["The strongest molecular predictor for ",{}],["AML",{"fg":1,"bold":true}],[" relapse is internal tandem duplications in the juxtamembr                                 ",{}]],"30":[["ane domain of the receptor tyrosine kinase ",{}],["Flt3",{"fg":1,"bold":true}],[" (",{}],["Flt3",{"fg":1,"bold":true}],["-ITD). These mutations are present in approximately one third of the pa                          ",{}]],"31":[["tients [12]. ",{}],["Flt3",{"fg":1,"bold":true}],["-ITD are associated with increased DNA repair [13], an observation suggesting that these cells are able to recover from              ",{}]],"32":[["DNA damage caused by topoisomerase II blockage and thus have a more drug-resistant phenotype. The expression of anti-apoptotic Bcl-2 protein family me",{}]],"33":[["mbers is also influenced by the mutational status of ",{}],["Flt3",{"fg":1,"bold":true}],[" [14]. We have recently shown that a duplication of Y591 in ",{}],["Flt3",{"fg":1,"bold":true}],["-IT                          ",{}]],"34":[["Ds is associated with elevated Bcl-2 protein and hyper-phosphorylated wild type (wt) p53 in ",{}],["AML",{"fg":1,"bold":true}],[", proposing a mechanism for inactivation o             ",{}]],"35":[["f p53 [14].                                                                                                                                           ",{}]],"36":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Mcl-1 is an anti-apoptotic member of the Bcl-2 family of proteins. High levels of Mcl-1 have been detected in ce                    ",{}]],"37":[["lls from patients with relapsed ",{}],["AML",{"fg":1,"bold":true}],[" [15]. Therapeutic targeting of Bcl-2 family proteins seems to depend on Mcl-1 to trigger apoptosis [1             ",{}]],"38":[["6]. It may therefore be of particular interest to examine the Mcl-1 modulation in DNA damage therapy.                                                 ",{}]],"39":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["In contrast to solid tumors, more than 90% of the ",{}],["AML",{"fg":1,"bold":true}],[" cases comprise wild type p53 [17,18]. On the                                  ",{}]],"40":[["other hand, the E3 ubiquitin ligase Hdm2 is usually strongly expressed in ",{}],["AML",{"fg":1,"bold":true}],[", contributing to block the growth inhibitory and pro-apopto             ",{}]],"41":[["tic effect of p53 [19]. IR induces DNA damage and rapid down regulation of Hdm2 through induction of auto-ubiquitination and subsequent proteasomal de",{}]],"42":[["gradation [20]. Recent reports indicate that Hdm2 have important p53-independent activities, including regulation of cell membrane receptors like insu",{}]],"43":[["lin-like growth factor (IGF) 1 receptor and β2-adrenergic receptor through ubiquitination [21]. However, it is not known whether the ",{}],["Flt3",{"fg":1,"bold":true}],["             ",{}]],"44":[[" receptor is regulated by Hdm2.                                                                                                                       ",{}]],"45":[["                                                                                                                                                      ",{}]],"46":[["GOODBYE! ... :-P",{"fg":1}],["                                                                                                                                      ",{}]],"47":[["                                                                                                                                                      ",{}]],"48":[["                                                                                                                                                      ",{"fg":0}]],"49":[["vstuart:$                                                                                                                                             ",{"fg":0}]]},"cursor":{"x":10}}],[1.911074,{"lines":{"49":[["vstuart:$ e                                                                                                                                           ",{"fg":0}]]},"cursor":{"x":11}}],[0.232092,{"lines":{"49":[["vstuart:$ ex                                                                                                                                          ",{"fg":0}]]},"cursor":{"x":12}}],[0.303899,{"lines":{"49":[["vstuart:$ exi                                                                                                                                         ",{"fg":0}]]},"cursor":{"x":13}}],[0.15201,{"lines":{"49":[["vstuart:$ exit                                                                                                                                        ",{"fg":0}]]},"cursor":{"x":14}}],[0.207976,{"lines":{"0":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Acute myeloid leukemia (",{}],["AML",{"fg":1,"bold":true}],[") cells are characterized by non-mutated ",{}],["TP53",{"fg":1,"bold":true}],[", high levels                                               ",{}]],"1":[["of Hdm2, and frequent mutation of the ",{}],["Flt3",{"fg":1,"bold":true}],[" receptor tyrosine kinase. The juxtamembrane mutation of ",{}],["FLT3",{"fg":1,"bold":true}],[" is the strongest ind                          ",{}]],"2":[["ependent marker for disease relapse and is associated with elevated Bcl-2 protein and p53 hyper-phosphorylation in ",{}],["AML",{"fg":1,"bold":true}],[". DNA damage forms              ",{}]],"3":[["the basic mechanism of cancer cell eradication in current therapy of ",{}],["AML",{"fg":1,"bold":true}],[".                                                                             ",{}]],"4":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Hdm2 and pro-apoptotic Bcl-2 members are among the most intensely induced genes immediately after chemotherapy a                    ",{}]],"5":[["nd Hdm2 is proposed a role in receptor tyrosine kinase regulation. Thus we examined the DNA damage related modulation of these proteins in relation to",{}]],"6":[[" ",{}],["FLT3",{"fg":1,"bold":true}],[" mutational status and induction of apoptosis.                                                                                                   ",{}]],"7":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Within one hour after exposure to ionizing radiation (IR), the ",{}],["AML",{"fg":1,"bold":true}],[" cells (NB4, MV4-11, HL-60, prima                                 ",{}]],"8":[["ry ",{}],["AML",{"fg":1,"bold":true}],[" cells) showed an increase in ",{}],["Flt3",{"fg":1,"bold":true}],[" protein independent of mRNA levels, while the Hdm2 protein decreased. The ",{}],["                                   ",{"fg":1,"bold":true}]],"9":[["FLT3",{"fg":1,"bold":true}],[" mutant MV4-11 cells were resistant to IR accompanied by presence of both Mcl-1 and Hdm2 protein three hours after IR. In contrast, the           ",{}]],"10":[["FLT3",{"fg":1,"bold":true}],[" wild type NB4 cells responded to IR with apoptosis and pre-apoptotic Mcl-1 down regulation. ",{}],["Daunorubicin",{"fg":1,"bold":true}],[" (DNR) induced contin                    ",{}]],"11":[["uing down regulation of Hdm2 and Mcl-1 in both cell lines followed by apoptosis.                                                                      ",{}]],"12":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Both IR and DNR treatment resulted in concerted protein modulations of Mcl-1, Hdm2 and ",{}],["Flt3",{"fg":1,"bold":true}],[". Cell d                                 ",{}]],"13":[["eath induction was associated with persistent attenuation of Mcl-1 and Hdm2. These observations suggest that defining the pathway(s) modulating       ",{}]],"14":[["Flt3",{"fg":1,"bold":true}],[", Hdm2 and Mcl-1 may propose new strategies to optimize therapy for the relapse prone ",{}],["FLT3",{"fg":1,"bold":true}],[" mutated ",{}],["AML",{"fg":1,"bold":true}],[" patients.                                  ",{}]],"15":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Anthracycline",{"fg":1,"bold":true}],["s like ",{}],["daunorubicin",{"fg":1,"bold":true}],[" (DNR) are used in the induction treatment of acute my                                              ",{}]],"16":[["eloid leukemia (",{}],["AML",{"fg":1,"bold":true}],["), obtaining short time complete hematological remission for more than 65% of adult ",{}],["AML",{"fg":1,"bold":true}],[" patients with de                           ",{}]],"17":[["novo ",{}],["AML",{"fg":1,"bold":true}],[" [1]. Successful hematological remission after only one induction cycle is a favorable prognostic parameter and is associated wit             ",{}]],"18":[["h decreased risk of later ",{}],["AML",{"fg":1,"bold":true}],[" relapse [1,2]. Induction therapy causes rapid activation of the tumor suppressor p53 followed by dominating             ",{}]],"19":[[" p53-targeted gene expression in vivo [3]. A major mechanism for this p53 induction is DNA damage through ",{}],["anthracycline",{"fg":1,"bold":true}],["-stabilization of              ",{}]],"20":[["the DNA:topoisomerase II complex [4], but cell death induction by ",{}],["anthracycline",{"fg":1,"bold":true}],["s may also involve other molecular targets independent of              ",{}]],"21":[["p53 [4-7].                                                                                                                                            ",{}]],"22":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Ionizing radiation (IR) is frequently used in the treatment of solid cancers, in the conditional treatment befor                    ",{}]],"23":[["e allotransplantation of ",{}],["leukemia ",{"fg":1,"bold":true}],["patients and in radioisotope-conjugated therapeutic antibodies directed against ",{}],["AML",{"fg":1,"bold":true}],[" cells                           ",{}]],"24":[["[8,9]. IR and ",{}],["anthracycline",{"fg":1,"bold":true}],["s induce growth arrest and cell death through DNA-damage, but also involve cell membrane-related effects in re             ",{}]],"25":[["gulation of apoptosis [4-7,10]. We have previously reported that ",{}],["AML",{"fg":1,"bold":true}],[" patient cells respond with varying sensitivity to IR-induced prolife             ",{}]],"26":[["ration arrest [11], and it may therefore be of interest to determine molecular mechanisms for radioresistance in more detail.                         ",{}]],"27":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["The strongest molecular predictor for ",{}],["AML",{"fg":1,"bold":true}],[" relapse is internal tandem duplications in the juxtamembr                                 ",{}]],"28":[["ane domain of the receptor tyrosine kinase ",{}],["Flt3",{"fg":1,"bold":true}],[" (",{}],["Flt3",{"fg":1,"bold":true}],["-ITD). These mutations are present in approximately one third of the pa                          ",{}]],"29":[["tients [12]. ",{}],["Flt3",{"fg":1,"bold":true}],["-ITD are associated with increased DNA repair [13], an observation suggesting that these cells are able to recover from              ",{}]],"30":[["DNA damage caused by topoisomerase II blockage and thus have a more drug-resistant phenotype. The expression of anti-apoptotic Bcl-2 protein family me",{}]],"31":[["mbers is also influenced by the mutational status of ",{}],["Flt3",{"fg":1,"bold":true}],[" [14]. We have recently shown that a duplication of Y591 in ",{}],["Flt3",{"fg":1,"bold":true}],["-IT                          ",{}]],"32":[["Ds is associated with elevated Bcl-2 protein and hyper-phosphorylated wild type (wt) p53 in ",{}],["AML",{"fg":1,"bold":true}],[", proposing a mechanism for inactivation o             ",{}]],"33":[["f p53 [14].                                                                                                                                           ",{}]],"34":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["Mcl-1 is an anti-apoptotic member of the Bcl-2 family of proteins. High levels of Mcl-1 have been detected in ce                    ",{}]],"35":[["lls from patients with relapsed ",{}],["AML",{"fg":1,"bold":true}],[" [15]. Therapeutic targeting of Bcl-2 family proteins seems to depend on Mcl-1 to trigger apoptosis [1             ",{}]],"36":[["6]. It may therefore be of particular interest to examine the Mcl-1 modulation in DNA damage therapy.                                                 ",{}]],"37":[["AML_PMCID_1876473",{"fg":5}],[":",{"fg":6}],["In contrast to solid tumors, more than 90% of the ",{}],["AML",{"fg":1,"bold":true}],[" cases comprise wild type p53 [17,18]. On the                                  ",{}]],"38":[["other hand, the E3 ubiquitin ligase Hdm2 is usually strongly expressed in ",{}],["AML",{"fg":1,"bold":true}],[", contributing to block the growth inhibitory and pro-apopto             ",{}]],"39":[["tic effect of p53 [19]. IR induces DNA damage and rapid down regulation of Hdm2 through induction of auto-ubiquitination and subsequent proteasomal de",{}]],"40":[["gradation [20]. Recent reports indicate that Hdm2 have important p53-independent activities, including regulation of cell membrane receptors like insu",{}]],"41":[["lin-like growth factor (IGF) 1 receptor and β2-adrenergic receptor through ubiquitination [21]. However, it is not known whether the ",{}],["Flt3",{"fg":1,"bold":true}],["             ",{}]],"42":[[" receptor is regulated by Hdm2.                                                                                                                       ",{}]],"43":[["                                                                                                                                                      ",{}]],"44":[["GOODBYE! ... :-P",{"fg":1}],["                                                                                                                                      ",{}]],"46":[["                                                                                                                                                      ",{"fg":0}]],"47":[["vstuart:$ exit                                                                                                                                        ",{"fg":0}]],"48":[["exit                                                                                                                                                  ",{"fg":0}]],"49":[["                                                                                                                                                      ",{"fg":0}]]},"cursor":{"x":0}}]]